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Abstract 
Abstract 
For a cell to exert a specialized function certain genes have to be expressed, 
others repressed. Transcription factors, regulating this expression, do not function 
alone, but are often part of multi-protein complexes. Regulating a single gene with 
more than one transcription factor is an efficient way to integrate responses to a 
variety of signals using a limited number of proteins. DNA binding proteins often 
interact with each other and with non-DNA binding proteins in a specific 
arrangement. The assembly of these complexes is often highly cooperative and 
promotes high levels of transcriptional synergy. 
The center of my thesis is the family of POU transcription factors. 
Specifically, I elaborate the interaction within the POU protein family, with members 
of other transcription factor families and with cofactors. In all cases, the assembly of 
the correct array of polypeptides on the DNA requires specific protein-protein and 
protein-DNA interactions. 
As an example of POU factors interacting with each other and with a cofactor 
I investigated the properties of a protein-DNA complex with the B-cell-specific 
cofactor OBF! and the Octl dimer. Depending on the DNA sequence they bind to, 
Octl dimers are arranged in configurations that are either accessible (PORE 
sequence) or inaccessible (MORE sequence) to OBF!. In Chapter 3 I show that the 
expression of Osteopontin, which contains a PORE sequence in its enhancer region, 
depends on the presence of OBFI in B-cells. OBFI alleviates DNA sequence 
requirements of the Octl dimer on PORE-related sequences in vitro. Furthermore, 
OBFI enhances POU dimer-DNA interactions and overrides Oct! interface 
mutations, which abolish PORE-mediated dimerization without OBFl. Based on the 
biochemical data, I propose a novel Oct! dimer arrangement when OBF 1 is bound. 
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As an example of Oct factors interacting with members of another 
transcription factor family I studied the interactions of Sox2 with Octl and Oct4, 
respectively. POU and Sox transcription factors exemplify partnerships established 
between various transcriptional regulators during early embryonic development. The 
combination of Oct4 and Sox2 on DNA is considered to direct the establishment of 
the first three lineages in the mammalian embryo. 
Although functional cooperativity between key regulator proteins is pivotal 
for milestone decisions in mammalian development, little is known about the 
underlying molecular mechanisms. The data in Chapter 4 validate experimental high-
resolution structure determination, followed by model building. The study shows that 
Oct4 and Sox2 are able to dimerize on DNA in distinct conformational arrangements. 
The binding site characteristics of their target genes are responsible for the correct 
spatial alignment of the Velcro-like interaction domains on their surface. 
Interestingly, these surfaces frequently have redundant functions and are instrumental 
in recruiting various interacting protein partners. 
In Chapter 5 I investigated how Sox2 and Oct4 regulate transcription of a 
target gene. The first intron of Osteopontin contains a Sox-binding site and a unique 
PORE to which Oct4 can either bind as a monomer or a dimer. The study reveals that 
Sox2-specific repression depends on an upstream Sox site and an intact PORE, 
although neither the Sox nor the PORE sites are negative elements on their own. A 
mechanism is being proposed how Sox2 represses Oct4-mediated activation of 
Osteopontin. 
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1.1 Transcription factors 
For a cell to exert a specialized function certain genes have to be expressed, 
others repressed. The expression of genes is primarily regulated at the level of 
transcriptional initiation of mRNA synthesis. Thus, transcription factors that control 
cell- or tissue specific transcription are important developmental regulators. In 
general, these are sequence-specific DNA-binding proteins whose recognition sites 
are present in promoters and enhancers. Although there is significant variation in the 
structures of transcription factors, they all share one property: they have various 
functional domains or regions, one of which is a DNA-binding domain that 
recognizes a specific DNA sequence within the enhancer or promoter and binds to it. 
Various different structural motifs that mediate sequence-specific contacts with DNA 
were revealed by structural studies and sequence comparisons. In most cases, the 
DNA-binding motif is a distinct structural domain that has been conserved through 
evolution among a wide range of species, as far as from prokaryotes to mammals. 
Transcription factors are grouped into families according to DNA-binding motifs such 
as zinc-fingers, leucine zippers, helix-tum-helix motifs, and helix-loop-helix motifs, 
to provide just some examples (Pabo and Sauer, 1992). Variations within these 
structural motifs provide an additional way to recognize different sequences, thus 
creating functional specificity. 
Regions other than the DNA binding domain of the protein are often not well 
conserved among members of a transcription factor family. These domains are 
located amino (N)- or carboxy (C)-terminal of the DNA binding domain and may be 
involved in oligomerization, interaction with other proteins, transcriptional activation 
or repression, ligand binding, and response to intracellular signals. Deletion 
experiments and studies with chimeric proteins have indicated that the functional 
4 
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domains typically operate independently, implying that transcription factors are 
modular in structure (Frankel and Kim, 1991). One known exception from this rule is 
the reported interaction between the DNA-binding POU domain and the C-terminal 
transactivation domain of Oct4 (Brehm et al., 1997) 
Transcription factors do not function alone, but rather in concert with other 
proteins. Regulating a single gene with a combination of more than one protein is an 
efficient way to integrate responses to a variety of signals using a limited number of 
transcription factors resulting in either repression or activation of transcription. The 
permutations of protein arrangements based on the DNA sequence facilitate the 
establishment of complex regulatory networks, as they indeed exist in higher 
eukaryotes. Transcription factors bind DNA and often interact with each other in a 
specific arrangement. The assembly of these complexes is often highly cooperative 
and promotes high levels of transcriptional synergy (Carey, 1998). One example of a 
well-studied gene that is activated by an array of transcription factors is the human 
interferon-~ (IFN-~) gene (Maniatis et al., 1998). Upon viral infection IFN-~ is 
activated by an enhanceosome consisting of three transcription activator complexes 
(including NF-KB, ATF-2/c-Jun heterodimer, interferon regulatory factors IFR-3 and 
IFR-7 and further transcription factors) and the architectural protein HMO I(Y) (see 
section 1.3). An enhanceosome is a higher-order nucleoprotein complex whose 
specific array of transcription factors is required for efficient recruitment of the 
transcription machinery to the promoter. Thus, the relative rotational positions of the 
binding sites with respect to each other are crucial for enhancer activity. 
In the work presented in this thesis I have studied the interaction of 
transcription factors with other members of the same or different families or with a 
transcriptional cofactor. Cofactors often do not recognize DNA elements directly, but 
5 
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are tethered by interacting specifically with other transcription factors. In all cases 
that I will describe, the assembly of the correct array of polypeptides on the DNA 
requires specific protein-protein and protein-DNA interactions. 
1.2 Oct factors 
Oct factors are a subfamily of the POU transcription factors. The term POU 
was derived from the names of the first 4 factors shown to have a particular region of 
similarity, Pit1 (a pituitary-specific transcription factor), Oct1 (a ubiquitously 
expressed octamer binding protein first shown to regulate immunoglobulin gene 
transcription), Oct2 (another octamer binding factor expressed in lymphoid cells) and 
unc-86 (a C. elegans protein) (Clerc et al., 1988; Finney et al., 1988; Herr et al., 
1988; Ingraham et al., 1988; Sturm et al., 1988). The Oct factors were named after the 
8bp DNA element they bind to. This so called octamer motif (A TOCAAAT) was first 
found to regulate the expression of immunoglobulin genes (Falkner and Zachau, 
1984; Parslow et al., 1984). 
POU factors consist of a DNA binding domain called the POU domain 
flanked by two transactivation domains (Herr et al., 1988). The POU domain is 
subdivided into two modular DNA binding subdomains. An unstructured linker 
region, variable in sequence and length (15-56 amino acids), connects both 
subdomains (Herr and Cleary, 1995). The C-terminal part of the POU domain consists 
of a homeodomain, called the POU homeodomain (POUH), containing the three usual 
a-helices. The N-terminal domain is unique to the POU proteins and together with 
POUH is required for DNA binding. A significant sequence homology with other 
proteins could not be found so it was called POU specific domain (POUs). It consists 
of four a-helices connected by short loops (figure 1.1). Structural comparisons 
6 
Figure 1.1 
Sequence alignment ofPOU domains from different transcription factors. 
The seven a-helices within the POU domain are indicated. Amino acid residues 
conserved to Octl are indicated by dots. Residues involved in DNA interaction of the 
monomer are highlighted in green (Klemm et al., 1994), those interacting with OBFl 
in orange (Chasman et al., 1999). Amino acids involved in POUS-POUH interface 
formation in the OctllMORE and OctllPORE dimers are highlighted red and blue, 
respectively (Remenyi et al., 2001). Serine/threonine residue 107, which is an in vitro 
and in vivo phosphorylation site (Roberts et al., 1991: Segil et al., 1991; Kapiloff et 
al., 1991) is marked by a yellow star. 
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revealed a high similarity to the prokaryotic bacteriophage lambda and the 434 
repressor, despite the lack of sequence homology (Assa-Munt et ai., 1993). POUs 
favors binding to an A TOC sequence and POUH recognizes (AlT)AAT resulting in 
the combined POU recognition sequence of ATOC(T/A)AAAT (Verrijzer et ai., 
1992). 
Members of the POU family are grouped into seven classes according to the 
amino acid sequence of their POU domains and conservation of the linker that 
separates the two subdomains (Ryan and Rosenfeld 1997). In contrast to the DNA 
binding domain, the composition and length of the activation domains differ 
considerably between various POU proteins, which may partly reflect different 
activation potential. 
Resolution of the crystal structure of the Oct! POU domain on the octamer 
site of the H2B promoter by Klemm et ai. (1994) showed that the second and third 
helices of both subdomains comprise a helix-turn-helix motif with a-helices 3 (DNA 
recognition helices) contacting specific bases in the major groove of the DNA (figure 
1.2A). This protein-DNA binding is supported by further amino acids that interact 
with phosphates of the DNA backbone via hydrogen bonds. Almost all residues in the 
recognition helix of Octl, which make contacts with DNA, are conserved between 
POU family members (figure 1.1). When binding the octamer motif, POUs and POUH 
lie on opposite sides of the double helix. There are no protein-protein contacts 
between the subdomains, but they contact overlapping DNA backbone phosphates. 
The POUs and POUH lie in the major groove of the DNA but the basic N-terminus of 
POUH is positioned in the minor groove and makes contacts with the DNA backbone 
(figure 1.2A). This indicates, that the linker transverses the DNA through the minor 
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Figure 1.2 
Illustration of Oct I crystal structures solved to date. 
(A) Overview of the POUI monomer bound to the octamer motif (Klemm et al., 
1994). Upper: numbered cylinders represent the respective a-helices of PO Us and 
POUH. The smaller case numbers represent the residues comprising the a-helices. The 
dotted line shows the estimated path of the flexible linker between the POU 
subdomains. The octamer motif (ATGCAAAT) is labeled on the DNA helix. Lower: 
POUH (red), POUs (yellow) and the DNA (blue) are illustrated by ribbons. The 
phosphorylation site serine 107 is pointed out (see section 1.5.4) 
(B) Ternary complex consisting of the OBFI peptide (purple), Octl POU domain 
(POUH = red, POUs = yellow), and DNA containing the octamer sequence (Chasman 
et al., 1999). The OBFl peptide traverses the major groove at the A-T base pair at 
position 5 (green) of the octamer site. At the C-terminus the OBF I peptide forms a 
short a-helix and makes extensive contacts with POUs, at the N-terminus it contacts 
POUH. 
(e) POUI dimerizes on the PORE and the MORE in two distinct configurations 
(Remenyi et al., 2001). The subdomains allocated to the same POUI molecule are 
depicted in the same color. Nand C designate the N- and C-terminus of each POU 
molecule, respectively. The dotted line shows the estimated path of the flexible linker 
between the POU subdomains. 
Lower panel: Close-up of the POUS-POUH interfaces. On the MORE, 1159 from the 
C-terminal part of POUH interacts with a hydrophobic pocket consisting of residues 
from POUs. The C-terminal helix of the POUH is depicted in green; the POUs is 
shown as a surface representation in purple with the hydrophobic residues in yellow. 
On the PORE the N-terminal nonhelical part of POUH is located in the minor groove 
of the PORE element. One DNA phosphate group forms H bonds with Arg20 (POUs) 
and Serl07 (POUH). POUs is colored purple; POUH green. The DNA molecule is 
shown as a gray surface representation. The image is inverted in comparison to the 
illustration above it. 
(A, Band C reproduced fromKlemm et al. (1994); Chasman et al. (1999) and 
Remenyi et al. (2001), respectively) 
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groove although it is not detectable in the electron density map of the crystal, 
revealing that it is distorted in the crystal and not rigid as the subdomains. 
Both subdomains are able to bind the octamer motif independently, in the 
absence of the linker (Klemm and Pabo, 1996). Despite the lack of intra-molecular 
contacts between POUs and POUH in the DNA complex, the domains influence each 
other's DNA-binding specificities (Aurora and Herr 1992; Verrijzer et ai., 1992). The 
cooperative binding of the two domains could result from binding-induced changes in 
the DNA structure (Klemm et ai., 1994; Klemm and Pabo, 1996). The main purpose 
of the linker might be to increase the binding affinity since binding of one domain to 
its subsite tethers the other, thereby facilitating binding or rebinding to the adjacent 
site. Moreover, the various linker lengths might allow the POUs and POUH domains 
to adopt various relative positions and orientations on the DNA and therefore playa 
key role in the flexibility exhibited in the DNA recognition (Herr and Cleary, 1995). 
This would give Oct factors a versatility of binding a range of different DNA site 
arrangements (varying in spacing between and orientation of the half-sites) and 
cofactors. 
The versatility of DNA binding is also influenced by phosphorylation and 
interaction on DNA as homo- and heterodimers as will be outlined in section 1.5 of 
the introduction. 
1.2.10ett 
Most biochemical studies have been performed with Oct 1 serving as a model for the 
other Oct factors (see sections 1.2, 1.5.1 and 1.5.4). Oct! is ubiquitously expressed 
and regulates transcription of small nuclear RNA genes (snRNA) and the histone H2B 
13 
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gene, which also are ubiquitously expressed genes (LaBella et al., 1988; Segil et al., 
1991; Yang et al., 1991; Hinkley and Perry, 1992; Mittal et al., 1996). 
In other cases, Oct! needs to recruit cofactors to upregulate transcription. Octl 
and VP 16, for example, activate expression of the herpes simplex virus (HSV) 
immediate early (HSV IE) genes (Cleary et ai., 1993). After viral infection of a cell, 
VP16 recruits Octl to the immediate early genes of the virus. Deletion analyses 
showed that the VP 16 transactivation domain is sufficient for VP 16 dependent 
promoter activation (Sadowski et al., 1988; Cleary et al., 1993). To support sequence 
specific IE gene activation by its own activation domain VP16 requires the Oct! POU 
domain (Wu et al., 1994). The regulatory regions of HSV IE genes contain a POUH 
(TAAT) and a 3' POUs binding site (GARAT; R= purine: A or G). In this case POUs 
would bind to the GARA T sequence together with VP 16 (Cleary et al., 1995). With 
the strong VP16 transactivator the herpes simplex virus has acquired an adaptor 
protein to boost the activity of OctI. This interplay gives insights into transcription 
factor-cofactor interaction. 
By interacting with cell specific transcription factors or cofactors, Oct! can 
also activate genes whose expression is restricted to specific cell types. Together with 
OBF 1, a lymphoid specific cofactor, which I will cover in greater detail in section 1.4 
of the introduction and Chapter 3, Octl can upregulate lymphoid-specific genes 
(figure 1.3). 
1.2.2 Det2 
In contrast to Oct!, the expression of Oct2 is restricted to only a few organs 
and cell types. It was first found in the lymphoid system (B- and T -cells) (Staudt et 
al., 1986) and later detected in the nervous system, including the developing neural 
14 
Figure 1.3 
Interaction of transcription factors and cofactors 
Chart illustrating interaction of different transcription factors and cofactors discussed 
in this thesis. Their target elements and target genes are also listed. E.g. the Oct! 
dimer interacts with OBF 1 on the PORE element to activate osteopontin and possibly 
with an unknown factor on the MORE to activate genes encoding heavy chains of 
immunoglobulins. 
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Primary transcription factor Octl dimer 
interacts with 
on DNA element 
to activate VH Ig heavy chain genes 
eg BeLl, LR35, B9c 
Primary transcription factor 
interacts with 
on DNA element 
to regulate 
Primary transcription factor 
interacts with 
on DNA element 
to activate 
activate: 
osteopontin 
? (osteopontin, see Chapter 3) 
activate: FGF4, lITFI 
repress: osteopontin (PORE) 
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tube and the adult brain, the kidney, the intestine, and testis (Hatzopoulos et al., 1990; 
He et al., 1989). Oct2 expression and function has been studied in great detail during 
B-cell differentiation. 
The early stages of B-cell differentiation are antigen-independent. They 
include the three sequential stages: pro-B, pre-B and immature B-cells (Rolink and 
Melchers, 1991). In the adult mouse these cells are generated in the bone marrow 
from where the immature B-cells migrate to the lymph nodes and spleen, where they 
further differentiate and become mature B-cells upon antigen stimulation (Melchers et 
al., 1995). The differentiation from pro-B to mature B-cells requires DNA 
rearrangements and specific gene expression profiles. Thus, the various stages of B-
cell development are characterized by the rearrangement status of Ig genes as well as 
the expression of distinct combinations of intracellular or cell-surface markers. 
Oct2 is expressed at low levels in pro- and pre-B-cells and at higher levels in 
more mature B-cells (Staudt et al., 1988; Miller et al., 1991; Corcoran et al., 1993). In 
pre-B-cells Oct2 expression can be further enhanced by treatment of the cells with 
e.g. bacterial lipopolysaccharide LPS, a po1yclonal B-cell mitogen (Staudt et ai., 
1986; Staudt et al., 1988). 
The function of Oct2 was assessed by gene ablation experiments. Oct2 
deficient mice die at birth (Corcoran et al., 1993). The reason is yet unknown but 
possibly related to a pivotal role ofOct2 in the nervous system (Schubart et al., 2001). 
Since the focus of Oct2 research lies in the lymphoid system the effect of the ablation 
there was analyzed in greater detail. It was found that fetal pre-B-cells did not seem to 
be compromised by the lack of Oct2 (Corcoran et al., 1993). Grafting fetal Oct2 _1_ 
liver to wild-type irradiated mice circumvented the problem of the early death of the 
animals when analyzing the function of Oct2 in later stages of B-cells in postnatal 
17 
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mice (Schubart et al., 2001). The cells exhibit defects in events that commonly occur 
after B-cell activation, making unique functions for Oct2 in late-stage cells evident. 
For instance, Oct2 -/- mice have significantly reduced serum Ig levels due to reduced 
B-cell proliferation upon antigen or LPS activation (Corcoran et at., 1993). This study 
showed that Oct2 is required for antigen dependent differentiation and proliferation of 
B-cells. Furthermore, several target genes, have been identified, e.g. CD36, which is 
activated by Oct2 in B-cells and the tyrosine hydroxylase gene, which is repressed by 
Oct2 in neuronal cells (Konig et at., 1995; Dawson et al., 1994). Oct2 also inhibits 
expression of the herpes simplex virus immediate-early genes, which contain the 
octamer-related TAA TGARA T motif in their promoters (Lillycrop et al., 1991; see 
Oct! section 1.2.1). 
1.2.30ct4 
Oct4 is an important factor in early mammalian development. In order to 
understand its significance I will briefly outline early mammalian development 
(Gilbert, 2003; figure 1.4). After fertilization the zygote undergoes several successive 
cleavages. At the 8-cell stage the embryo undergoes compaction where the cells 
huddle together, maximizing their contact with one another. These cells divide to 
become the 16-cell morula. The external cells will later become the trophoblast cells, 
which are not part of the embryo proper, but will give rise to the chorion, the 
embryonic portion of the placenta. The chorion will enable the connection of the fetus 
with the uterine wall of the mother. The internal compartment of the compacted 
morula will become the inner cell mass (lCM), which will give rise to the embryo 
proper and the yolk sac. During cavitation the trophoblast cells secrete fluid into the 
morula to create a blastocoel. The resulting structure is called the blastocyst. Now, the 
ICM is located on one side of the ball of trophoblast cells. The ICM further 
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Figure 1.4 
Schematic diagram showing the derivation of tissues in mammalian embryos (after 
Gilbert, 2003). Stages at which Oct4 is expressed are written in capital, those at which 
Sox2 is expressed (see section1.5.2.1) are underlined. (Sox2 is only seen in some cells 
of the morula, but Oct4 in all cells. Furthermore only the inner cells of the blastocyst 
express the two transcription factors.) 
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differentiates into the hypoblast (primitive endoderm) and epiblast (primitive 
ectoderm). The hypoblast will contribute to the yolk sac and the epiblast will give rise 
to the embryo proper and the amnionic ectoderm. The cells of the epiblast that give 
rise to the embryo proper are called embryonic epiblast. During gastrulation these 
differentiate into embryonic ectoderm, mesoderm and endoderm. The embryonic 
ectoderm generates the outer layer of the embryo. It produces the outer layer 
(epidermis) of the skin and of the nerves. The embryonic endoderm becomes the 
innermost layer of the embryo and produces the digestive tube and associated organs 
including the lungs. The embryonic mesoderm is between the other two layers and 
generates blood, heart, kidney, gonads, bones, and connective tissue. The germ cells 
originate in the epiblast of the gastrulating embryo, within the extraembryonic 
mesoderm. From here the germ cells migrate through the hindgut to the genital ridge. 
Oct4 is expressed specifically in the germline, i.e. in pluripotent cells of the 
pre gastrulation embryo (ICM and then epiblast) and in germ cells. (Scholer et al., 
1989a; 1990; Pesce et al., 1998). More specifically, Oct4 is expressed in all cells from 
the zygote to the morula, becomes restricted to the cells forming the ICM, and is 
downregulated in the trophectoderm and the hypoblast. It is maintained in the epiblast 
and is downregulated at gastrulation in an anterior-posterior pattern excluding the 
primordial germ cells (POCs). Subsequently, Oct4 is maintained in the germ cells 
until the initiation of sexual differentiation of the gametes and meiosis (in the female 
at l3-14 days post-coitum (dpc) and at the beginning of spermatogenesis in the 
newborn males). After birth Oct4 is re-expressed in the arrested oocytes. In addition, 
Oct4 is expressed in cell lines derived from embryos and fetuses, i.e. embryonic stem 
(ES), embryonic carcinoma (EC) and embryonic germ (EO) cells. As these cell lines 
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correspond to different stages of the germline, they have turned out to be powerful 
tools to address molecular biological and biochemical questions (Yeom et al., 1996). 
The presence of Oct4 is associated with a pluripotent cell fate (Scholer et al., 
1989a; Yeom et al., 1996). Cells in which Oct4 is downregulated differentiate along 
specific lineages to form embryonic and extraembryonic somatic tissue. Gene ablation 
experiments have shown that ES cells heterozygous for Oct4 show a 30-40% 
reduction of this protein and maintain their stem cell characteristics (Nichols et al., 
1998). Mice, derived from these ES cells and heterozygous for Oct4 appear normal 
and are fertile. The absence of Oct4, on the other hand causes early embryonic 
lethality because cells that should give rise to the ICM of the blastocyst acquire a 
trophectodermal fate. This indicates that Oct4 is necessary for the maintenance of the 
pluripotency of embryonic cells. It still has to be shown if Oct4 is required in germ 
cells. 
In contrast to its downregulation during the first differentiation processes, the 
Oct4 protein level transiently increases during the formation of the hypoblast before it 
is downregulated (Palmieri et al., 1994; Botquin et al., 1998). This expression profile 
had been taken as an indication that increased levels of Oct4 may be involved in the 
establishment of the hypoblast, a notion that has been further supported by 
experiments in which Oct4 had been inducibly expressed at various levels in ES cells 
(Niwa et al., 2000). According to this study ES cells require a certain level of Oct4 
protein to maintain their cellular identity as ES cells. An increase to more than 150% 
of normal expression levels in undifferentiated stem cells triggers differentiation into 
hypoblast and mesoderm, whereas a decrease to less than 50% triggers differentiation 
into trophectoderm. Overall, Oct4 is assumed to be involved in maintaining 
pluripotency by two ways of action: by the activation of genes involved in the 
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maintenance of an undifferentiated state and the repression of genes involved in the 
differentiation of somatic and extraembryonic cell lineages (Pesce and Scholer 2000). 
There are several known target genes of Oct4: FGF4, Osteopontin and UTFI 
(figure 1.3) (Yuan et al., 1995; Botquin et al., 1998; Nishimoto et al., 1999). 
FGF4 (fibroblast growth factor 4) is coexpressed with Oct4 in the early 
embryo, ES and EC cells. Later during development it is expressed in the developing 
limb and tooth but is transcriptionally silent in the adult (Schoorlemmer and Kruijer, 
1991; Niswander and Martin, 1992). FGF4 is thought to playa role in embryonic 
growth prior to gastrulation, induction of the neuroectoderm, neuronal differentiation 
and survival, and growth and patterning of the developing limb (Goldfarb 1996). 
FGF4 -1- embryos die at peri-implantation (Feldman et al., 1995). FGFs act by 
binding to transmembrane cell surface receptors (FGFr), which have intrinsic tyrosine 
kinase activities. 
Osteopontin (OPN), also termed Eta-l (early T-Iymphocyte activation 1) and 
originally provisionally called 2ar, is a secreted phosphorylated acidic glycoprotein. It 
is expressed in various tissues, including bone, kidney, cartilage, the placenta, in the 
inner ear, carcinomas, and is present in most body fluids (Denhardt et al., 1995). 
Furthermore, OPN is expressed in the immune system, e.g., in T -lymphocytes and 
activated pro-B-cells (Lin et al., 2000). Secreted OPN stimulates B-cells to produce 
immunoglobulins and, in conjunction with an unidentified 14kD peptide, to 
proliferate (Nabel et al., 1981 PNAS; Fresno et al., 1982 Cell). Moreover, B-
lymphocytes have been shown to playa role in new bone formation in which OPN is 
also involved (Marusic et al., 2000). One common theme that has emerged from 
several of these studies is that OPN is involved in cell migration and adhesion. 
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UTFI (undifferentiated embryonic cell transcription factor 1) is a 
transcriptional cofactor expressed in pluripotential cells, such as those of the inner cell 
mass (ICM), the epiblast, and in ES and EC cell lines (Okuda et aI., 1998). Upon 
differentiation of these cells UTF I is no longer expressed. Unlike Oct4 it is later re-
expressed in extraembryonic tissues. UTFI is rich in proline and basic amino acids, 
especially arginine. It contains two conserved domains, CD 1 and CD2 (Fukushima et 
al., 1998). CDI is involved in the interaction with TFIID of the basal transcription 
machinery and is located at the N-terminus of the protein. CD2 contains a leucine 
zipper motif through which the protein interacts with the metal binding motif of 
A TF2, which is a leucine zipper transcription factor involved in cellular stress 
response. UTF 1 is thought to act downstream of Oct4 in the regulatory cascade 
(Okuda et al., 1998). 
1.3 HMG proteins 
The HMO (high mobility group) superfamily can be divided into two large 
subfamilies: (i) the classical HMOIUBF family, whose members bind DNA non-
specifically; and (ii) the SoxlMA T AlTCF family which bind in a sequence specific 
manner (Laudet et al., 1993). Members of both subfamilies are found in all metazoan 
species, and play key roles in embryonic development including germ layer 
formation, cell type specification, and organogenesis. Proteins of the classical HMO 
subfamily generally contain more than one HMO DNA binding domain and are 
ubiquitously expressed throughout embryogenesis. Since they bind DNA non-
specifically, recognizing unusual DNA structures, such as four-way junctions and 
kinks, and bend the DNA upon binding, their role in transcriptional regulation was 
proposed to be primarily architectural (Orosschedl et al., 1994). 
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Members of the Sox family (reviewed in Wegner, 1999; Pevny and Lovell-
Badge, 1997) were originally grouped together on the basis of their high homology to 
the HMG domain of the testis-determining gene SRY (Gubbay et al., 1990; Denny et 
al., 1992). The similarity to Sry gave them their name .s.ry box (Sox) proteins. The 
mammalian Sox family consists of at least 30 genes and can be divided into 10 
subgroups based on the homology within and outside of the HMG domain (Bowles et 
al., 2000). 
The HMO domain contains about 80 amino acids and forms an L-shaped 
module composed of three a-helices (Weir et al., 1993; Chapter 4). Sox factors all 
recognize similar binding motifs, C(NT)TTG(NT)(NT) to which the HMG domain 
docks (Harley et al., 1992; Wegner, 1999). All HMO proteins bind on one side of the 
DNA compressing the major groove and widening the minor groove (Chapter 4; 
Ferrari et al., 1992; Connor et al., 1994; Love et al., 1995; Werner et al., 1995; 
Murphy et al., 1999). They induce a sharp bend of the double helix, which can 
enhance binding of unrelated transcription factors to neighboring DNA sites. The 
bending angle varies among the different HMG and Sox proteins (Weiss, 2001). 
Each Sox factor is expressed in a variety of cellular contexts and a given cell 
type can co-express a number of Sox factors; their expression is nonetheless restricted 
temporally and cell specifically. 
1.4 Cofactor OBFl interacts with Octl and Oct2 
Cofactors facilitate the interaction between the sequence-specific transcription 
factors and the general RNA polymerase II machinery. OBF1, also termed OcaB and 
Bob 1, is the most extensively studied cofactor of Oct factors (Luo et al., 1992; 
Gstaiger et al., 1995; Strubin et al., 1995). It has a modular structure that includes a 
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C-terminal transactivation domain and an N-terminal domain involved in contacting 
the POU domain (Gstaiger et al., 1996; Cepek et al., 1996). At the molecular level, 
the exact interaction between OBF 1 and the POU domain has been mapped to a short 
segment in the N-terminal part of OBFl, as directly evidenced by the structure of the 
monomeric Oct! in complex with the octamer motif and an N-terminal peptide of 
OBFl (figure 1.2B; Chasman et al., 1999). OBFI also contacts the DNA and requires 
an adenine at the fifth position of the octamer element (ATGCAAAT). 
OBFl is expressed in lymphoid cells and interacts specifically with Octl and 
Oct2 (Luo et al., 1992; Gstaiger et al., 1995; Luo and Roeder, 1995; Strubin et al., 
1995). The interplay of Oct! and Oct2 with OBF 1 is crucial for several aspects of the 
development and function of B-Iymphocytes (Kim et al., 1996; Nielsen et al., 1996; 
Schubart et al., 1996; Qin et al., 1998; Schubart et al., 2000). In the absence ofOBF1, 
the immune response is dramatically impaired and germinal centers (GCs) do not 
form. In agreement with this, it was found that expression of OBF I is upregulated in 
GC B-cells during the course of an immune response. Germinal centers usually form 
in the spleen and lymph nodes during the initiation of the acquired immune response 
(Delves and Roitt, 2000a, 2000b). They create a microenvironment where all 
necessary antigen-specific and innate antigen-presenting cells can interact. Within 
GCs hypermutation and class switching of immunoglobulins occur and memory B-
cells and plasma-cell precursors are generated. Furthermore, in the absence of OBF 1, 
B-cell development is impaired at the transition between bone marrow and peripheral 
organs (Kim et al., 1996; Nielsen et al., 1996; Schubart et al., 1996). 
Further investigation of Oct I and OBFl by Tomilin et al. (2000) proposed that 
the Oct I or Oct2 dimer is the primary target of OBF 1 by showing that the dimer-
mediated activation in cotransfection experiments is more enhanced by the cofactor 
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than the monomer-mediated activation. However, the interaction of OBFl with the 
Octl dimer is dependant on the conformation of the POU/DNA complex, as it can 
only bind to PORE-mediated dimers and not to those on MOREs. The PORE and the 
MORE are two different DNA elements on which Oct factors dimerize (see section 
1.5.1). The recently solved crystal structures of the POU domains of the Octl dimer 
bound to the MORE and PORE revealed the structural basis for this selectivity of 
OBFl (Remenyi et ai., 2001). The two POU dimers can adopt two different 
configurations, using different surface patches to dimerize on each element (section 
1.5.1). As a result, the same amino acids that are available to interact with OBF 1 in 
the PORE configuration (Chasm an et ai., 1999) form part of the POUS-POUH dimer 
interface on the MORE, precluding an interaction with OBFl (figures 1.1 and 1.2B) 
(Tomilin et ai., 2000, Remenyi et ai., 2001). 
Another reason for the impaired immune response, besides the lack of 
germinal center formation, in OBF1-/- mice is the deficiency of immunoglobulin 
production commonly known as antibodies. Immunoglobulins (lg) are glycoproteins 
consisting of 2 identical heavy chains and 2 identical light chains (Delves and Roitt, 
2000a). The light chains consist of 3 regions (V: variable, D: diversity and J: joining) 
and are divided into 2 types, K and A. Recently, OBFl was shown to be essential for 
transcription and VDJ recombination of a subset of IgK genes in vivo (Casellas et al., 
2002). 
The heavy chains (IgH) consist of 4 regions (V, 0 and J like the light chains 
and a constant region C) and are divided into 5 classes (lgG, IgA, IgM, IgO and IgE) 
depending on which constant region was recombined to the VOJ (figure 1.5; 
Arulampalam et al., 1997). All heavy chain mRNA transcripts are regulated by a 
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Figure 1.5 
Heavy and light chain genes recombine in pre-B-cells (after Delves and Roitt, 2000a). 
The recombination enables an efficient immune response upon infection of the very 
diverse pathogens. After recombination a specific mature B-cell only expresses one 
type of antibody. Clonal expansion of this B-cell upon infection ensures that the 
pathogen can be eliminated as soon as possible. 
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heavy chain (V H) promoter, which is located 5' of the V segment. Every V segment 
has its own specific VH promoter. The VH promoters become fully active when 
recombination brings them into proximity of an enhancer in the C gene segment. The 
V H promoter closest to the C enhancer is then active after VDJ recombination, which 
has to occur for specific antibodies to be expressed. 
V H promoters were reported to mediate interaction and synergism between 
Oct! (and Oct2) and OBFl via a DNA binding site called the heptamer-octamer motif 
(Luo et al., 1992). However, Tomilin et al. (2000) have shown on three examples of 
VH promoters that these heptamer/octamer sequences represent MORE variants (see 
section 1.5.1), which bind Oct1 (and Oct2) dimers in a configuration that does not 
permit OBF 1 binding. This apparent data conflict can be attributed to the deletion of 
the heptamer part in earlier studies thus disrupting the MOREs and thereby, allowing 
OBF 1 recruitment to the remaining octamer subsite (Luo et al., 1992; Luo and 
Roeder, 1995). Although this deletion allowed isolation and characterization of 
OBF1, the cofactor does not bind the intact VH promoters in vitro (Tomilin et al., 
2000), and appears not to activate Ig gene transcription via the octamer motif within 
the VH promoter. The finding that the heptamer/octamer motif is a MORE also 
provided an explanation for the observations that in the absence of OBFI Ig gene 
transcription is only marginally impaired (Kim et al., 1996; Nielsen et al., 1996; 
Schubart et al., 1996; Schubart et al., 2001). The gene ablation experiments did show 
though that OBF 1 exerts an effect on Ig heavy chain transcription after VDJ 
recombination via a 3' distal enhancer that contains sequences OBF 1 can get recruited 
to. The Ig locus rearrangement activates the 3' enhancer by bringing it into the 
proximity to the VH promoters. On another note, Oct1 stimulates the MORE-
containing VH promoters less effectively in non-lymphoid than in B-cells, 
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suggestingthe existence ofa lymphoid-specific cofactor other than OBFl, as proposed 
in earlier work (Kim et ai., 1996; Schubart et ai., 1996; Schubart et ai., 2001). This 
hypothetic cofactor should interact with Octl bound in the MORE configuration and 
playa role in Ig gene transcription. 
1.5 Factors affecting transcriptional activation of POU protein 
activity 
The 15 members of the POU family identified in mouse have a 
multifunctional capacity and are critical regulatory components of a broad range of 
biological processes (see section 1.2.1-3). Despite the small number of POU factors 
their regulatory potential is enormous due to inter-dependant control mechanisms 
such as postranslational modifications, flexible DNA sequence recognition, 
oligomerization, and interaction with transcriptional cofactors (Herr and Cleary, 1995 
and this thesis). Many of these properties are conferred by the evolutionary conserved 
bipartite DNA binding structure, the POU domain. 
1.5.1 Dimerization: Two DNA motif-induced protein conformations 
Oct proteins were initially identified to act as monomeric transcription factors, 
binding to the octamer sequence and related DNA motifs. Dimerization on certain 
DNA elements such as the heptamer/octamer motif have also been described, but 
structure-functional aspects have not been characterized to the same extent (reviewed 
in Herr and Cleary, 1995). More recently, DNA-mediated dimerization of POU 
factors and its impact on eukaryotic gene expression received substantial attention. 
(Jacobson et al., 1997; Botquin et al., 1998; Rhee et al., 1998; Scully et al., 2000; 
Tomilin et al., 2000; Remenyi et al., 2001) Pitl homodimers and POU heterodimers 
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with other transcription factors such as Sox2 had been identified earlier (Ingraham et 
al., 1990; Dailey et al., 1994). 
For Oct factors two types of DNA elements, the PORE (Palindromic Oct 
factor Recognition Element, ATTTGAAA[T/G]GCAAAT, 15bp) and the MORE 
(More PORE, AT[G/A][C/A]AT[N]o_3ATGCA[A/T], 12-15 bp) have been 
characterized (Botquin et al., 1998; Tomilin et al., 2000; Remenyi et al., 2001). 
The PORE was first identified as an Oct4 binding sequence in the first intron 
of the opn gene (Botquin et al., 1998). Homo- and heterodimers of various POU 
factors, including Octl, Oct2 and Oct4 can assemble on the PORE in vitro, and 
cotransfection experiments using a series of PORE mutations suggest that dimer 
formation also occurs in cells. However, it has not yet been proven if POU dimers 
indeed form in vivo and it is far from clear if POU homo- or heterodimers playa role 
during mammalian development. MOREs and related sequences (e.g., the 
Heptamer/Octamer motif) are found in immunoglobulin heavy chain promoters (see 
section 1.4; Tomilin et al., 2000). Oct family members can also bind cooperatively as 
homo- and heterodimers on the MORE in vitro. 
The quaternary arrangements of the four POU subdomains in a dimer, two 
POUs and two POUH, are different for the MORE and PORE type dimers. This was 
first shown by a series of biochemical experiments and ultimately determined by 
solution of X-ray structures of the dimeric OctllPORE and OctllMORE complexes 
(figure 1.2C; Remenyi et al., 2001). The POUs and POUH subdomains contain two 
different non-overlapping pairs of surface patches that are capable of forming 
unrelated dimerization interfaces, dictated by the DNA sequence. 
In the PORE configuration, the two main protein-protein interfaces formed in 
the complex are located across the semi-palindromic center of the PORE motif, thus 
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each protein extends across the longitudinal axis of the DNA molecule (see figure 
1.2C; Botquin et al., 1998; Remenyi et al., 2001). The N-terminus of POUH of one 
molecule interacts with residues of a-helices 1 and 2 of POUs of the other molecule. 
In the MORE configuration, on the other hand, the interface between the POUs and 
POUH domains is located within each half-site of the DNA element therefore each 
protein molecule is arranged along the longitudinal axis of the DNA (see figure 1.2C). 
The C-terminal residues (157-160) of POUH of one molecule dock onto a loop region 
between a-helices 3 and 4 of POUs of the other molecule. The Octl side chain of 
1159 (S 159 in Oct4) fits snuggly into a hydrophobic pocket consisting of residues of 
POUs. With these findings Remenyi et al. (2001) introduced the concept of interface 
swapping in dimers as a general mechanism of modulating the activity of 
transcription factors. 
1.5.2 Heterodimerization with Sox proteins 
Oct factors may heterodimerize with transcription factors not belonging to the 
POU family. In order for Sox proteins to exert their specificity, it has been proposed 
previously that they combine with different protein partners to direct gene expression 
required for a particular cell type. Indeed, interaction and/or cooperation between Sox 
factors and various POU factors have been observed, including Soxl0 with 
Tstl/Oct6/SCIP, Soxll and Sox4 with Bml, and Sox2 with Oct4 (Yuan et al., 1995; 
Botquin et al., 1998; Nishimoto et al., 1999; Kuhlbrodt et ai., 1998a,b). 
1.5.2.1 Sox2 
Sox2 is coexpressed with Oct4 in the ICM, the epiblast and germ cells. 
Consistent with this, Sox2 and Oct4 are also coexpressed in ES and EC cells (Botquin 
et al., 1998; Chapter 5). 
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Unlike Oct4, Sox2 is expressed in multipotent trophoblast cells and the 
chorion. Sox2 is downregulated in both the embryonic and the extraembryonic 
lineages as the cells differentiate and lose their multi potency (Avilion et al., 2003). 
Later, Sox2 is expressed in the developing nervous system (Collignon et al., 1996) 
and the lens (Kamachi et al., 1995). 
The expression of genes such as fibroblast growth factor 4 (FGF4) and 
undifferentiated embryonic cell transcription factor 1 (UTF1), which are coexpressed 
with Sox2 and Oct4, depends on enhancer elements that contain binding sites for 
these HMO and POU transcription factors (Yuan et al., 1995; Nishimoto et al., 1999; 
section 1.2.3). Sox2 not only acts as a transcriptional activator but it can also repress 
transcription in some contexts, as observed in the regulation of the OPN gene early in 
development (figure 1.3) (Botquin et al., 1998). 
Sox2 homozygous null embryos die soon after implantation, revealing that 
Sox2 is essential during embryogenesis (Avilion et al., 2003). Despite its importance 
in early developmental gene regulation, little is known about the transcriptional 
regulation of the Sox2 gene itself. Only recently Sox2 was found to be regulated by 
the Oct4/Sox2 heterodimer in undifferentiated ES and EC cells (Tomioka et al., 
2002). 
1.5.3 Extension of the network: Sox proteins interact with Pax proteins 
Members of the Sox protein family also interact with members of the Pax 
protein family. For example, Sox2 interaction with Pax6 (see below) is crucial for 
proper eye development in mammals. Pax proteins possess a 128 amino acid DNA 
binding domain, the 'paired domain' (PD) and a C-terminal transactivation domain 
(Stuart et al., 1994). Pax proteins are known to play critical roles in mammalian 
development and oncogenesis (Chi and Epstein, 2002). 
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The PD consists of two subdomains which both structurally resemble a 
helix-turn-helix (HTH) motif, similar to the HTH motif found in homeodomains (Xu 
et ai., 1995, 1999). The subdomains are connected by a flexible linker. Several Pax 
proteins, including Pax6, also contain an additional homeodomain (HD). Cooperative 
dimerization with the paired domain of the same molecule allows these 
homeodomains to recognize sequences not bound by other HDs (Jun and Desplan, 
1996; Underhill and Gros, 1997). 
Pax6 is expressed in the nose, pancreas, and coexpressed with Sox2 in the 
developing eye and the central nervous system (Walther and Gruss, 1991; Turque et 
ai., 1994; Kamachi et ai., 1995; Collignon et ai., 1996; Grindley et ai., 1997). Pax6 
and Sox2 bind cooperatively to the DCS DNA element to synergistically activate the 
expression of the b-crystallin gene (Kamachi et al., 2001; figure 1.3), which is 
essential for lens development during late embryogenesis. Formation of the ternary 
complex involves direct protein-protein interactions between the Pax6 paired domain 
and the HMG domain of Sox2 (Chapter 4). Exogenous Sox2 and Pax6 in the head 
ectoderm can induce ectopic lens placode development showing the significance of 
Pax6 and Sox2 for initiation of lens development. 
The additional identification of Pax3 as an interactive partner of Sox 10 
suggests that various Pax and Sox factors might work in combination to affect tissue-
specific gene expression (Bondurand et al., 2000; Lang and Epstein 2003). 
1.5.4 Phosphorylation 
One of the most frequently used ways to regulate the activity of transcription 
factors in response to different extra- and intracellular signals is phosphorylation and 
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dephosphorylation (Whitmarsh and Davis, 2000). This is also true for the POU family 
of transcription factors. For example, several members become hyperphosphorylated 
during the M-phase of the cell cycle (Roberts et ai., 1991; Segil et ai., 1991; CaeHes 
et ai., 1995). The purpose of this mitotic phosphorylation is likely to be the prevention 
of the POU protein from binding to DNA, thereby precluding transcription as the cells 
enter mitosis. Entry into the G 1 growth phase is accompanied by dephosphorylation 
and regain of DNA binding activity and transcription. One target for phosphorylation 
was identified within the POU homeodomain at serine 107 (Octl) or threonine 107 
(Pitl), which is located very close to the DNA when the protein is bound (figure 1.1 
and 1.2A). Phosphorylation of this residue leads to reduced DNA binding (Kapiloff et 
ai., 1991; Segil et ai., 1991; CaeHes et ai., 1995), probably because the negative 
charge in the phosphate is repulsed by the negative DNA backbone. 
Besides cell-cycle dependent phosphorylation of POU proteins, which seems 
to disrupt overall DNA binding, several observations suggested that specific target 
genes are regulated by POU phosphorylation upon cell signals. Pit 1 binding sites have 
been implicated in regulating prolactin and growth hormone promoter activity in 
response to agents activating signal transduction pathways such as cAMP, phorbol 
esters (TP A) and activin A. The latter three are known to activate specific protein 
kinases. Treatment of cells with either of these signaling agents activates specific 
cellular protein kinases leading to increased Pitl phosphorylation. This in turn was 
found to affect Pitl binding to particular sites (Kapiloff et ai., 1991; Struthers et ai., 
1992; Caelles et al., 1995). Kapiloff et al. (1991) particularly showed how 
phosphorylation differentially affects protein binding to DNA response elements 
depending on their nucleotide sequence. Thus, signal-induced phosphorylation of 
transcription factors may be a means of differentially regulating transcription of two 
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genes, which are under the influence of the same transcription factor. In vitro, Pitl 
can be phosphorylated by cAMP dependent protein kinase PKA and PKC. Analysis of 
the PKA phosphorylation sites showed that one site was identical to the mitotic 
phosphorylation site T 107 (Kapiloff et al., 1991; Segil et al., 1991; Roberts et al., 
1991). PKA, however, is not accountable for the M-phase phosphorylation because 
specific inhibition of PKA did not block Pitl phosphorylation by mitotic extracts 
(Caelles et al., 1995). The in vivo relevance of PKA in mediating Pitl activation still 
needs to be proven. 
1.6 Aim of this thesis 
It has been established that transcription factors often interact with each other 
but the exact modes of interaction and target genes mostly still remain to be 
investigated. 
The overall objective of this thesis is to elucidate how Oct transcription factors 
interact with other transcription factors or cofactors to regulate transcription. I chose 
two paradigmatic POU factors, Octl and Oct4, to discover novel target transcriptional 
functions, and assess how their activities are influenced by multi-level control 
mechanisms. More specifically the scope of the work was to investigate the 
interaction of Oct I with the B-ceU specific cofactor OBFl and the interaction ofOct4 
with Sox2. 
Based on the knowledge that OBF 1 specifically interacts with PORE-type 
Oct! dimers but not with those on the MORE (Tomilin et al., 2000; Remenyi et al., 
2001) the effect of OBFl binding on the PORE-type Oct! dimer was to be 
investigated further. To this end the effect of OBFl on Oct! dimer interface mutants 
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and DNA sequence requirements had to be studied. Furthermore, the biological 
relevance ofthis Octl-0BFl interaction was sought (Chapter3). 
Another focus was to study the way of Oct4 and Sox2 regulating various early 
embryonic stage specific enhancers: 
The following question arose from the knowledge that Oct4 and Sox2 activate 
FGF4 and UTFI expression (Yuan et ai., 1995; Nishimoto et ai., 1999): how do Sox2 
and Oct4 interact on these DNA binding elements and is the interaction similar or 
identical for the two enhancers? The solution of a crystal structure and the use of 
models would give a basis for biochemical experiments to address these issues 
(Chapter 4). 
Whereas Oct4 and Sox2 activate FGF4 and UTFI expression, Sox2 represses 
Oct4 activation of osteopontin (Botquin et ai., 1998). This calls to examine the 
mechanism of repression. Attending to this issue, the physical interference of Sox2 
with Oct4 mediated activity should be solved (Chapter 5). 
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2.1 Materials 
2.1.1 Chemicals 
Powder for bacterial media and agar was purchased from Fisher Scientific, 
USA (LB agar: BP-1425-2; LB broth: BP-1426-2) Cell culture media were obtained 
from Gibco-BRL and Sigma. All other organic and inorganic chemicals were 
obtained from Sigma unless specified otherwise. All protocols use ultrapure water 
(Millipore) . 
2.1.2 Radioactive isotopes 
(a_32P)dCTP (IOmCi/ml) was obtained from Amersham Bioscience, USA (# 
AA0075-250J,lCi) for labeling double-stranded (ds) oligonucleotides (section 2.3.8) 
for electrophoretic mobility shift assays (section 2.8). 
2.1.3 Enzymes 
Restriction enzymes, DNA polymerase I Klenow fragment, calf intestinal 
phosphatase (CIP), T4 DNA ligase, and T4 DNA polymerase were purchased from 
New England Biolabs. P/uTurbo® DNA polymerase was obtained from Stratagene. 
2.1.4 Synthetic oligonucleotides 
Oligonucleotides were synthesized by Invitrogen ™ Life Technologies and desalted. 
For the DNA-binding studies using double-stranded oligonucleotides, the 
complementary strands were synthesized such that upon hybridization a 4 base 
(CTGA) 5' overhang at each end occurred. The top strands of the double stranded 
oligonucleotides are indicated below. The PORE and MORE elements, Sox and Pax 
binding sites are written in capital letters, the octamer motif is underlined, the Sox 
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binding site is double underlined and mutations are written bold. Some of these 
sequences are already published in Botquin et al. (1998), Tomilin et al. (2000), 
Kamachi et al. (2001). 
Oligonucleotides used in mobility shift assays: 
Igle: 5' -ctgactcctgccttcagggtA TGCAAATtattaagtctcgag-3' 
PORE, DM: 5' -ctgaaagttaaaatcacATTTGAAA TGCAAA T ggaaaagcaag-3 ' 
PORED, Dm: 5' -ctgaaagttaaaatcacATTTGAAAGGCAAATggaaaagcaag-3' 
POREM , dM: 5' -ctgaaagttaaaatcacATGTGAAATGCAAATggaaaagcaag-3' 
PORE-A I C: 5' -ctgaaagttaaaatcacA TTTGAACTGCAAA Tggaaaagcaag-3' 
PORE-A5T: 5' -ctgaaagttaaaatcacATTTGAAA TGCTAA Tggaaaagcaag-3' 
PORE-A6G: 5' -ctgaaagttaaaatcacA TTTGAAA TGCAGA Tggaaaagcaag-3' 
PORE-A 7C: 5' -ctgaaagttaaaatcacATTTGAAA TGCAACTggaaaagcaag-3' 
P+ 1: 5' -ctgaaagttaaaatcacA TTTGAT AATGCAAATggaaaagcaag-3' 
P-I: 5' -ctgaaagttaaaatcacA TTTGA ATGCAAA Tggaaaagcaag-3' 
PORED ->IgK: 5' -ctgaaagttaaaatcacA TTTGAAAGGCAAA Ttaaaaagcaag-3' 
5SDM 5' -ctgaaaagatatCTTTGTTtctttA TTTGAAATGCAAATggaaaagc-3' 
MORE: 5' -ctgaaagttaaaatctcATGCA TA TGCATggaaaagcaag-3' 
BCLI: 
FGF4: 
5' ctgacctgtctcA TGAA T A TGCAAatcaggtgagtctatggtggtaaatatagggatatca-3' 
5' -ctgaaagaaaactCTTTGTTtggATGCT AA Tgggatactaagctga-3' 
UTFl: 
DC5: 
lW: 
5' -ctgaaagatgagagccctCAIIGTTATGCT AGTgaagtgccaagctga-3' 
5' -ctgatattCATTGTTGTTGCTCACCTACCATGGATCCGAActga-3' 
5' -ctgacttattttagaaA TGCAAA Ttacccaggtggtgtttgc-3 ' 
Oligonucleotides used for Transformer™ site-directed mutagenesis (section 
2.3.6) have a 5' phosphate group attached. Those used for QuikChange® site directed 
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mutagenesis (section 2.3.7) do not have the 5' phosphate group. Furthennore, only the 
reverse primer (R) plus the AISpSDMtogl primer were used for the Transfonner™ 
site-directed mutagenesis, whereas the upper and lower primer were used for the 
QuikChange® site directed mutagenesis. Mutations from the original sequences are 
indicated by bold letters; the underlined sequences are the codons encoding an amino 
acid supposedly involved in a protein-protein interface mutated to another (indicated 
in nomenclature); the double underlined sequence represents the introduction of a 
restriction site (AlwNI instead of SpeI). 
AlwNI-SpeI toggle: 
5'p GCA GCC ACT GGT AAC AGG ATT 3' 
POUlml (Q18A, 121A) 
F: 5' -GTTTGCCAAGACCTTCAAAGCAAGACGAGCCAAACTTGGATTCACTCAG-3' 
R: 5' -CTGAGTGAA TCCAAGTTTGGCTCGTCTTGCTTTGAAGGTCTTGGCAAAC-3' 
POUlm3 (I21Y) 
F: 5' -AGCCTTCAAACAAAGACGATACAAACTTGGATTCACTCAG-3' 
R: 5' -CTGAGTGAATCCAAGTTTGTATCGTCTTTGTTTGAAGGCT -3' 
POUlm4 (121G, K22A) 
F: 5' -CCTTCAAACAAAGACGAGGCGCACTTGGATTCACTCAGG-3' 
R: 5' -CCTGAGTGAA TCCAAGTGCGCCTCGTCTTTGTTTGAAGG-3' 
POUlml (KI04S, EI09A) 
F: 5' -GAGCCGTAGGAGGAAG:rg;,CGCACCAGCATAGCGACCAACATCCGTGTGGC_3' 
R: 5' -GCCACACGGATGTTGGTCGCTATGCTGGTGCGGGACTTCCTCCTACGGCTC-3' 
POUlmll (Sl07A) 
F: 5' -GGAGGAAGAAACGCACCGCCATAGAGACCAACATCCG_3' 
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R: 5' -CGGATGTTGGTCTCTATGGCGGTGCGTTTCTTCCTCC-3' 
POUlm12 (S107D) 
F: 5' -GGAGGAAGAAACGCACC GAC ATAGAGACCAACATCCG-3' 
R: 5' -CGGATGTTGGTCTCTATGTCGGTGCGTTTCTTCCTCC-3' 
POUlm13 (S107E) 
F: 5' -GGAGGAAGAAACGCACC GAA ATAGAGACCAACATCCG-3' 
R: 5' -CGGATGTTGGTCTCTATTTCGGTGCGTTTCTTCCTCC-3' 
Sox2 R75E: 
F: 5'-GAT TAT AAA TAC CGG CCG GAG CGC AAA ACC AAG-3' 
R: 5' -CTT GGT TTT GCG CTC CGG CCG GTA TTT ATA ATC-3' 
Sox2 K57E, R60E: 
Chapter 2 
F: 5' -CCGTTCATCGACGAGGCCGAGCGGCTGGAAGCTCTGCACATGAAG-3' 
R: 5' -CTTCATGTGCAGAGCTTCCAGCCGCTCGGCCTCGTCGATGAACGG-3' 
Sox2 R60E, M64E: 
F: 5'-GAG GCC AAG CGG CTG GAA GCT CTG CAC GAG AAG GAG CAC 
CCG GAT TAT AAA TAC-3' 
R: 5'-GTA TTT ATA ATC CGG GTG CTC CTT CTC GTG CAG AGC TTC CAG 
CCG CTT GGC CTC-3' 
POUI 121Y, D29R: 
F: 5'-CC TTC AAA CAA AGA CGA TAC AAA CTT GGA TTC ACT CAG GGT 
CGT GTT GGG CTC GCT ATG GGG-3' 
R: 5' -CCC CAT AGC GAG CCC AAC ACG ACC CTG AGT GAA TCC AAG TIT 
GTA TCGTCTTTGTTTGAAGG-3' 
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POU4/0ct4 121 Y, D29R: 
F: 5'-CTG CTG AAG CAG AAG AGG TAC ACC TTG GGG TAC ACC CAG GCC 
CGT GTG GGG CTC ACC CTG-3' 
R: 5' -CAG GGT GAG CCC CAC ACG GGC CTG GGT GTA CCC CAA GGT GTA 
CCT CTT CTG CTT CAG CAG-3' 
Oligonucleotides used for annealing with complementary oligonucleotides 
(giving rise to 5' CTGA-overhangs) and subsequent hexamerization of part of 
osteopontin's intron 1 are shown below. Hexamers were then cloned into tk luciferase 
reporter plasmids. Sox sites and POREs are underlined, mutations are indicated by 
bold letters, lowercase letters are non-opn sequences. 
SDM: 5'-ctgaTCTTTGTTTCTTTCAGCTTTGTATAATGTAAGTTAAAATCACAT 
TTGAAATGCAAATGGAAAAGCaagtcga-3' 
sDM: 5'-ctgaTGCACTGACCTTTCAGCTTTGTAT AA TGTAAGTTAAAATCACA 
TTTGAAA TGCAAATGGAAAAGCaagtcga-3' 
SDm: 5'-ctgaTCTTTGTTTCTTTCAGCTTTGTAT AA TGTAAGTTAAAATCACAT 
TTGAAAGGCAAATGGAAAAGCaagtcga-3' 
SdM: 5'-ctgaTCTTTGTTTCTTTCAGCTTTGTATAATGT AAGTTAAAATCACAT 
GTGAAATGCAAATGGAAAAGCaagtcga-3' 
sDm: 5'-ctgaTGCACTGACCTTTCAGCTTTGTAT AA TGTAAGTTAAAATCACA 
TTTGAAAGGCAAATGGAAAAGCaagtcga-3' 
sdM: 5'-ctgaTGCACTGACCTTTCAGCTTTGTATAATGTAAGTTAAAATCACA 
TGTGAAA TGCAAA TGGAAAAGCaagtcga-3' 
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5SDM: 5'-ctgaAAAGATATCTTTGTTTCTTTATTTGAAA TGCAAATGGAAAAG 
Cagtcga-3' 
11 SDM: 5'-ctgaAAAGAT ATCTTTGTTTGTT AAA TCACATTTGAAATGCAAAT 
GGAAAAGCagtcga-3 ' 
2.1.5 Synthetic oligopeptide 
The OBFI peptide used in Chapter 3 (MLWQKPTAPEQAPAPARPYQGVR 
VKEPVKELLRRKRGHASSSSGAA) was chemically synthesized by Sigma-
Genosys, USA, and is identical to the peptide used for crystallization by Chasman et 
al. (1999). Its composition and purity were checked by HPLC and Mass Spectral 
analysis. The lyophilized peptide was resuspended in 10mM HEPES (pH? .6), 100mM 
NaCI, 5mM ~-mercaptoethanol (~-ME) and stored at -80°C. 
2.1.6 Antibodies 
Immunization of rabbits with bacterially expressed Oct4 protein and 
preparation of antibody was performed by Karin Hubner at the EMBL, Heidelberg. 
Sox2 antibody was kindly provided by Lisa Dailey, NYU, New York. Oct! antibody 
was purchased from Santa Cruz, USA (C-21: sc-232). Antibodies were used to 
supershift protein-DNA complexes in EMSAs (section 2.8) and to detect the 
corresponding proteins by Western blot analyses (section 2.6.3). 
2.1. 7 Other materials 
Kodak X-OMATTM Blue XB-l and Biomax™ ML films were purchased from 
Sigma USA. Dialysis tubing and membranes were purchased from Pierce, USA. 
Nylon membrane Hybond-N+ and ECL™ Western Blotting Detection Reagents were 
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purchased from Amersham Pharmacia. QIAGEN Plasmid Kits and QIAquick ™ Gel 
Extraction Kits (Cat# 28704) were purchased from Qiagen, Germany. 
2.2 Bacterial techniques 
2.2.1 Bacterial strains 
The E.coli XL I-Blue strain (genotype: recAl endAl gyrA96 thi-l hsdR17 
supE44 relAl lac [F' proAB lacflZ!:l.M15 TnlD (Tetr)]) was used for propagation of 
double stranded plasmids. 
At other times the E.coli DH5a strain (genotype: sup E44.1lacU169 
(cfJ8OlacZL1M15) hsdR17 recAl endAl gyrA96 thi-l relAl) was used for propagation 
of double stranded plasmids. 
The mismatch repair deficient E.coli BMH 71-18 mutS strain (genotype: thi, 
sudE, ll(lac-proAB), [mutS::Tnl0][F'proAB, laclQZllMl5] was used after site-
directed mutagenesis with the Clontech kit. 
The BL21-CodonPlus(DE3)-RIL strain (Stratagene #230345) (genotype: E. 
coli B F- ompT hsdS(rB- mB-) dcm+ Tetr gal;" (DE3) endA Hte (argU ileY leuW 
Camr]) was used for bacterial protein expression. It is a general protein expression 
strain that lacks both the Lon protease and the OmpT protease, which can degrade 
recombinant proteins during expression and purification. The naturally lacking Dcm 
methylase is inserted into the genome. Efficient expression of heterologous proteins is 
often limited by the rarity of certain tRNAs in the bacteria that are abundant in the 
organisms from which the proteins are derived. BL21-CodonPlus-RIL cells contain 
extra copies of the argU, i/eY, and leu W tRNA genes, which recognize the 
AGAIAGG, AVA, and CVA codons, respectively, facilitating the expression of 
heterologous genes, which contain these rare codons. The DE3 lysogen contains the 
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T7 polymerase gene, which is under the control of the IPTG inducible lacUV5 
promoter. The polymerase in turn activates protein expression driven by T7 
promoters, such as in pET vectors used in this thesis. 
2.2.2 Maintenance and Media 
E.coli cells were grown at 37°C (unless specifically mentioned otherwise) in 
L-broth, shaking at 200 rpm, or on LB agar plates containing antibiotics when needed 
as described in Sambrook et al. (1989). Carbenicillin was used instead of ampicillin. 
2.2.3 Preparation of competent E.coli cells 
The protocol for competent cells (chemical transformation) published in the 
user manual of the Transformer™ Site-Directed Mutagenesis Kit from Clontech 
(Catalog #K1600-1) was used for XL I-Blue, DH5a, BMH 71-18 mutS and BL21-
CodonPlus(DE3)-RIL cells. Only the BMH 71-18 mutS bacteria were grown on 
tetracycline LB plates and in tetracycline L-broth. 
2.2.4 Chemical transformation of competent E.coli cells 
A IOOIlI aliquot of competent cells was thawed on ice. Then 5-101l1 DNA was 
added to the bacteria in the Eppendorf tube, mixed gently and incubated on ice for 
30'. After a I' heat shock at 42°C, cells were allowed to recover with 400lli LB media 
at 37°C for Ihr. Typically IOOIlI of the culture were plated onto an LB plate 
containing the appropriate antibiotic. The plates were incubated overnight (12-16brs) 
at 37°C. 
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2.3 Recombinant DNA Techniques 
2.3.1 Phenol/Chloroform extraction and ethanol precipitation of DNA 
This procedure was carried out routinely to remove proteins from DNA 
containing solutions. The volume of the solution was brought to 200-S00~1 with 
ultrapure H20, proteins were then removed with the help of phenol/chloroform as 
described by Sambrook et al. (1989). The DNA was precipitated by adding 0.1 
volumes 3M Na-acetate (pHS.2) and 2.S volumes ice-cold ethanol. The solution was 
mixed and incubated at -20°C for S'. The DNA was recovered by centrifugation in a 
cooled microcentrifuge (IS'at 13,OOOrpm) The DNA pellet was washed with 500~1 
70% ethanol, air-dried and resuspended in an appropriate volume of TE (pH8.0; 
10mM Tris pH8.0, ImM EDTA). 
2.3.2 CsC} purification of DNA 
CsCI purification of DNA started by spinning 300ml bacteria culture 
(ThermoForma centrifuge model 5696, swinging bucket rotor (No. 5808947), 
3000rpm) for 15' at 4°C. The pellet was resuspended in 5ml lysozyme compatible 
buffer (SOmM glucose, lOmM EDTA, 25mM Tris (pH 8.0)) and transferred to a 50ml 
Falcon tube. Then another 5ml lysozyme compatible buffer containing 100mg 
lysozyme was mixed in well and incubated on ice for 5'. Next, lOml 0.2M NaOH, 1% 
SDS were added, mixed immediately by gentle shaking and incubated on ice for 5-
10'. Then 8.4ml KOAc (3M with respect to potassium, 5M with respect to acetate; 
Sambrook et ai., 1989) were mixed in and incubated on ice for 15'. Then the solution 
was centrifuged for 15' at 4°C (see conditions above). The supernatant was 
transferred to a new 50ml Falcon tube. If necessary, autoclaved gauze was used to 
remove floating debris. Next, 0.6 volumes isopropanol were added and mixed in to 
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precipitate the DNA by incubating the mixture on ice for 30'. Then the solution was 
centrifuged again as above. The pellet was air-dried moderately and resuspended in 
3ml TE (pH8.0). RNase A was added to a final concentration of 125~g/ml and 
incubated for 60' at RT. For each ml of TE Ig CsCI and 50~1 EtBr (lOmglml) were 
added. The samples were spun for 10' at RT. Using a Pasteur pipet the supernatants 
were transferred to polyallomer centrifugation tubes (Beckman Coulter Cat. # 
326819), which were then balanced. The samples were centrifuged in a Beckman 
Coulter™ Optima™ MAX-E ultracentrifuge (swinging bucket rotor MLS-50) for 
20hrs at 40,000 rpm. The supercoiled plasmid was recovered by puncturing a syringe 
with an 18 gauge needle directly underneath the lower pink band and removing it (see 
Sambrook et al. (1989). The EtBr was removed by extracting the DNA solution 3 
times with 3 volumes of n-BuOH saturated with TE. After all visible EtBr was 
extracted the DNA solution was dialyzed against TE at RT with 3 changes (lL, Ihr, 
each). Then the DNA was precipitated with 0.1 volumes 3M Na-acetate (pH5.2) and 
2.5 volumes ethanol. The DNA pellet was washed with 500~1 70% ethanol, air-dried 
and resuspended in 100~1 TE (pH8.0; lOmM Tris pH8.0, lmM EDTA). 
2.3.3 Cloning strategy 
All DNA used for cloning was dissolved in TE. Precautions were taken to 
maximize the generation of recombinant plasmids: Both vector and insert fragments 
were purified by gel extraction with the QIAquickTM Gel Extraction kit (Cat.# 28704) 
to exclude the presence of undigested plasm ids in the ligation reaction. 
Recircularization of vector fragments was minimized in two ways: (a) Where possible 
DNA fragments were inserted into vectors cut with two enzymes generating 
incompatible ends. (b) The 5 'phosphate moieties of the vector fragments were 
removed with calf intestinal phosphatase (CIP). As ligation by T4 DNA ligase 
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requires the presence of 5'phosphate groups on only one of the two DNA fragments 
this treatment counteracts recircularization of the vector without significantly 
affecting ligation of untreated insert with treated vector. 
(i) Preparation of vector and insert: 3-10llg vector plasmid and insert carrying 
plasmid were digested with 20-30 units of the appropriate restriction enzymes for 1-
2hrs. Digestions with two restriction enzymes requiring different digest buffers were 
carried out sequentially. If compatible ends were present, 1 unit CIPIllg DNA was 
added in a compatible buffer to the vector preparation and the incubation was 
continued for 30-60'. If incompatible ends had to be ligated recessive ends were filled 
in with Klenow fragment as specified by New England Biolabs. 
(ii) Purification of vector and insert: vector and insert were separately subjected to 
electrophoresis (see section 2.5) through a preparative agarose gel containing EtBr. 
Linearized vector and insert bands were cut out from the gel with sterile scalpels 
under longwave UV light (36Snm) in order to minimize DNA nicking. Then they 
were transferred to a clean Eppendorf tube. Next, the DNA was isolated from the 
agarose gel with the QIAquick ™ Gel Extraction Kit (Cat# 28704) from Qiagen. The 
DNA was eluted in 30ll110mM Tris (pH8.S; provided with the kit). 
(iii) Ligation of purified linearized vector and insert: Typically, 50ng purified vector 
and insert of a 3-fold higher molarity were incorporated into a lOlllligation reaction 
(50mM Tris-HCI pH7.5, lOmM MgCh, 10mM OTT, ImM ATP, 251lg/ml BSA, 
5units T4 DNA ligase). The reaction was incubated at 16°C for 4hrs. A control 
ligation lacking the insert was routinely carried out to assess the background of 
recircularized vector molecules. Competent E.coli were transformed with 51l1ligation 
reaction (section 2.2.4). 
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2.3.4 Small scale preparation of plasmid DNA after ligation 
Single bacterial colonies resulting from the transformation were picked and 
grown in 3ml L-broth supplemented with the appropriate antibiotic for 8-14hrs. For 
preparation of plasmid DNA from 2ml cultures the alkaline lysis method was 
employed as described by Sambrook et al. (1989). The plasmid was resuspended in 
SOfJ.I TE. The RNA was digested during the lysis of the bacteria with solution I, and 
not after resuspension of the DNA. Typically, 4fJ.I (approximately O.3-0.6fJ.g) were 
used for restriction analysis and subsequent agarose gel electrophoresis. The 
restriction enzymes were selected such that the fragment pattern resulting from the 
recircularized vector and recombinant plasmid were easily distinguishable thus 
allowing the identification of clones harboring the desired recombinant plasmid 
("positive clones"). If the identification of positive clones required the determination 
of DNA sequence (e.g. after site directed mutagenesis; sections 2.3.6 and 2.3.7), the 
preparation was extracted with phenol/chloroform (see section 2.3.1) and sent to the 
sequencing service at the University of Pennsylvania (section 2.3.9). Cultures of 
positive clones, which were needed for further manipulation or transfection into 
mammalian cells, were diluted into fresh 100ml L-broth supplemented with the 
appropriate antibiotic and grown at 37°C overnight for large scale preparation of 
plasmid DNA. 
2.3.5 Large scale preparation of plasmid DNA 
DNA was prepared using a modified alkaline lysis method and purified by 
anion-exchange chromatography (QIAGEN Plasmid Maxi Kit Cat# 12163). The 
protocol published in the Qiagen manual was followed for large scale preparation of 
plasmid DNA. After that the DNA pellet was resuspended in IOOfJ.I TE and 
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centrifuged in a microcentrifuge (lO'at 13,OOOrpm). This resulted in the formation of 
a white precipitate, which is insoluble in TE. The supernatant was transferred to a 
fresh tube and the centrifugation was repeated. The concentration of the plasmid 
preparation was determined spectrophotometric ally by measuring the absorption of a 
200-fold dilution at A = 260nm and applying the formula: 
Concentration of double stranded DNA (Ilg/ml) = 200 (dilution factor) x 50 x 
OD260nm. 
2.3.6 Transformer™ Site-directed mutagenesis (Cion tech) 
This is an outline of how the Transformer™ kit works. The exact protocol can 
be found in the manufacturer's manual. 
This site directed mutagenesis is based on the USE (unique site elimination) 
method. By this method single or multiple specific base mutations as well as deletions 
or insertions can be introduced. A selection or toggle primer, which mutates a unique 
restriction site into another anneals to one strand of DNA simultaneously with one or 
more mutagenic primers. After standard elongation with T4 DNA polymerase 
followed by ligation with T4 DNA ligase and a primary selection by restriction digest 
of the mutated unique restriction site the hemi-mutated plasm ids are transformed into 
the BMH71-18 mutS E coli strain defective in mismatch repair. Transformants are 
pooled, and plasmid DNA is prepared from the mixed bacterial population. The 
isolated DNA is then subjected to a second selective restriction enzyme digestion. 
Since the mutated DNA lacks the restriction enzyme recognition site, it is resistant to 
digestion. The parental DNA, however, is sensitive to digestion and will be cut and 
linearized, making it far less efficient in transformation of bacterial cells. A final 
transformation with the selectively digested DNA results in highly efficient and 
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specific recovery of the desired mutated plasmid. 
2.3.7 QuikChange@ Site-directed mutagenesis (Stratagene) 
This is an outline of how the QuikChange@ kit works. The exact protocol can 
be found in the manufacturer's manual. Stratagene's QuikChange® site-directed 
mutagenesis kit allows site-specific mutation in virtually any double-stranded 
plasmid. It requires no specialized vectors or unique restriction sites. 
This method uses PfuTurbo® DNA polymerase and a temperature cycler (PCR 
machine). The basic procedure utilizes a plasmid with an insert of interest and two 
complementary oligonucleotide primers containing the desired mutation. The primers 
are extended during the PCR by P/uTurbo® around the whole plasmid. P/uTurbo® 
works with high fidelity and does not displace the mutant oligonucleotide primers. 
Incorporation of the oligonucleotide primers generates a mutated plasmid containing 
staggered nicks. After the PCR reaction the product is treated with Dpnl. The Dpnl 
endonuclease (target sequence: 5' -Gm6ATC-3 ') is specific for methylated and 
hemimethylated DNA and is used to digest the parental DNA template and to select 
for mutation-containing synthesized DNA. DNA isolated from almost all E. coli 
strains is dam methylated and therefore susceptible to Dpn I digestion. The nicked 
vector DNA containing the desired mutations is then transformed into XLI-Blue E. 
coli cells. More than 50% of the colonies were positive for the mutation. 
The following PCR conditions were used: 
94°C 2'10" 
94°C 50" 
50°C 2' 
68°C 15' 
16x 
54 
Material and Methods 
94°C 50" 
65°C l' 
68°C 15' 
68°C 15' 
lOx 
2.3.8 Labeling oligonucleotides 
Chapter 2 
Oligonucleotides were annealed by heating equimolar amounts of compatible 
oligonucleotides in 100mM NaCl, ImM MgCh, 20mM Tris (pH 8) for 5' at 95°C and 
letting the solution cool down slowly to RT. 
The Klenow fragment of E.coli DNA polymerase was used to fill-in and label 
annealed oligonucleotides with 5' overhangs: 5pmol annealed oligonucleotides were 
filled-in with 2mM dATP, dGTP and dTTP each, plus 2.51-11 (a_32P)dCTP (10mCi/ml) 
by 2.5 units Klenow enzyme in 10mM Tris (pH 7.5), 5mM MgCh, 7.5mM DTT. 
After 15' incubation at RT the reaction was filtered through a G25 Sepharose column 
(Roche, Cat. # 1273949) according to manufacturer's instructions to remove free 
deoxyribonucleotides. 
2.3.9 Sequencing of double-stranded plasmid DNA 
Sequencing was performed by the sequencing facility of the School of 
Veterinary Medicine at the University of Pennsylvania under Dr Jikang Fang. The 
ABI PRIS~ BigDye™ Terminator Cycle Sequencing Kit was used with the ABI 
PRIS~ 377 DNA Sequencer from Applied Biosystems. 
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2.4 Recombinant DNA Construction 
The POU1, POU4, Oct4 and HMO bacterial expression vectors (pET24d(+)) 
were obtained from Attila Remenyi (Remenyi et al., 2001; Remenyi et al., 2003) and 
mutated by Transformer™ or by QuikChange® site-directed mutagenesis (sections 
2.3.6 and 2.3.7; Chapter 3 and 4). pCOOctl was obtained from David Denhard and 
mutated by QuikChange® site-directed mutagenesis for use in transfection assays 
(Chapter 3). The oligonucleotides used for mutation are listed in section 2.1.4. 
The reporter plasmids PORE, PORED and POREM , used in Chapter 3 consist 
of hexamers of the respective oligonucleotides in front of a thymidine kinase (tk) 
promoter and a luciferase gene (luc) and are described in Botquin et al. (1998) where 
they are called 6xO, 6xO-1 and 6xO·3, respectively. 
The following constructs were used in Chapter 5: 6xSDM, 6xsDM reporters 
(previously named 6xOS and 6xOS-, respectively) and i-opn PCR II were described 
in Botquin et al. (1998). 6xSdM, 6xSDm, 6xsdM, 6xsDm, 6x5SDM, 6xllSDM 
plasmids were obtained by multimerizing the corresponding oligonucleotides. The 5' 
overhangs were filled in by Klenow polymerase and fragments of 6 oligonucleotide 
repeats were precloned into the EcoRV site ofpBluescript KS and from there into the 
HindIlI-BamHI sites of the -37tkluc plasmid. 
2.5 Electrophoresis 
2.5.1 Agarose Gel Electrophoresis 
Horizontal agarose gel electrophoresis was carried out essentially as described 
by Sambrook et al. (1989). The required weight of agarose was dissolved in Ix TBE 
by boiling the agarose for several minutes to generate 0.7-2% (w/v) gels. Before 
pouring the agarose solution into the gel chamber, ethidium bromide was added to a 
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final concentration of 0.2llglml. The gel was left to cool down and solidify at RT and 
was then submerged in 1xTBE running buffer before removal of the comb. Prior to 
loading, each sample was mixed with 1/6 volume of a 6x native loading buffer 
(0.15% bromophenol blue, 0.15% xylene cyanol, 50% glycerol, 60mM EDTA in 
H20) The gel was run at 10-15 V/cm and separated DNA fragments were visualized 
byUV. 
2.5.2 Non-denaturing Polyacrylamide Gel Electrophoresis 
Two glass plates, one "notched" plate and one backing plate, were cleaned 
extensively with ethanol. The size of the plates differed from experiment to 
experiment. The plates were separated by spacers of 1-1.5mm clamped together and 
taped. Gels with 5 or 6% acrylamide were routinely used. (150ml of 5% gel: 25ml of 
30% acrylamide solution (29:1 acrylamide:bisacrylamide), 30ml 5xTBE, 1.5ml 10% 
APS, 88.5ml H20, 150111 TEMED; the acrylamide and H20 volumes were adjusted to 
vary the acrylamide concentration.) The solution was mixed, poured between the 
glass plates, a comb was inserted and the gel left to polymerase for 20-30'. After 
polymerization the sealing tape was removed, the plates assembled on the gel 
apparatus and the wells cleaned with 1 xTBE. The gel was exposed to a prerun in 
IxTBE at 100V for 30'. Then the samples (5-15J.11 depending on well size) were 
loaded and the gel was run at 10V/cm. For some experiments the Novex Mini-Cell 
system (Cat. # EIOOOl) from Invitrogen was used with precasted 6% TBE gels (Cat. # 
EC62652). 
2.5.3 SDS-Polyacrylamide Gel Electrophoresis (SDS-P AGE) 
Proteins were separated according to size by the standard Laemmli procedure 
of one-dimensional gel electrophoresis under denaturing conditions (Laemmli, 1970), 
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SDS-PAGE. Experiments were carried out using the MGV -202 vertical mini-gel 
system from C.B.S. Scientific Co., USA. 
Two glass plates are assembled using 1mm spacers and the Gel Wrap (used 
instead of tape). Clamps hold the plates together and hold it upright. To prepare a 
10% separating gel 3.325ml acrylamide (29:1 acrylamide:bisacrylamide), 1.25ml 3M 
Tris (pH8.9), 200).11 SDS (10%), 4.875ml H20, 100).11 TEMED (5%) and 250).11 APS 
(10%) were mixed. For preparation of gels with lower or higher acrylamide 
concentration the volumes of acrylamide and H20 were adjusted accordingly. The gel 
solution is applied to the assembled plates until I cm beneath the top of the notched 
plate. 1 ml H20 is added on top of the gel to prevent oxygen from diffusing into the 
gel and inhibiting polymerization. The gel was left to polymerize for 45'. After 
polymerization the overlaid H20 was removed and the stacking gel (825).11 acrylamide 
(29:1 acrylamide:bisacrylamide), 625J.lI 3M Tris pH 6.7, 100).11 SDS (10%), 3.05ml 
H20, 50J.Ll TEMED (5%) and 350).11 APS (10%)) was added on top of the running gel. 
A 1 mm comb was inserted into the stacking gel and it was left to polymerize for 15'. 
Samples were loaded after the gel was mounted on the gel chamber and after running 
buffer (23mM Tris pH 8.4, 190mM glycine, 0.2% SDS) was added. The proteins were 
run at 100V through the stacking gel and at 180V through the separating gel. 
2.6 Handling of Proteins 
2.6.1 Detemination of protein concentration 
The Bio-Rad protein assay (Cat# 500-0006), based on the Bradford dye-
binding procedure, was used to determine protein concentration. Protein standards 
ranging from 1-20J,lg were prepared with BSA. Standards and proteins were brought 
to 20J.L1. To these 800J,l1 H20 and 200J,l1 Bio-Rad protein assay solution were added. 
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After 15' incubation at RT the absorption was measured with a spectrophotometer at 
595nm in plastic cuvettes. Absorption values of the BSA standards were used to 
calculate the protein concentration of the samples. In addition, protein concentrations 
were estimated by running SDS-PAGE gels (section 2.5.3) with known amounts of 
protein along with newly purified protein and concentrations were estimated by 
comparison using Coomasie Blue staining (section 2.6.2). 
2.6.2 Coomassie staining of protein gels 
The SDS gel was submerged in Coomassie Blue staining solution (50% 
methanol, 12% acetic acid, 0.05% Coomassie Brilliant Blue R250 (w/v)) so that it 
was covered completely and incubated oln at RT shaking at 65rpm. The staining 
solution was then replaced by de staining buffer (50% methanol, 12% acetic acid). The 
gel was washed 3-4 times for 20-40' with the destaining buffer until blue colored 
protein bands became visible against a clear background within the gel. The gel was 
then dried on Whatman paper (grade 3) in the Slab Gel Dryer from Savant 
(SGD5040) coupled to the Universal Vacuum System (Savant, UVS400) for lhr at 
80°C for long term storage. 
2.6.3 Western blotting 
The following protocol was used to transfer proteins from an SDS-PAGE gel 
(section 2.5.3) to BA23 nitrocellulose membrane (Schleicher Schuell; pore size 
0.2!J.m) using the EBU-202 transfer chamber from C.B.S. Scientific Co., USA. All 
required components were soaked in Western transfer buffer (25mM Tris (pH 8.3), 
192mM glycine, 20% (v/v) methanol) before use and assembled in the following 
order: a plastic sponge pad, 3 sheets ofWhatman paper (grade 3), the polyacrylamide 
gel, a piece of nitrocellulose membrane, a second group of 3 sheets of Whatman 
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paper, and then another plastic sponge. Before assembly air bubbles that were trapped 
between the gel and the nitrocellulose were removed by rolling a serological pipette 
over the surface of the nitrocellulose and following Whatman paper. The entire 
assembly was placed into the plastic holder and slid into the transfer chamber filled 
with Western transfer buffer so that the nitrocellulose was facing the anode and the 
gel was facing the cathode. Proteins were transferred to the nitrocellulose by applying 
a constant voltage l30mA o/n at 4°C. During this time the transfer buffer was stirred 
continuously with a magnetic stirrer bar. 
The transfer efficiency was analyzed by incubating the nitrocellulose 
membrane in Ponceau-S solution (composition: 2% Ponceau-S (w/v) in 30% 
trichloroacetic acid, 30% sulfosalicylic acid) for a couple of minutes and rinsing it 
with ultrapure H20 until the protein bands were clear and there was minimal 
background staining of the membrane. 
After all Ponceau-S staining was removed by washing the nitrocellulose 
membrane with ultrapure H20, the membrane was transferred into blocking solution 
(PBS, 5% fat free milk powder, 0.05% Tween-20) either for 2hrs at RT or o/n at 4°C. 
The primary antibody was appropriately diluted (about 1: 1 000) in fresh blocking 
buffer and incubation was continued with gentle agitation for 1 hr at R T. The 
membrane was washed 4 times in PBS + 0.05% Tween-20 (5' each) to remove any 
unbound antibody. Then it was incubated with a secondary horseradish peroxidase 
coupled anti-rabbit antibody (1: 1500) in fresh blocking solution for Ihr and washed as 
before. Next, the membrane was submerged in ECLTM Western blotting detection 
solution (reagents 1 and 2 freshly mixed 1: 1; Amersham Pharmacia) for 1'. ECLTM 
Western blotting is a light emitting non-radioactive method for detection of 
immobilized specific antigens, conjugated with horseradish peroxidase-labeled 
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antibodies. The membrane was exposed to Kodak ML Biomax™ film for 30 seconds 
and developed for visualization of reactive protein bands. The developed film 
determined how strong the ECL reaction was and the length of exposure (30"-30') 
for the final image. 
2.6.4 Purification of proteins 
POUI, HMG and their derivatives were isolated in the following way. All 
other proteins used were isolated similarly by collaborators (Remenyi et ai., 2001; 
Remenyi et ai., 2003; Botquin et ai., submitted). 
E. coli of the BL21-CodonPlus(DE3)-RIL strain were transformed with the 
pET24d(+) vector containing the His-tagged POU domain of Oct 1, the HMO domain 
of Sox2 or mutants thereof. After growth on an agar plate supplemented with 
Kanamycin o/n, one colony was used to inoculate 6ml LB medium + Kanamycin and 
incubated at 3rC o/n (preculture). The next morning 200ml LB + Kanamycin were 
inoculated with 4ml of the preculture (1 :50 dilution). At an OD600 of 0.4-0.6 protein 
expression was induced by adding I mM IPTO. After 2-4hrs of protein expression 
(shaking at 30°C) the cells were pelleted (15' at 3600rpm = 2550 rcf in Thermo 
Forma Multi RF Centrifuge with the swinging bucket rotor #5808947). The pellet was 
resuspended in ice cold 50ml PBS to wash the bacteria from the media, and pelleted 
again (15' at 3600rpm = 2550 rcf). This pellet was taken up in lOml lysis buffer 
(500mM NaCI, 20mM Hepes pH7.6, 10mM imidazole, 5mM I3-ME, 0.1% IOEPAL-
CA-630) and transferred to a Falcon tube. The sample was then sonicated for 5' on 
ice (Ultrasonic processor CP130 (Cole Parmer Cat. # EW-04714-20); amplitude: 
70%, pulser: 10", using a 6mm titanium probe and tip (Cat. # EW-04712-14)). After 
the cells were completely lysed the solution was centrifuged at 10000rcf for 30' 
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(SLC-2S0T rotor in Sorvall Super 21 T centrifuge). Batch purification was performed 
using Ni-NTA agarose resin (Qiagen #1000 630). 800111 of the resin were added 
(previously equilibrated with lysis buffer) to the supernatant and incubated at 4°C 
rotating at SOrpm for 1-12hrs. Next the bacteria-resin solution was transferred to 
Polyprep chromatography columns (BioRad #731-1SS0). The resin was washed with 
10mllysis buffer, then Sml NaCI solution (1M NaCI, 20mM Hepes pH7.6, 10mM 
imidazole, 5mM ~-ME, 0.1 % IGEPAL-CA-630) followed by Sml 3SmM imidazole 
solution (150mM NaCI, 20mM Hepes pH7.6, 35mM imidazole, 5mM ~-ME, 0.1% 
IGEPAL-CA-630). The protein was eluted in 800lli elution buffer (150mM NaCI, 
20mM Hepes pH7.6, 300mM imidazole, 5mM ~-ME, O.l% IGEPAL-CA-630 and 
dialysed against dilution buffer (150mM NaCI, 20mM Hepes pH7.6, ImM EDTA, 
5mM ~-ME, 0.1 % IGEPAL-CA -630) oln at 4°C. 
2.7 Cell Lines and Cell Culture 
2.7.1 Cell culture media, reagents and cell lines 
Cell culture reagents were prepared and all tissue culture manipulations were 
carried out in sterile conditions in a standard laminar flow hood. Dulbecco's Modified 
Eagle's Medium (DMEM), supplements (L-Glutamine, penicillin/streptomycin) and 
reagents (Trypsin-EDTA, PBS) were purchased from Invitrogen, USA. Defined Fetal 
Calf Serum (FCS) was obtained from HyClone, USA. The 293, F9 and Rl cells were 
propagated in an incubator maintaining a constant temperature of 370 C and a 
humidified, 5% C02 atmosphere. Cells were grown in cell culture dishes (15cm 
diameter, 24-well dishes). The cell lines utilized are indicated below: 
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Cell line: Cell type: 
293 Human, adenovirus-transfonned 
line derived from embryo kidney 
Chapter 2 
Obtained from: 
P. Gruss, MPI, Gottingen, Gennany 
BJA-B Human, B-celllymphoma derived P. Gruss, MPI, Gottingen, Gennany 
F9 Mouse, embryonal carcinoma (EC) A TCC, USA 
RI Mouse, embryonal stem cells (ES) Nagy, Mount Sinai Hospital, 
Toronto, Canada 
The 293 and F9 EC cells were maintained in DMEM supplemented with 10% 
FCS, penicillin/streptomycin (PIS) and L-Glutamine (L-Glu) (per liter: 880ml 
DMEM, 100ml FCS, 10mls 100x PIS, 10mls 100x L-Glu). Rl ES cells were cultured 
in DMEM (0.45% glucose (wt/vol)), 15% FCS, 100 J!M ~ - ME, 
penicillin/streptomycin (PIS), L-Glutamine (L-Glu) and in the presence of 1000 U/ml 
leukemia inhibitory factor (LIF, GIBCO-BRL). Murine EC and ES cells were grown 
on 0.1 % gelatin-coated tissue culture plates. For methods concerning BJA-B-cells see 
Lins et al. (2003). 
2.7.2 Passage of cells 
Cells were passaged using conventional cell culture techniques. Briefly, when 
reaching 80-90% confluency, cells were washed with sterile PBS and incubated in 
3ml trypsin-EDTA (for 15cm plate) for I '. Trypsinization was stopped by the addition 
of medium and a single cell suspension was created by pipetting the suspension up 
and down. An appropriate volume was then transferred to dishes with fresh medium. 
For long tenn storage cells were frozen in 40% DMEM, 50% FCS, 10% DMSO. To 
bring cells into culture from a frozen stock the suspension was thawed quickly and 
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directly added to the appropriate amount of pre-warmed supplemented medium in a 
culture dish. 
2.7.3 Transient transfection of 293, F9 and Rl cells 
Cells were transfected with the non-liposomal FuGENE 6 Transfection 
Reagent from Roche (Cat. # 1 814443). FuGENE 6 Transfection Reagent is a multi-
component lipid-based transfection reagent that complexes with and transports DNA 
into the cell during transfection. 
Cells were fed with supplemented medium without PIS, since this may 
adversely affect transfection efficiency, 2hrs before the transfection. Per well of a 24-
well dish, Illg DNA was transfected. For this, 2111 FuGENE 6 were added to 100111 
DMEM followed by addition of Illg DNA, always consisting of 100ng pcmv{3gal to 
measure galactosidase activity as an internal standard and 200ng reporter plasmid. 
When appropriate different amounts of expression vectors were added. The 
suspension was incubated at RT for 15' and then added to the cells dropwise. After 
48hrs cells were harvested and whole cell extracts were prepared (section 2.7.5). 
2.7.5 Preparation ofwbole cell extracts from transfected cells 
Cells in 24-well dishes were lysed in the wells. The cells were washed with 
500111 ice-cold PBS twice. Then 150111 lysis buffer (250mM Tris pH7.8, ImM DTT 
protease inhibitors Aprotinin (2J.1g1ml) and Leupeptin (Sllglml) (Roche) were added to 
each well. The cells were freeze-thawed three times, placing the plates alternately in 
liquid N2 and a 37°C water bath. The lysates could then be stored at -80°C or used 
directly. Whole cell extracts prepared in this manner were used for luciferase, {3-
galactosidase and electrophoretic mobility shift assays. 
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2.7.6 Enzymatic assays of extracts from transfected cells 
Luciferase Assay 
Chapter 2 
The luciferase assay measures the activity of the luciferase reporter constructs 
in the transfected cells and was performed in the Mediators PhL luminometer 
(Mediators Diagnostika, Austria; Cat. # GOIOOOl.Ol) 
150/l1 of freshly prepared Mix A (for 30samples: 4.9ml Glycylglycine pH7.8, 
50/l1 ATP pH7.5 (0.2M), SO/ll MgS04 (1M)) were added in each well of a 
FluoroNunc 96-well Module (MaxiSorp Surface, Nunc #437591). 20/l1 whole cell 
extract were added to the wells. Freshly prepared Mix B (for 30 samples: 4ml 
Glycylglycine pH7.8, Iml D-luciferin solution (Smg/16.Sml of the above 
Glycylglycine buffer) was put in a light protected tube. After the machine was primed 
(see user manual) the Mix B tube was hooked up to the Mediators PhL luminometer 
and the FluoroNunc plate was placed in the machine. Luciferase activities were 
measured with the following settings: 30"integration time, 2" lag time, 50~1 injection 
volume for Mix B. The luciferase measurements were normalized for (divided by) the 
corresponding ~-galactosidase value. 
~-galactosidase assay 
To determine the relative amount of ~-galactosidase protein in the whole cell 
extract of transfected cells a colorimetric enzyme assay was employed. 10-20/l1 
extract were added to 60~1 solution I (60mM Na2HP04, 40mM NaH2P04, 10mM 
KCl, 1mM MgCh, SOmM ~-ME) in a transparent 96-well plate. 20~1 solution II 
(2mglml ONPG (~-galactosidase enzyme substrate) in Solution I) were added and 
samples were incubated at RT. Conversion of ONPG by ~-galactosidase results in a 
color change of the solution from transparent to yellow and thus allows 
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spectrophotometric quantification of ~-galactosidase present in the sample. When the 
color in the wells turned obviously yellow, 50~1 solution III (1M Na2C03) were added 
to terminate the reaction. The optical densities at 420nm were read in the Mediators 
PhL luminometer. As ~-galactosidase expression was used as an internal standard in 
the transfection experiments, i.e. each well in a transfection series was transfected 
with the same amount of f3-galactosidase expression vector, differences in ~­
galactosidase activity were assumed to reflect differences in transfection efficiency 
and the reporter (luciferase) values were corrected accordingly. 
2.8 DNA/protein binding assays 
2.8.1 Electrophoretic Mobility Shift Assays (EMSAs) 
F or experiments in Chapter 3: 
Approximately 30ng POUI (wild-type or mutant) protein was incubated with 
radio labeled oligonucleotides (see section 2.3.8) in the presence or absence of lOng 
chemically synthesized OBFl polypeptide (see section 2.1.5). The following protein-
DNA binding buffer was used for the reaction: 25 mM Tris pH 8.0, 100 mM NaCI, 
0.5 mM EDTA, 0.04% Triton-X, 10% glycerol, 10 mM DTT, lOng/ill poly[d(I-C)]. 
F or experiments in Chapters 4 and 5: 
Combinations of approximately 25ng POUl, 100ng Oct4, 25ng POU4, 100ng 
Pax6 and 50ng HMG or indicated amounts of F9 whole cell extract (see section 2.7) 
were incubated with the appropriate labeled oligonucleotides in the protein-DNA 
binding buffer (lOmM Tris, pH 8.0, 150mM NaCI, 0.05% Triton-X, 5 Jlg/JlI BSA, 
50ng/1l1 salmon testes DNA, 10% glycerol, 10mM DTT, 10nglJlI poly[d(G-C)]) and 
complex formation was analyzed by EMSA. Titration experiments were carried out 
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under similar conditions using the same amount of Oct4 (1 OOng) with increasing 
amounts of HMG domain of Sox2 (0, 6.25, l2.5, 25, 50, and 100ng) per binding 
reaction. 
The EMSA gels were dried on Whatman paper (grade 3) in the Slab Gel Dryer 
from Savant (SGD5040) coupled to the Universal Vacuum System (Savant, UVS400) 
at 80°C for 45'. The dried gel was then exposed to Kodak X-OMATTM Blue XB-1 
film for 15-90'. The radioactive signal was enhanced by an NEN intensifying screen 
atRT. 
2.8.2 Off-rate EMSA and dissociation rate constants 
For the off-rate experiment (figure 3.7), a 500-fold excess of unlabeled 
oligonucleotide was added to the reaction. Aliquots of the reaction mixture were 
loaded onto the gel at indicated time intervals. 
The dissociation rates of Oct4 and Sox2 containing complexes were 
determined in Chapter 5. The retarded bands were quantified using the Fujifi1m-2000 
phosphorimager, Basread and Aida version 2.0 programs. Percentage of bound 
complex at a specific time (bound protein-DNA complex at time-x)/(L of total bound 
protein-DNA complex at time-x) was then plotted as a function of time as a semi-
logarithm graph. The half-life was derived from the dissociation curve as the time at 
which 50% of the DNA-protein complex was still intact and had not dissociated yet. 
From the slopes, the dissociation rate constants (~) of the dimension l/sec were 
calculated with the equation k<t = In21T 50% complex bound. 
67 
OBF] enhances transcriptional potential of Oct] Chapter 3 
Chapter 3 
OBFl enhances transcriptional potential of Octl 
3.1 Abstract ............................................................................................................. 69 
3.2 Introduction ....................................................................................................... 69 
3.3 Results ............................................................................................................... 73 
3.3.10steopontin is a target gene ofOBFl. ........................................................... 73 
3.3.2 Identification of potential PORE-interface mutants ...................................... 76 
3.3.3 Structural Basis ofOBFl Interaction with the OctllPORE Complex ............ 83 
3.3.4 OBFI rescues mutations that impair POUI dimerization .............................. 86 
3.3.5 OBF1 alleviates DNA sequence requirements .............................................. 89 
3.3.6 OBFIIPOUI dimer tolerates changes in PORE binding site separation ........ 90 
3.3.7 OBF1 stabilizes POU1 dimer on DNA by reducing its dissociation rate ....... 96 
3.4 Discussion ......................................................................................................... 99 
3.4.1 Osteopontin in B-cells: gene regulation and function ................................... 99 
3.4.2 OBFl alleviates DNA sequence requirements for POU dimerization and 
stabilizes the dimer on the DNA ......................................................................... 100 
3.4.3 Mimicking phosphorylation at the PORE dimer interface prohibits POUl-
DNA interaction ................................................................................................. 104 
3.4.4 Novel POU1 dimer configuration upon interaction with OBFI .................. 106 
68 
OBF I enhances transcriptional potential of Octl Chapter 3 
3.1 Abstract 
The POU transcription factors Oct! and Oct2 bind to DNA in various 
monomer and dimer configurations. Depending on the DNA sequence they bind to, 
the dimers are arranged in configurations that are either accessible (PORE sequence) 
or inaccessible (MORE sequence) to the B-cell specific cofactor OBFI (OcaB, Bobl). 
As shown previously, the MORE and related sequences (such as the 
Heptamer/Octamer motif) are found in immunoglobulin heavy chain promoters. In 
this chapter I show that the expression of Osteopontin, which contains a PORE 
sequence in its enhancer region, depends on the presence of OBFl in B-cells. OBFl 
alleviates DNA sequence requirements of the Oct! dimer on PORE-related sequences 
in vitro. Furthermore, OBFI stabilizes POU dimer-DNA interactions and overrides 
Oct! interface mutations, which abolish PORE-mediated dimerization without OBFI. 
The data presented here indicate that the PORE-type Octl or Oct2 dimer, rather than 
the monomer, is the primary target of the cofactor OBFI. Based on this biochemical 
data, I propose a mode of OBFl-Octl dimer interaction, indicating a novel 
arrangement of the subdomain connectivities. 
3.2 Introduction 
Specificity in the transcriptional regulation of gene expression is necessary to 
enable the correct temporo-spatial expression pattern during development. The 
combination of multiple factors represents an efficient adaptation to integrate 
different signal pathways and to coordinate cell type and cell cycle specificity. To this 
end, transcription factors bind to DNA directly and assemble with each other and with 
coactivators and/or corepressors. This leads to the formation of specific 
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transcriptional complexes with distinct characteristics based on the DNA-binding 
sequence of the regulatory regions and the particular factors involved. 
The POU family of transcription factors is involved in the transcriptional 
regulation of a wide array of ubiquitous and tissue-specific genes. Octl, often 
regarded as the prototype POU factor, is broadly expressed. Oct2 and Oct4 are 
exemplary POU genes with a narrow expression profile. Oct2 is mainly found in cells 
of the lymphoid system and Oct4 is limited to the mammalian germline, including 
stem cells of the early embryo and germ cells (reviewed in Ryan and Rosenfeld, 
1997). 
Members of the POU transcription factor family share a conserved bipartite 
DNA-binding domain called POU domain, containing the modular POU-specific 
domain (POUs) and POU-homeodomain (POUH). The subdomains are connected by a 
flexible linker, variable in sequence and length (15-56 amino acid residues). POU 
factors bind to DNA elements, such as the octamer motif (ATGCAAAT), as 
monomers (Staudt et ai., 1986; Scholer et ai., 1989b). More recently, POU factors 
have been shown to homo- and heterodimerize on specific DNA motifs (Jacobson et 
ai., 1997; Botquin et ai., 1998; Rhee et at., 1998; Scully et ai., 2000; Tomilin et ai., 
2000; Remenyi et al., 2001). The Oct-factor subgroup binds two of these octamer-
related sequences - the PORE (~alindromic Oct factor Recognition Element: 
A TTTGAAATGCAAAT) and the MORE (More palindromic Oct factor Recognition 
Elements: ATGCATATGCAT). The PORE was first identified as an Oct4 binding 
sequence in the first intron of the osteopontin (OPN) gene in embryonic carcinoma 
(EC) cells (Botquin et al., 1998). Homo- and heterodimers of various POU factors, 
including Octl, Oct2, Oct4 and Oct6, can assemble on the PORE in vitro. 
Dimerization on the PORE mediates strong transcriptional activation supporting the 
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notion of dimer formation in vivo (Botquin et ai., 1998). MOREs and related 
sequences (e.g., the Heptamer/Octamer motif) are found in immunoglobulin heavy 
chain promoters (V H)' Oct family members can also bind cooperatively as homo- and 
heterodimers on the MORE in vitro (Tomilin et al., 2000). 
Furthermore, POU proteins form heterodimers with transcription factors of 
other families. Several POU factors have been shown to interact with members of the 
HMO family, such as Sox2, in vitro (Yuan et al., 1995; Botquin et ai., 1998; 
Nishimoto et ai., 1999; Ambrosetti et ai., 2000; Chapter 4, Chapter 5) or to assemble 
with cofactors (Sauter and Matthias, 1998; Scully et ai., 2000). The most extensively 
studied cofactor is OBF 1, which is expressed in lymphoid cells and interacts 
specifically with Octl and Oct2 monomers and dimers (Luo et ai., 1992; Gstaiger et 
ai., 1995; Luo and Roeder, 1995; Strubin et al., 1995; Tomilin et al., 2000). The 
interaction with the dimer is dependant on the conformation of the POU/DNA 
complex, as OBFl can only bind to PORE-mediated Octl dimers but not to those on 
MOREs. The recently solved crystal structures of the POU domains of the Octl dimer 
bound to the MORE and PORE revealed the structural basis for this selectivity of 
OBF 1. The two POU dimers adopt two different configurations, using different 
surface patches to dimerize on each element (Tomilin et ai., 2000, Remenyi et ai., 
2001). As a result, the same amino acids that are available to interact with OBFl in 
the PORE configuration (Chasman et al., 1999) form part of the POUS-POUH dimer 
interface on the MORE, precluding an interaction with OBFl. 
Osteopontin (OPN) is expressed in various tissues (Denhardt et ai., 1995) and 
the immune system (Weber and Cantor, 1996 and O'Regan and Berman, 2000), e.g., 
in T -lymphocytes and activated pro-B-cells (Lin et ai., 2000). Secreted OPN 
stimulates B-cells to produce immunoglobulins and, in conjunction with an 
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unidentified 14kD peptide, to proliferate (reviewed in Weber and Cantor, 1996). 
Moreover, B-lymphocytes have been shown to playa role in new bone formation in 
which OPN is also involved (Marusic et al., 2000). One common theme that has 
emerged from several of these studies is that OPN is involved in cell migration and 
adhesion. 
In this chapter, I first demonstrate a regulatory link between POU proteins, 
OBFI and OPN expression in B-cells. I then describe the effect of an N-terminal 
OBF 1 peptide (sufficient for protein and DNA binding) on the PORE-mediated 
dimerization of the POU domain of Octl (POUI). The transfection experiment with 
BJA-B-cells reveals that OPN expression in lymphoid cells depends on OBF! and 
that the PORE element is active in B-cells. Consequently, lymphoid cells provide (i) 
an environment conducive to the differential expression of genes via different 
conformations of the same transcription factor and (ii) cofactor recruitment, which are 
both dictated by the DNA sequence. Using Octl interface mutants that specifically 
inhibit dimerization on the PORE, I show that OBFl can compensate for the loss of 
the PORE-specific dimer interface. Besides overriding the effect of the mutations, 
OBFl alleviates DNA sequence requirements by clamping the dimer to the DNA, 
significantly stabilizing the protein-DNA complex. My results suggest that an 
arrangement of the POU subdomains is adopted by the Oetl-OBFI complex on the 
PORE that is different from that proposed for Oetl alone. 
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3.3 Results 
3.3.10steopontin is a target gene of OBFl 
So far, MOREs have been shown to mediate transcriptional activation in B-
cells while POREs are active in pluripotent embryonal cells (Botquin et al., 1998; 
Tomilin et al., 2000). To determine whether both regulatory elements can be 
functional in the same cell type in vivo, my collaborators and I examined if POREs 
are active in B-cells. To this end, I studied the PORE located in the first intron of 
OPN, which is known to regulate OPN expression in ES and Ee cells (Botquin et al., 
1998). First, the levels of OPN transcripts were analyzed by Northern blot analysis 
(performed by Steffen Massa, FMI, Basel, Switzerland; for method see Lins et al., 
2003) to compare the mRNA of normal and OBF I-deficient splenocytes, stimulated 
in vitro (figure 3.1A). OPN transcription was far stronger in wild-type splenocytes 
than in OBF I-deficient cells. We concluded that 0 P N is a target gene of this 
transcriptional coactivator in vivo. However, indirect stimulation of OPN via 
activation of another gene cannot be excluded. 
To determine whether OBFl has the potential to stimulate the OPN gene 
directly, we analyzed several PORE variants in B-cells. For this purpose, three 
different PORE-variant reporter plasmids were transfected into BJA-B-cells known to 
express high levels of OBFl protein (performed by Alexey Tomilin, UPENN, USA; 
for method see Lins et al., 2003). Hexamers of the PORE sequence were cloned in 
front of the thymidine kinase minimal promoter (tk) driving the luciferase gene. The 
mutation in the PORED restricted binding to the POU dimers in vitro while that in the 
POREM restricted binding to POU monomers (Botquin et al., 1998). In F9 Ee cells, 
both the PORE and PORED were more active than POREM , which was only slightly 
more active than the tk-promoter alone (Botquin et al., 1998). In B-cells, reporter 
73 
Chapter 3 OBF 1 enhances transcriptional potential of Octl 
Figure 3.1 
Osteopontin is regulated by OBFl in lymphoid cells 
{A} Analysis of OPN expression in wild-type {wt} and OBFl -/- {ko} splenocytes. 
Cells were stimulated in vitro and total RNA was analyzed by Northern blotting. 
Osteopontin (OPN) transcripts were found at high levels in wild-type splenocytes. 
OBF 1 -/- splenocytes show reduced OPN transcript levels. Actin: control for 
comparable mRNA levels in both samples; OBFl: control to show presence of 
transcripts in wild-type cells and absence in knock-out cells. 
{8} Comparison of enhancer activities of PORE-derived elements in transient 
transfection experiments. BJA-B-cells were transfected with different luciferase 
reporter plasmids (X axis). Y axis: activation of transcription, expressed as relative 
luciferase activities. The tk minimal promoter served as a control. BJA-B-cells 
naturally express OBFl. PORED and POREM are derivatives of the PORE, to which 
only the POU dimer and monomer can bind, respectively. 
74 
OBF 1 enhances transcriptional potential of Octl Chapter 3 
A 
wt ko 
OBF1 
OPN 
actin 
B 
.0 14 
... 
> 12 ... .... 
CJ 
== 10 ~ 
rIJ 
== 8 I. ~ 
.• 6 CJ 
= 
-~ 4 
> ... 
.... 2 
== 
-~ ~ 0 
tk POREM PORED PORE 
Reporter plasmid transfected 
75 
OBF 1 enhances transcriptional potential of Octl Chapter 3 
activity compared to that of the tk reporter alone, was about 9-fold higher for the 
PORE, 12-fold higher for the PORED, and 3-fold higher for the POREM (figure 3.1B). 
These levels of increased reporter activity are comparable to those obtained in 
cotransfection with OBF1 experiments using 293 cells. OBFI stimulates PORE 
activity, with the PORED mediating higher transcriptional activity than the PORE and 
POREM (Tomilin et al., 2000). This result suggests that OPN expression can be 
activated by different sets of POU factors and their coactivators binding to the PORE, 
e.g., by Octl (Oct2) with OBFI (B-cells) and by Oct4 possibly with a yet unknown 
coactivator (early pluripotent embryonic cells). These results also show that in this 
experimental setup, a POU dimer is required for high OPN expression levels whereas 
a POU monomer appears to be insufficient to support full transcriptional activation. 
These results extend the finding that the PORE in the first intron of the OPN 
gene is not only important for the transcriptional activation of OPN in pluripotent 
embryonal cells but also in lymphoid cells. Moreover, in addition to previous findings 
(Botquin et al., 1998; Tomilin et al., 2000), these data further imply that the activation 
is modulated through synergism between the Octl (Oct2) dimer formed on this PORE 
and the lymphoid-specific cofactor OBFl. They furthermore confirm my earlier 
hypothesis that OPN is a target gene of an Octl (and/or Oct2) dimer in conjunction 
with OBF 1 in lymphoid cells. 
3.3.2 Identification of potential PORE-interface mutants 
The above-mentioned experiments suggest that an Oct dimer together with 
OBF! plays a critical role in regulating OPN expression in lymphoid cells. To analyze 
the molecular interaction between these proteins, a set of specific mutations were 
introduced into the POU domain of Oct 1 (POU 1), based on the information provided 
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by the crystal structure of the PORE-mediated POUI dimer (Remenyi et al., 2001). 
The non-overlapping nature of the MORE and the PORE dimerization interfaces 
allowed us to design mutants that were able to selectively affect one type of POU 
dimer formation while leaving the other intact (figure 3.2A and published in Remenyi 
et al., 2001). 
In the crystal structure of the POU-PORE complex, the POUS-POUH dimer 
interface is formed by three types of interactions: (i) POUS-POUH salt bridges (D29-
KI04 and K22-EI09); (ii) specific hydrogen bonds ofR20 (POUs) and S107 (POUH) 
to a common phosphate group in the minor groove of the DNA; and (iii) van der 
Waals interactions within the POUS-POUH interface (by Q18, 121, K22, KI04, Sl07 
and EI09) (figure 3.2B, C). In order to affect dimer formation on the PORE element, 
amino acid residues that playa prominent role in the PORE-type interface (POUs: 
Q18, 121 and K22; POUH: KI04, S107 and E109) were mutated either into small 
amino acids (A, G or S) to remove side-chain specific interactions, or into amino 
acids containing bulky or charged side-chains (Y, D or E) to cause steric clashes or 
electrostatic repulsion within the interface. Two of these mutations are particularly 
interesting since they imitate phosphoserines (mI2, S107D; ml3, S107E; 
Maciejewski et al., 1995). The list of the Octl POU domain mutants is shown in 
figure 3.2D. 
The POU 1 dimer-interface mutants were expressed in E. coli and their 
protein-DNA and protein-protein interactions were analyzed by electrophoretic 
mobility shift assays (EMSAs). First, monomer formation on the canonical octamer 
motif was tested using an oligonucleotide derived from the IgK promoter (Bergman et 
al., 1984; figure 3.3 odd lanes). Two mutants - m3 (I21Y) and mll (S107A) - had 
only little effect on DNA binding. For m3 monomer binding was only affected 
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Figure 3.2 
POUs-POUH interface in the PORE-type dimer 
(A) Interface mutants selectively disrupt the MORE- and PORE-type Oct! dimer. 
Amino acid residues from the MORE- or PORE-type POUS-POUH interfaces were 
mutated to disrupt the respective dimer (MORE-interface mutant: I159D, N160A; 
PORE-interface mutant: 121 V). According to the EMSA, the interface-specific 
mutations do not interfere with monomer binding to the IgK octamer site but 
selectively disrupt the MORE- or PORE-type complex formation. WT, wild-type 
POU domain of Oct!; IgK, oligonucleotide containing the octamer motif from the 
immunoglobulin kappa chain promoter; P, POU monomerlDNA complex; and PIP, 
POU dimerlDNA complex. The unmutated POUI and I159D,NI60A mutant proteins 
exhibit a slightly higher mobility than the 121 Y mutant protein, which has an 
additional 3kD histidine tag. The tag slows down migration in the gel, but does not 
affect interaction with the DNA. 
(B) Representation of the POUI dimer on the PORE. The coordinates were taken 
from the crystal structure published by Remenyi et al. (2001). One POUI molecule is 
colored in purple; the other in green. 
(C) Close-up of the POUS-POUH interface focusing on the intermolecular protein-
protein interactions. All amino acid residues mentioned are predicted to playa role in 
forming the dimer interface. POUs is colored in purple, POUH in green. The critical 
residues are indicated in yellow and the DNA is colored grey. Two-digit amino acids 
are part of POUs; three-digit amino acids belong to POUH. 
(D) List of all mutants used in this study. 
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Figure 3.3 
EMSA showing different effect of POUI mutants on monomer binding to IgK, an 
octamer-containing promoter. Odd lanes: Binding pattern of POUI and its mutants, 
respectively, on the octamer site. Even lanes: Binding pattern ofOBFI plus POUI or 
its mutants on the octamer site. P: POUIIDNA complex; PO: POUl/OBFIIDNA 
complex. 
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slightly, as 121 is not involved in DNA binding and this residue is far away from the 
double helix (figure 3.2B+C; Klemm et a/., 1994). In mIl, the serine at position 107 
(S 107) was changed to alanine - a mutation that has no effect on DNA binding, as 
this residue is not involved in POU monomer contacts to IgK (Klemm et a/., 1994). In 
ml, which was generated to preclude dimerization between POUs and POUH, 
residues Q18, 121, Kl04 and El09 were mutated into alanines and one serine (see 
figure 3.2D), which affected monomer binding very slightly. The effect of mutations 
in m4 was slightly stronger. It is unlikely that the 121 G mutation resulted in the 
weaker interaction with the DNA, since the m3 mutant (121 Y) does not affect DNA-
monomer binding. The K22A mutation, on the other hand, may prevent an interaction 
with El09. In marked contrast, the phospho serine mimicking mutants m12 and ml3, 
in which S 107 is mutated into an aspartic acid or glutamic acid, abolished monomer 
binding to IgK (figure 3.3). Since S107 is located close to the DNA helix when it is 
bound to IgK, replacing it with the bulky and negatively-charged residues probably 
interferes with DNA binding due to electrostatic repUlsion and steric clash. In 
summary, m 1, m3, m4 and mil mutants bind to IgK as monomers whereas m 12 and 
ml3 do not. 
Several studies had previously described a clamping effect of OBF I on the 
POUI monomer to DNA (Babb et al., 1997; Sauter and Matthias, 1998). To assess 
whether OBFl can overcome the compromised DNA binding activities of some of 
these POUI mutant proteins, 1 compared their DNA binding in the presence and 
absence of the OBFl peptide used for solving the Octl/OBF/DNA crystal structure 
(figure 3.3; Chasman et al., 1999). None of the mutations had a negative effect on the 
POUI-0BFl interaction. OBFl-assisted binding was equally weak for all POUI 
proteins that showed normal DNA binding and did not correlate with their intensity of 
82 
OBF 1 enhances transcriptional potential of Oct1 Chapter 3 
monomer binding to IgK DNA (compare even and odd lanes). Furthermore, m12 and 
m13, which cannot bind to IgK alone, also formed an OBF1-containing complex. 
These latter results indicate that OBFl enables Octl binding to IgK DNA when 
monomer binding is severely compromised. 
3.3.3 Structural Basis of OBFl Interaction with the Octl/PORE Complex 
The crystal structure of the POUl/PORE dimer complex (Remenyi et al., 
2001) suggests the way OBFl could bind to the PORE mediated Octl dimer. This 
structure shows how the deviations of the PORE sequence from palindromic 
symmetry lead to differences in the geometric parameters of the two DNA half-sites 
which in tum result in an asymmetric dimer arrangement. Superposition of the two 
half-site POUS-POUH arrangements of the PORE dimer onto the Octl/octamer/OBFl 
complex (Chasm an et al., 1999) shows that only one of them, covering the octamer-
like half-site of the PORE (ATTTGAAATGCAAAT), matches the OBFl binding site 
geometry of the Octl/octamer/OBFl complex (figure 3.4A). Within the other 
POUs/POUH/DNA associate from the nonoctamer half-site, the POUH domain is 
displaced with respect to the arrangement of the Octl/octamer motif complex as a 
reference. In this conformation, the C-terminus of the third POUH helix, which is 
critical for POU/OBFIIDNA complex formation (Chasman et al., 1999), would be 
too far away to be involved in any specific interactions with the coactivator. These 
structural data are validated by a biochemical experiment showing that only one 
OBFl coactivator molecule binds to the Octl PORE dimer (figure 3.4B). In essence, 
these data demonstrate that regulation of Octl by binding of the coactivator OBF 1 not 
only depends on its overall dimer arrangement but also on the specific geometry of 
the DNA element (figure 3.4C). 
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Figure 3.4 
Model of Oct IIPORE/OBF 1 ternary complex 
(A) Superposition of the Octl POU domain from the octamer/OctllOBFI peptide 
ternary complex (Chasman et aI., 1999) with the two POU domain monomers from 
the Octl/PORE crystal structure (see text). The POU domain from the ternary 
complex is shown in red, the OctllPORE complex in blue. Notice that the POUH 
domain superimposes well only for the monomer bound to the upper (octamer-like) 
half of the PORE motif. The other POUH shows an offset and is moved away from the 
DNA. 
(B) EMSA results with the PORED oligonucleotide, the POU domain of Oct!, full-
length OBFl protein, and a 46 amino acid containing OBFl peptide (AOBFl). The 
binding of the full-length coactivator (-30kD) and the OBFl peptide (-SkD) to the 
OctllPORE dimeric complex (PIIPI) result in the formation of differently migrating 
ternary complexes. The absence of a complex with intermediate mobility between 
these two ternary complexes indicates that only one OBFt molecule can bind to the 
OctllPORE dimer (see lane 3). 
(C) The OctllPORE complex could contain two coactivator binding sites at first 
glance. The figure shows the OctllPORE crystal structure with the superimposed 
coactivator peptides in red. Due to the different geometric parameters of the PORE 
DNA half-sites, the lower site is not capable of binding OBFl (crossed out; see text). 
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3.3.4 OBFt rescues mutations that impair POUt dimerization 
After having seen the effect POUI mutants have on binding the octamer motif 
(figure 3.3), 1 examined their effect on dimerization using a PORE variant, PORED, 
that only binds POU dimers but not monomers (referred to as 0-1 in Botquin et al., 
1998; Tomilin et al., 2000). While the unmutated POUI domain formed a dimer on 
PORED, confirming previous data, none of the six mutants retained this capability 
(figure 3.5A), as predicted by the structural analysis of the POUS-POUH dimer 
interface in the POUI-PORE complex (Remenyi et al., 2001). 
The OBF I peptide was mixed with each of the seven Octl derivatives to 
examine its effect on dimerization. A strong heterotrimer was formed when OBF I 
was added to unmutated POUI and PORED (figure 3.5A lane 2). This is in contrast to 
a weak OBFl induced ternary complex formation with POUI on IgK (figure 3.3 lane 
2). This finding supports the notion that the POUI dimer is a better substrate for 
interaction with OBFl than the monomer (Tomilin et al., 2000). Strikingly, each 
POUI mutant that failed to dimerize in the absence of OBFI, formed ternary 
complexes on the PORED in the presence of OBFl (figure 3.5A, even lanes). The 
complexes formed with m3, mIl, ml2 and ml3 POUI mutants were as strong as 
those with unmutated POU1; the ml and m4 mutants showed about six- and four-fold 
reduced capability for heterotrimer formation, respectively. Similar results were 
obtained when the original PORE motif was used as a probe (figure 3.5B). These 
results demonstrate that OBFI rescues the detrimental effect of all POUI mutations 
tested on binding to PORED. Similar to the POUl/OBFl (PO) complex formed by the 
Octl derivatives, the POUllPOUI/OBFl (PPO) complex showed relatively little 
variation in binding intensity. This is in striking contrast to the high variability of 
POUI monomer binding intensities. 
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Figure 3.S 
Dimer binding activities of POUI and its derivatives under the influence of OBF 1. 
(A, B) EMSA showing effect of mutants and OBFl on dimer binding on PORED (A) 
and PORE (8). Setup as in figure 3.3A. PPO: POUIIPOUI/OBFlIDNA complex; 
PO: POUlI OBFIIDNA complex; PP: POUIIPOUIIDNA complex; P: POUIIDNA 
complex. The OBF! containing complex on the PORED consists of two POUI 
molecules and one OBF! molecule (Tomilin et al., 2000; Remenyi et al., 2001). 
The unmutated POUI protein exhibits a slightly higher mobility than the mutant 
proteins, which have an additional 3kD histidine tag. The tag slows down the 
migration in the gel, but does not affect interaction with the DNA. 
(C) Comparison of Oct! variants' transactivities in transient transfection experiments. 
293 cells were transfected with PORED luciferase reporter plasmid, wild-type or 
mutant Oct! expression vectors (none in the control) +1- OBFl expression vector (X 
axis). Y axis: activation of transcription, expressed as relative luciferase activities. 
This result was repeated 3 times. 
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To address the question of whether the Oct! mutants could also be rescued in 
vivo, cotransfection experiments of a PORED luciferase reporter plasmid (referred to 
as 6xO-1 in Botquin et ai., 1998) together with OBFl and Octl expression vectors into 
293 cells were performed (figure 3.SC). Oct! alone activated luciferase activity very 
little compared to the control (figure 3.SC cf. control and Oct! -OBF and Tomilin et 
ai., 2000) and activation by the mutant Octl proteins was even smaller (-OBF bars). 
Upon addition of the OBFI expression vector, reporter activity was highly stimulated. 
The unmutated Oct! caused the activity to double compared to OBFI transfected 
alone (cf. control and Oct! +OBF). In agreement with the results obtained in the 
electrophoretic mobility shift assay (figure 3.5A) the activity of the mutated and 
unmutated Octl cotransfected with OBF I showed little variation in transactivation 
intensity. All Octl variants increase OBFI-induced activity about two-fold. As in the 
gel shift assay, ml has the smallest potential. The high background of OBFI alone 
could be due its synergy with endogenous Oct I in 293 cells. 
3.3.5 OBFl alleviates DNA sequence requirements 
The experiments above showed that mutations that abolish dimerization of 
POUI on PORED due to interface disruptions could be rescued by OBFl. Another 
interface involved in the complex formation is that between the DNA and POUL The 
next question to be solved was whether the OBFI peptide may not only overcome 
mutations in the POUS-POUH interface but may also exert positive effects if the 
protein-DNA interface is unfavorably mutated. To this end, various oligonucleotides 
containing mutations in the octamer site within the PORE were generated based on 
sequence requirements of the octamer motif for POUI binding reported by Verrijzer 
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et al. (1992). Then the formation of POUI monomers, dimers and OBF1-induced 
complexes on these PORE derivatives was examined. 
PORED is one of these unfavorable mutations. Here the T at the second 
position of the octamer motif is mutated into a G (T2G). The POU1 monomer cannot 
bind, whereas the POUI dimer can; a heterotrimer with OBFI binds even more 
efficiently (figure 3.SA). Further DNA mutants are shown in figure 3.6A and B. The 
AIC PORE mutant generally impairs POUI binding in the absence of OBFI. Upon 
addition of OBF1, however, a heterotrimer is formed, which binds as strongly to the 
mutant PORE as it does to the wild-type PORE sequence. Similar data are obtained 
for the PORE mutants A6G and A 7C (referred to as 0-4 in Botquin et al., 1998; 
figures 6A+B), albeit some weak monomer binding is obtained even in the absence of 
OBFl. In addition, on the POREM - a sequence highly related to PORED, where the 
octamer is intact but the T Sbp upstream of the octamer within the PORE is mutated 
into a G - no heterotrimer, but a weak heterodimer was formed (figure 3.6B). 
Furthermore, on PORE AST, a heterotrimer bound significantly weaker than on the 
wild-type PORE (figure 3.6A lanes 7 and 8). This supports previous data (Gstaiger et 
al., 1996; Cepek et al., 1996; Chasman et al., 1999), showing that the AST mutation 
generally reduces OBFI binding. None of these octamer-related motifs were 
identified as target sequences by Verrijzer et al. (1992), suggesting that OBF1 
dramatically alleviates DNA sequence requirements of POUI on PORE-derived 
elements. 
3.3.6 OBFIIPOUI dimer tolerates changes In PORE binding site separation 
The PORE P+ 1 sequence contains an insertion of one nucleotide between the 
two halves of the element. The Oct4 monomer binds to P+ 1 as well as to the wild-
type PORE, whereas Oct4 dimers cannot form (Botquin et al., 1998). Here the finding 
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Figure 3.6 
Sequence requirement alleviation mediated by OBFI 
(A, B) EMSA showing OBFI rescuing POUI binding on mutant POREs. Odd lanes: 
Binding pattern of POUI to the PORE and derivatives thereof. Even lanes: Binding 
pattern ofOBFI plus POUI to the PORE and derivatives thereof. The table shows the 
specific point-mutated PORE derivatives and their abilities to bind the POUI 
monomer (P), POUI homodimer (PP), and the POUIIPOUl/OBFI complex (PPO). 
(C) EMSA comparing POUI with (even lanes) and without OBFI (odd lanes) on IgK, 
PORE and derivatives thereof used to demonstrate differences and similarities in their 
mobilities through the gel. 
(D, E) EMSA with oligonucleotide POREM (0) and P+I (E). Odd lanes: Binding 
pattern ofPOUI and its mutants, respectively. Even lanes: Binding pattern of OBFI 
plus POUI and its mutants, respectively. 
The unmutated POUI protein exhibits a slightly higher mobility than the mutant 
proteins, which have an additional 3kD histidine tag. The tag slows down migration in 
the gel, but does not affect interaction with the DNA. 
Abbreviations: P: POUl/DNA complex; PP: POUl/POUI/DNA complex; PO: 
POUl/OBFIIDNA complex; PPO: POUIIPOUl/OBFIIDNA complex; P+l: PORE 
with one nucleotide inserted between the two half-sites. 
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is extended to Octl, showing that its POU domain only forms a monomer and not a 
dimer on P+ 1 (figure 3.6C, lane 7). For both, POUI and Oct4, these data are 
explained by the loss of the POUS-POUH dimer interface across the two binding sites 
observed in the POU1-PORE crystal structure and modeled in the Oct4-PORE 
complex (Remenyi et ai., 2001). However, when OBFI is added, it forms a higher-
order complex with POUI (lane 8). There are two reasons why I believe this complex 
contains two molecules of POUI and one molecule of OBFl. First, the complex 
migrates to the position of the higher-order complex with PORE and PORED (figure 
3.6C, lanes 4 and 6), which was described as a POUlIPOUl/OBFI heterotrimer on 
DNA, previously (figure 3.3; Tomilin et al., 2000; Remenyi et al., 2001). Second, the 
complex that is composed of only one POUI molecule and one OBFl migrates faster 
(lane 2), to the position of the POUI dimer (figure 3.6C, lanes 3 and 5). Therefore, on 
P+l, OBFl promotes binding of two POUI molecules. This result was surprising, 
because I had expected that only a POU1-OBFl complex was formed on the octamer 
motif, similar to the one formed on IgK DNA (figure 3.6C, compare lanes 2 and 7). 
The question remains: how can the second POU I molecule bind strongly enough to 
the non-octamer half of the PORE sequence (A TTTG) without the bridging interface 
that is required to link the two POU 1 molecules in the absence of OBF I (Botquin et 
al., 1998; Remenyi et al., 200l)? 
To reveal a molecular rationale for this apparent paradox, several experiments 
were carried out. First, binding of POUI to POREM was tested in the presence and 
absence of OBFt. The position of the POU1-OBFl complex on the POREM was 
identical to that formed on IgK but the intensity even weaker than for IgK (cf. figure 
3.6B and 3.6C). This indicates that the same octamer within the PORE can be a good 
or a poor substrate for the POU1-OBFl complex, depending on whether the second 
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POUI is able to bind or not. The m4 mutant protein bound weakly to IgK (figure 3.3, 
lane 7), whereas on POREM no binding was observed (figure 3.6D, lane 7). Therefore, 
I considered it unlikely that m4 would bind to P+ I comparable to the other POU 1 
variants, if a mere structural distortion were responsible for the POU I dimer-OBF I 
complex formation on P+ 1. In contrast, if the two POUI molecules are arranged 
parallel to the DNA axis in the presence of OBFI, and this new arrangement 
represents a better substrate for OBF I, m4 may bind well on P+ I in the presence of 
OBFl. The seven POUI-variant proteins were therefore tested for binding on P+I in 
the absence and presence of OBFI (figure 3.6E). None of the mutants could form a 
monomer on P+ I (figure 3.6E, odd lanes), which is in contrast to monomer binding 
on the IgK site (figure 3.3). This was not due to the nucleotide insertion, as they were 
also unable to form on the PORE, except for m3 and mIl, which bound very weakly 
(figure 3.5B). Only when OBFI was added, did complexes form with the unmutated 
POUI, ml, m3, m4 and mll, which, according to their position on the gel, 
presumably contain two molecules of POUI and one OBFI (figure 3.6E, even lanes; 
cf. figure 3.6C). Since the complexes of all four mutant proteins are similar in binding 
intensity to P+ 1, binding of m4 due to structural distortion seems to be an unlikely 
explanation. I consider it more likely that the POU subdomains are positioned so that 
the linkers between them are arranged parallel to the DNA axis (also see discussion 
section 3.4). 
Only m12 and m13 binding to P+l could not be rescued by OBFl (figure 
3.6E, lanes 11-14). These mutant proteins have an aspartic and glutamic acid instead 
of a serine at position 107, respectively. While OBFl helped tolerate these 
substitutions on the PORE, it appears to have reached its limit to clamp proteins with 
these bulky and negatively-charged side chains to P+ 1. 
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3.3.7 OBFI stabilizes POUI dimer on DNA by reducing its dissociation rate 
The data presented so far indicate that OBF I has a stabilizing effect on the 
POUI dimer on the PORE. Off-rate experiments were performed to further assess this 
effect. To this end, a binding mix was prepared into which a SOO-fold excess of 
unlabelled oligonucleotide was added. The reaction was loaded onto a gel at regular 
time intervals. An increasingly weaker intensity of the bands with time reflects 
proteins dissociating from the DNA and being adsorbed by the excess of unlabeled 
oligonucleotide, thus becoming undetectable. 
The POUI dimer dissociates from the PORED within 30 seconds of binding to 
it in the absence of OBFl (figure 3.7, left halt). This indicates a high off-rate and 
kinetic instability of the protein-DNA complex. The heterotrimer containing the 
OBFl peptide forms a much higher intensity band than the POUI dimer in the 
absence ofOBFI (compare 0 minute lanes in right and left halves). Furthermore, the 
coactivator dramatically reduces the off-rate of the POUI dimer (right half). Even two 
hours after addition of the unlabeled oligonucleotide, about 50% of the complex is 
still bound to the labeled probe, indicating that it has not dissociated from the DNA 
during that time. This reflects a greater than 200-fold reduction in the off-rate with 
OBF 1. This is in striking contrast to the lack of stabilization of the Oct I monomer by 
OBF I in similar off-rate experiments (Strubin et al., 1995), again indicating that the 
PORE-type Octl dimer is a preferred substrate of the coactivator compared to the 
POUI monomer. 
96 
Chapter 3 OBF 1 enhances transcriptional potential of Octl 
Figure 3.7 
Off-rate EMSA ofPOUl dimer vs. OBFl mediated heterotrimer 
Showing the stability of the POUl dimer and the POU1IPOUlIOBFI complex on 
DNA. A binding reaction is prepared into which a 500-fold excess of unlabeled 
oligonucleotide is added after the proteins have been allowed to bind the labeled 
probe. Aliquots of the reaction mixture are loaded onto a gel at regular time intervals 
between 30 seconds and 120 minutes after addition of the unlabeled oligonucleotide. 
Dissociating proteins become undetectable on the gel as they re-associate to the 
unlabeled oligonucleotide. 
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3.4 Discussion 
3.4.1 Osteopontin in B-cells: gene regulation and function 
POU factors exert a high level of flexibility in regulating gene expression, 
attributed in part to their ability to bind DNA as monomers, homo- and heterodimers. 
In addition, these dimers can adopt different configurations depending on the DNA 
sequence they bind to (Tomilin et al., 2000). In doing so, they expose different 
surface patches, which in consequence can recruit different cofactors. In the case of 
Oct4, the two dimer configurations that form on the PORE and MORE elements also 
react differently to phosphorylation of the POU factor (Remenyi et al., 2001). 
Within any given cell, genes cannot be separated spatially from one another 
and are thus exposed to the same transcription factors and cofactors. In such an 
environment, the differential regulation of many genes by the same transcription 
factor must occur. This may be at least partly attributed to the differential effect of 
phosphorylation on transcription factor binding to specific DNA elements in 
conjunction with the selective recruitment of cofactors. It was previously reported that 
the heavy chain of the immunoglobulins is regulated by the MORE-type dimer in 
lymphoid cells (Tomilin et al., 2000) and in this study it is established that 
osteopontin is a target gene of the PORE-like dimer and OBFl in the same cells. 
Thus, we found an environment conducive to various degrees of differential gene 
regulation. 
Secreted OPN stimulates B-cells to produce immunoglobulins and, together 
with an unidentified 14kD peptide, to proliferate (for review see Weber and Cantor, 
1996). Still, the precise function of osteopontin in B-cells remains elusive. In the 
absence ofOBF1, osteopontin is expressed at very low levels (figure 3.lA) and might 
consequently not be able to stimulate B-cells to proliferate, leading to reduced 
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numbers of mature B-cells in OBF1-deficient mice. This reduction of B-cell number 
in OBFl deficient mice has been reported by Kim et al. (1996), Nielsen et al. (1996) 
and Schubart et al. (1996). Thus, osteopontin, along with the 14kDa peptide, might 
have an autocrine effect on B-cells. 
3.4.2 OBFl alleviates DNA sequence requirements for POU dimerization and 
stabilizes the dimer on the DNA 
Verrijzer et al. (1992) analyzed the binding specificity of POU 1 by screening 
a library of randomly synthesized oligonucleotides with POU 1 for high affinity 
targets. Consequently, a sequence similar to the octamer motif was defined as the Oct-
binding consensus. Based on this consensus, I generated various oligonucleotides 
with unfavorable mutations within the PORE and tested them for monomer, dimer 
and OBF1-induced complex formation. I found that even though monomer and dimer 
binding were often impaired, OBF} would discount these unfavorable sequences and 
clamp the POU} dimer onto the DNA (figure 3.6A). The lack of an OBF1-induced 
complex on the POREM and the presence of a weak one on A5T proved that the 
cofactor does not bind indiscriminately. Nonetheless, OBFl alleviates sequence 
requirements substantially. This implies that a weak binding site might only be 
activated by the Octl dimer in the presence of OBF} whereas a strong PORE-type 
binding site may not require a cofactor to activate the target gene. 
The results obtained with P+} - an element in which the two Oct-factor 
binding sites have been moved apart by the insertion of one nucleotide - indicate that 
OBFl-induced dimerization tolerates changes in the separation of the two half 
binding sites on PORE (figure 3.6C). Botquin et al. (1998) showed that on P+} 
dimerization cannot occur, and proposed that this was a consequence of the interface 
having been lost between the two protein molecules. OBF} overcomes these binding 
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difficulties and mediates heterotrimer binding with the POU I dimer to the 
oligonucleotide. There are two possible explanations to account for this ability of 
OBFt: (i) OBFt may clamp the two molecules onto the DNA at a less favorable 
binding site so that the POU factors are bound like on the PORE, relative to each 
other, ignoring the phasing mutation. (ii) The POUI molecules bind to the same 
nucleotides on P+ 1 as on the PORE but protein-protein interaction is not required, 
because OBF! tethers the two molecules to the DNA. This has to be such a strong 
interaction that the POUI molecules do not have to support each other to remain 
bound to the DNA. 
I favor the second explanation partly because of the off-rate results (figure 
3.7), which revealed that the OBF I peptide has a strong stabilizing effect on the 
POUI dimer. This solid stabilizing potential of OBF 1 had not been detected on the 
POUI monomer. Babb et al. (1997) showed a slight OBFI stabilizing effect on the 
paul monomer by DNase I footprint assays. On the other hand, Luo and Roeder 
(1995) could not demonstrate an effect of OBFl on POUI stability by titration 
studies. Furthermore, Strubin et al. (1995) showed that the dissociation rate of the 
Oct! monomer from the octamer binding site was not influenced by the presence of 
OBF I, even though the cofactor exhibits a clamping effect by securing the two 
separate POUs and POUH domains onto the DNA, as shown by EMSA. 
In addition to the PORE-like sequence, the flanking nucleotides also influence 
the binding ability of the POUI dimer and OBFl. POUI does not bind PORED as a 
monomer, but if the two nucleotides 3' of the element are mutated from GG to T A it 
does (figure 3.8A, PD->IgK). The fact that none of the 56 target sites selected for 
POUI binding by Verrijzer et al. (1992) contained two Gs following the octamer 
motif may reflect how POU proteins need to interact as monomers and dimers with 
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Figure 3.8 
Influence of octamer flanking sequence 
(A) EMSA comparing POUI binding to IgK, PORED (PD) and PORED->IgK 
(PD->Igk), a derivative of the PORE with IgK-like 3'flanking nucleotides. 
(B) EMSA of POUI and mutants thereof on BeLl, a MORE, which occurs in 
numerous human and mouse VH promoters (Tomilin et al., 2000). The unmutated 
POU I protein exhibits a slightly higher mobility than the mutant proteins, which have 
an additional 3kD histidine tag. The tag slows down migration in the gel, but does not 
affect interaction with the DNA. 
(C) Sequences of oligonucleotides used to investigated the influence of 3' flanking 
region of the octamer. The octamer (in IgK), PORE (in PORED, PORED->lgK) and 
MORE (in BeLl) are underlined. The 2bp 5' flanking sequence analyzed is written in 
capitals, mutated nucleotides are highlighted in bold. 
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the PORE. This supports the notion that the two Gs following the PORE are 
disadvantageous for monomer formation. Moreover, POUI and its mutants ml, m3, 
m4 and mIl (cf. figure 3.2) can form monomers on BCLI (Tomilin et al., 2000 and 
figure 3.8B), which contains a consensus octamer motif followed by the nucleotides 
CA. For octamer flanking sequences of all oligonucleotides concerned see figure 
3.8C. Indeed, the T A and CA combinations 3' of the octamer motif, which allow 
monomer binding, were obtained as binding sequences in Verrijzer's experiment. 
Genes that should only be expressed in small quantities or when high levels of 
POUI are present in the cell might be regulated by elements to which OBFl cannot 
clamp the POU I dimer. In such a case, the dimer can dissociate from the regulatory 
element rapidly and thus discontinue transcription of the gene. Genes regulated by the 
OBF I-Oct! heterotrimer may need to be expressed at high levels once they are 
activated. This can be provided for, since the complex may remain bound to DNA for 
a longer time and may thus allow multiple rounds of transcription to occur. The 
osteopontin gene, for example, may require high levels of mRNA to be generated 
continuously, as the protein concentration is decreasing when it is secreted from the 
confined cell to the extracellular milieu. 
3.4.3 Mimicking phosphorylation at the PORE dimer interface prohibits POUl-
DNA interaction 
One of the most frequently used mechanisms to regulate the activity of transcription 
factors in response to different extra- and intracellular signals is phosphorylation and 
dephosphorylation (Whitmarsh and Davis, 2000). Activities of several members of 
the POU factor family are controlled by this mechanism. Octl is hyperphosphorylated 
as cells enter mitosis. This correlates with strongly reduced Octl binding to the 
octamer site and a concomitant inhibition of transcription. Phosphorylation of Octl is 
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rapidly reversed as cells exit mitosis and enter the G I phase of the cell cycle (Roberts 
et ai., 1991). It was shown that mitosis-specific phosphorylation of S 1 07 in the 
homeodomain of Octl was sufficient to inhibit the DNA-binding ability of this factor 
(Segil et ai., 1991). This serine is situated in a KRTSIE motif, which is a potential site 
for phosphorylation by a cAMP- or cGMP-dependent protein kinase. Another 
member of the POU factor family, Pitl, was shown to become phosphorylated at two 
distinct sites in the hom eo domain of the protein in pituitary cells in response to 
phorbol esters and cAMP. One of these sites is T107, which plays a similar role to 
S 107 in Octl (Kapiloff et ai., 1991). 
The mutations in m12 (SI07D) and ml3 (SI07E) imitate phosphoserines 
(Maciejewski et at., 1995). In agreement with previous observations, these mutants 
are unable to bind POU binding sites as both monomers and dimers (figure 3.5). The 
bulky and negatively-charged aspartic and glutamic acids get close to the negatively-
charged DNA and inhibit contact between the amino acid and the phosphate 
backbone. This implies that the S 1 07 -phosphorylated Oct 1 cannot bind the elements it 
could in the unphosphorylated state. 
OBF 1 overcomes the steric clash of the phospho serine mimic with the DNA. 
When the cofactor is added to the binding reaction it mildly rescues the 
phosphorylation-mimicked POUI mutant monomer on IgK. On the PORE and PORED 
binding is more enhanced. This difference correlates with the fact that OSF I 
stabilizes the dimer more than the monomer (figure 3.7 and Luo and Roeder, 1995; 
Strubin et at., 1995). On P+ 1, though, the phosphorylation-mimicked POU 1 dimer 
cannot be rescued by OBFl. Thus, in the presence of OBFl phosphorylation of S 107 
could inhibit transcription of a gene regulated by a P+ I-type element but not one 
regulated by a PORE-type sequence. By this distinction, genes could be differentially 
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regulated by the same transcription factor dimer depending on the presence or 
absence of a coactivator, the phosphorylation state of the transcription factor, and the 
DNA sequence of the regulatory element. 
There are multiple events that trigger kinases and phosphatases, changing the 
expression patterns of various genes, such as cAMP elevation, membrane 
depolarization/calcium influx, and growth factor reception. More specifically, cAMP 
levels play an important role in the costimulation of lymphoid cells, which is critical 
for an appropriate immune response. In T -cells, elevation of cAMP levels is 
inhibitory. CD28 co stimulation induces expression of a cAMP phosphodiesterase 
leading to reduced cAMP levels and thus stimulation of T -cells (for review see 
Frauwirth and Thompson, 2002). Similarly, cAMP could result in phosphorylated 
Octl in B-cells. Due to its phosphorylation, the transcription factor might not be able 
to activate all genes required to stimulate the cell, e.g., OPN. Upon costimulation 
mediated by a receptor resulting in a reduction of cAMP, Oct I could be 
dephosphorylated and regulate a wider variety of genes. Incidentally, serine 107, 
which is phosphorylated in vivo, is situated within a KRTSIE motif, which is a 
potential site for phosphorylation by a cAMP-dependent protein kinase. 
3.4.4 Novel POUl dimer configuration upon interaction with OBFl 
The data in this chapter show that OBFl compensates for PORE interface 
mutations and that the cofactor stabilizes the POUI dimer, locking it onto the DNA. 
Based on my observations, I speCUlate that OBFl may induce the Octl dimer to adopt 
yet a different arrangement than proposed for the PORE- and MORE-type binding 
(Botquin et a/., 1998; Tomilin et al., 2000; Remenyi et al., 2001). If the dimer binds 
as proposed for the PORE (figure 3.9B), why does OBFl have such a strong effect on 
two POUI molecules clamping only one of them to the DNA? How does this help the 
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Figure 3.9 
Model of POU1-0BF1 complexes bound to specific DNA elements in different 
configurations. 
(A) POUI and OBFl binding the octamer motif according to Chasman et al. (1999). 
(B) POUI dimer configuration as proposed by Botquin et al. (1998) with OBF 1 
binding to the POUI molecule at the octamer half-site as proposed by Remenyi et al. 
(2001). 
(C) POUI dimer as in (B), but with a different linker connectivity. Here, OBFl binds 
to the POUs domain of one POU1 molecule and to the POUH of another on the 
octamer half-site, with the individual subdomains arranged as in the crystal structure 
solved by Remenyi et al. (2001). 
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second molecule bind to the first and the DNA, especially if these molecules are 
mutated in the PORE dimer interface and bind to P+ 1 ? 
I propose two possibilities for the novel configuration. One may be a scenario 
in which the interaction with OBF1 slightly modifies the POUl dimer's overall 
configuration from that of the PORE-type dimer. In this case, the binding of OBF1 
would result in a minor shuffle of the POU1 molecules on the DNA, so that they 
interact differently from the PORE-type dimer in order to allow for all unfavorable 
binding conditions discussed above. This would appear as in figure 3. 9B but would 
show differences to the PORE-like dimer in a more detailed illustration. An 
alternative scenario would be that the POU 1 subdomains POUs and POUH are bound 
to the DNA sequence motif as observed for the PORE-type dimer (figure 3.9B; 
Botquin et al., 1998; Remenyi et al., 2001). 
In the PORE-type dimer, the two subdomains of one molecule are bound to 
one half site, whereas I propose that with OBF 1 binding, the two subdomains 
belonging to one molecule bind parallel to the DNA strand (figure 3.9C). Thus, OBF1 
would bind to the POUH and POUs from two different POU1 molecules leading to the 
two POUl molecules being clamped to the DNA. This model could provide a 
rationale as to why POU 1 is able to bind P+ 1 in the presence of OBF 1 but not in its 
absence, and how the cofactor overcomes mutations in the protein-protein and 
protein-DNA interface (figures 3.5A and 3.6). 
Furthermore, the fact that OBF 1 reduces the POU I dimer off-rate from the 
PORED so severely (figure 3.7) supports a novel arrangement, whose interaction 
between the different molecules is stronger than that of the PORE-type dimer. 
Moreover, this experiment does not show any PO intermediate complex fonning as 
time progresses. A PO intermediate would have been supportive of a PORE-type 
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configuration, with both linkers being perpendicular to the DNA axis (figure 3.9B). 
Had OBFl clamped the paUl dimer in the PORE configuration, the paUl molecule 
associated with OBFl might have remained bound to the DNA even after the first 
POU 1 had dissociated. In addition, the novel configuration supports the idea of the 
clamping effect being much more pronounced for the POUI dimer (figure 3.7) than 
for the monomer (Luo and Roeder, 1995; Strubin et al., 1995). 
The flexible nature of the linker connecting the POU subdomains argues 
against resolving this issue by a structural approach, since the linker region has 
remained invisible in all POUIDNA crystal structures solved so far. It might still be 
possible to elucidate which of the two arrangements is true by determining the crystal 
structure of the paUl dimer with OBFl on the PORE. If the POUI molecules bind 
like in the PORE-type dimer, the novel dimer configuration can be assumed in order 
to accommodate for the stabilizing impact of OBFl on the dimer. If the subdomains 
cannot be superimposed on the coordinates of the PORE-type dimer, the induced-fit 
model might be the more likely one. 
These results change our view on differential regulation and its fine-tuning via 
the various POU dimers in the context of coactivators. Most importantly, they 
highlight the limitations of a mutational in vitro analysis when it comes to applying 
the results to biological questions in cells or even living organisms. Prior to this study, 
one could have assumed that introducing specific dimer mutations into an endogenous 
POU gene might have exhibited a strong phenotype due to the total loss of dimeri-
zation in vivo. Now, one might anticipate a more subtle or even absent phenotype. 
However, only the introduction of PORE and MORE interface mutations into 
endogenous POU genes will provide an idea whether associated factors that facilitate 
dimerization in vitro, may also help to maintain the full regulatory program in vivo. 
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4.1 Abstract 
Members of the POU and Sox transcription factor families exemplify 
partnerships established between various transcriptional regulators during early 
embryonic development. Although functional cooperativity between key regulator 
proteins is pivotal for milestone decisions in mammalian development, little is known 
about the underlying molecular mechanisms. In this chapter, I focus on two 
transcription factors, Oct4 and Sox2, as their combination on DNA is considered to 
direct the establishment of the first three lineages in the mammalian embryo. The data 
presented here validate experimental high-resolution structure determination, 
followed by model building. This study shows that Oct4 and Sox2 are able to 
dimerize on DNA in distinct conformational arrangements. The binding site 
characteristics of their target genes are responsible for the correct spatial alignment of 
the Velcro-like interaction domains on their surface. Interestingly, these surfaces 
frequently have redundant functions and are instrumental in recruiting various 
interacting protein partners. 
4.2 Introduction 
Transcription factors form multi-protein complexes on DNA, in order to 
orchestrate the correct temporo-spatial expression of developmental genes. The 
process leads to the establishment of functional partnerships, with the combination 
rather than the individual activity of each factor eliciting specific transcriptional 
outcomes. Members of the transcription factor families POU and Sox exemplify this 
functional cooperativity during early embryonic development. POU (Herr and Cleary, 
1995) and Sox (Wegner, 1999) proteins selectively interact with each other via their 
conserved POU and HMO DNA-binding-domains. Their functional partnership has 
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been characterized on regulatory elements in various species, including human, 
mouse and the fruit fly (Dailey and Basilico, 200 I). POU and Sox proteins are 
differentially expressed during development, and their combinations may lead to the 
differential expression of genes critical for cell-fate determination (Dailey and 
Basilico, 2001). The genes encoding the transcription factors Oct4 and Sox2 are 
tightly regulated during development and in embryonic cell lines (see discussion, 
section 4.4). Their combination is critical, as it functions to specify the first three 
lineages in the mammalian embryo (Nichols et a/., 1998; Niwa et a/., 2000; Avilion et 
a/., 2003). While Oct4 and Sox2 are considered to define a combinatorial code in vivo 
(Avilion et a/., 2003), binding of POU factors by Sox2 in vitro is rather 
indiscriminate. For example, the POU domains of several family members, including 
the prototype member Oct!, bind cooperatively with the HMG domain of Sox2 onto 
the 3' UTR of the fibroblast growth factor 4 (FGF4) (Ambrosetti et a/., 1997). 
However, its activation in vivo is dependent on Sox2/0ct4 binding and is mediated by 
Oct4-specific regions external to the POU domain (Ambrosetti et al., 2000). Another 
POU/Sox dependent element is responsible for regulating expression of the 
Undifferentiated Transcription Factor 1 gene (UTF 1) (Nishimoto et al., 1999). 
In this chapter I investigate the interaction of Oct 1 and Oct4 with Sox2 on two 
different DNA binding elements to test whether a previously discovered regulation 
mechanism of DNA-mediated swapping of the arrangement of homodimers may also 
be applicable for unrelated transcription factor assemblies (Tomilin et ai., 2000; 
Remenyi et ai., 2001). The crystal structure of the ternary OctllSox2/FGF4 element 
complex was solved and homology modeling tools were used to construct an 
Oct4/Sox2/FGF4 as well as an Oct4/Sox2/UTF1 structural model, as discussed in this 
chapter. These models and the biochemical data verifying them revealed that the 
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FGF4 and the UTF 1 elements mediate the assembly of distinct POUfHMO complexes 
leading to different quaternary arrangements by swapping protein-protein interaction 
surfaces of Sox2. Moreover, data in this chapter show that Sox2 uses one of these two 
protein interacting surfaces to assemble a ternary complex with another unrelated 
transcription factor on a late embryonic stage specific enhancer (Pax6/Sox2 on the 
DCS element). The findings of this chapter outline a simple mechanism for 
promiscuous yet highly specific assembly of transcription factors, in which the 
sequence of DNA enhancers governs a combinatorial use of redundant protein-protein 
interaction surfaces. 
4.3 Results 
4.3.1 Oct4 and Sox2 interact differentially on the FGF4 and UTFI element 
Sox2 and Oct4 interact with each other on the FGF4 and the UTFI elements 
in order to activate expression of the corresponding genes (Yuan et ai., 1995; 
Nishimoto et ai., 1999). A comparative titration of Sox2 with Oct4 on the FGF4 and 
UTFI elements in an electrophoretic mobility shift assay (EMSA) revealed, that Oct4 
and Sox2 interact differently with each other on these two elements in vitro. A lower 
amount of Sox2 HMO domain was required for heterodimerization with Oct4 on 
UTFI than onFGF4 (figure 4.1A). Since only the POU domain of Oct factors is often 
used for experiments to investigate binding properties of Oct factors and to solve 
crystal structures I investigated whether the Oct4 POU domain (POU4) behaves 
similarly. Indeed, it was found that POU4 is sufficient to exert this differential 
cooperativity and the N- and C-terminal trans activation domains are not required here 
(figure 4.1H). 
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Figure 4.1 
Oct4 and Sox2 interact differentially onFGF4 and UTFI 
(A) EMSA assay of Oct4 and Sox2 with radiolabeled DNA oligonucleotides of FGF4 
and UTFI. Lane 1: no protein; lane 2: Oct4; lane 3-7: increasing amounts ofSox2-
HMG protein mixed with equal amounts of Oct4. Although less Oct4 binds alone 
onto UTFI DNA than onto FGF4, heterodimerization on UTFI is more pronounced 
with lower amounts of Sox2 than on FGF4. The significantly lower degree of 
Oct4IDNA interaction in the absence of Sox2 on UTF 1 compared to that of on FGP 4 
is very likely due to the non-optimal octamer motif sequence for POU binding within 
the UTFI element (Nishimoto et al., 1999). 
(B) EMSA as in figure 4.lA but only with the POU domain ofOct4 (POU4). 
(C) Differential spacing of binding sites for Oct4 and Sox2 in FGF4 and UTFI. 
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The FGF4 element, located within the 3' UTR of the gene, contains 3 base 
pairs between the POU (AT OCT AAT) and HMO (CTTTOTT) binding sites, while no 
such spacer is present between the respective sites within the UTF 1 promoter (figure 
4.1 C). I was therefore interested in whether the observed different biochemical 
properties of the POU/HMO complexes formed on the two elements could be 
attributed to this different spacing of the binding sites, similar to the earlier example 
of POU factor dimerization (Tomilin et a/., 2000; Remenyi et a/., 2001). Previous 
studies showed that the transcriptional activities of POU factor dimers, which are 
induced by binding to specific regulatory elements of target genes, are regulated by 
alterations in their quaternary arrangement (Tomilin et a/., 2000; Remenyi et a/., 
2001). 
4.3.2 Crystal structure determination of the Octl/Soxl/FGF4 ternary complex 
The crystal structure of the POUIHMG ternary complex on the FGF4 element 
was determined by my collaborator Attila Remenyi (EMBL Hamburg) using the POU 
domain ofOctl and the HMO domain ofSox2, as described in Remenyi et a/. (2003). 
POU factor homodimerization on two different elements, PORE and MORE, has been 
characterized structurally with the POU domain of Oct 1, and it represents an example 
analogous to POU/Sox heterodimerization There too could differential transcriptional 
activity be achieved by the same set of transcription factors when interacting on the 
two different elements. The POU/SoxIDNA structure was solved with the POU 
domain of Oct 1 rather than with Oct4 for various reasons. Oct 1 is the archetype of the 
POU transcription factor family, its POU domain is -60% identical to that of Oct4 
and has previously been shown to form a cooperative ternary complex with the HMG 
domain of Sox2 (Ambrosetti et a/., 1997). Furthermore, consistently using Octl for 
structural studies allows the direct comparison of POU homodimerization and 
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POU/Sox heterodimerization on different DNA elements. The 3 'UTR of the FGF4 
gene was the first DNA element that was described to contain a composite DNA 
element binding Sox2 and Oct4 (Yuan et al., 1995). Further biochemical work 
demonstrated the cooperative nature of this interaction with Oct4 as well as with Oct 1 
(Ambrosetti et al., 1997). 
The crystal structure of the OctllSox2/FGF4 ternary complex reveals a novel 
heterotrimeric domain arrangement, in which the centrally positioned POU specific 
domain (POUs) interacts with the HMG domain of Sox2 and the POU homeodomain 
(POUH) of Oct1 (figure 4.2A). The Sox2 HMG domain adopts an L-shaped structure 
and its N-terminal 70-residue segment folds like other structurally characterized 
HMG domains (Weiss, 2001). 
Sox2 binds in the minor groove of the DNA and forms an HMG/DNA 
interaction surface that is comparable in size to that of the POU/DNA (1350 A2 and 
1400 A2, respectively) (figure 4.2B). The size of an interaction surface reflects the 
strength of the van-der-Waals interactions involved. Even though the HMG domain is 
a lot smaller than the POU domain they interact with the DNA with comparable 
surface sizes. In contrast to the straight POU binding site of FGF4, the Sox2-HMG 
domain bends its cognate sequence towards the major groove in an angle of about 
90°, similar to what is reported of other Sox factors (Weiss, 2001). Figure 4.2B 
depicts the sequence specific hydrogen bonds, which contribute to the protein-DNA 
interaction. The amino acids responsible for bending the DNA by inserting their 
hydrophobic side chains between two basepairs are also shown. Side chains from 
residues of a-helix 1 and a-helix 2 of the Sml2-HMG domain are inserted between 3-
bp stacks of the recognition sequence (C"T"T"TGTT; figure 4.2B), leading to 
unwinding of the DNA a-helix at the Sox2 binding site. This insertion and unwinding 
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Figure 4.2 
Crystal structural of the OctllSox21FGF4 ternary complex 
(A) The centrally positioned POD specific domain (PODs) interacts with the HMO 
domain of Sox2. The HMO domain of Sox2 is colored in blue and the POU domain of 
Octl in green (POUs: light green; POOH: dark green). Some part of the POU linker 
region connecting POUs and POOH is invisible in the crystal structure. 
(B) Protein-DNA interactions between HMO, POUI and the FGF4 element. The 
figure shows the sequence of the oligonucleotide used for crystallization. The HMO 
and the POU domain binding sites are colored blue and green, respectively. For 
simplicity, only DNA sequence-specific hydrogen bonds are shown. The hydrophobic 
side chains ofM7, FlO and MIl are inserted between base pairs T5-A45 and T6-A44 
causing a -45° bend of the DNA axis. These and other amino acid residues that playa 
role in bending the DNA at three different base stack levels are either underlined or 
written in black. 
(C) EMSA results of Octl/Sox2IDNA ternary complex formation on the FGF4 
element using mutant versions of the HMO domain of Sox2 (ml) and POU domain of 
Octl (mut). The mutants were designed to interfere with the POU-HMO interface 
fonnation based on the OctIlSox2IFGF4 crystal structure. The R7SE mutation in 
Sox2 (ml) and the 121Y,D29R mutation in POUI (mut) were introduced to reverse 
the charges or increase the bulkiness of important amino acids within the POUIHMG 
interface. wt: wild-type protein. 
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results in the minor groove becoming shallow and expanded at the Sox binding site. 
The minor groove is compressed downstream of the widened Sox binding site due to 
the unwinding and bending. Interestingly, the C-terminal tail of the Sox2-HMO 
domain snugly fits into the compressed minor groove between the Sox2 and the POU 
binding sites. 
The Sox2 part of the crystal structure obtained for the Octi/Sox21FGF4 
complex was compared to crystal structures of HMO-D (Murphy et al., 1999), Lefl 
(Love et al., 1995) and Sry (Werner et al., 1995) in complex with DNA (figure 4.3A). 
Sox2 generates a similar bend angle (90°) in DNA as reported for the other 
HMOIDNA complex structures (HMO-D: 111°; Lefl: 117°; Sry: 75°). a-Helix 1 and 
2 form extensive contacts with the DNA in the widened minor groove and are 
involved in bending the DNA in all structures. However, the proteins show significant 
differences in how their C-terminal region interacts with the DNA molecule. In 
HMO-D, which binds DNA without sequence specificity, only a-helices I and 2 
interact with the DNA. The C-terminus of the Lefl HMO domain lies in the 
compressed major groove and stabilizes the bent DNA conformation. In the Sry/DNA 
structure, the C-terminal part is mainly disordered and is not positioned in the minor 
groove either. 
4.3.3 The POUIHMG interface 
In contrast to the other HMO structures, the C-terminus of the HMO domain 
(residues 68-79) in the Octl/Sox21FGF4 complex is ordered and bound in an 
extended ~-strand-like confonnation in the compressed minor groove located between 
the HMO and the POU domain DNA binding sites (figure 4.3A). This C-terminal 
segment interacts with the DNA and also forms a protein-protein interface by 
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Figure 4.3 
Comparison of different HMO domains 
(A) Structures of different HMO domains from HMO-D (Murphy et al., 1999), Lefl 
(Love et al., 1995), Sry (Werner et al., 1995) and Sox2 (taken from the 
OctllSox21FGF4 crystal structure) in complex with DNA. The DNA sugar-phosphate 
backbone is colored in red-brown and the bases belonging to different chains of the 
DNA molecule are depicted by different colors (yellow and orange). a-Helix 2 (a2) is 
behind the DNA molecule and, therefore, cannot be seen in this orientation. 
(B) Multiple sequence alignment of HMO domains of several proteins from different 
organisms (y: yeast; c: Caenorhabditis elegans; d: Drosophila melanogaster; m: 
mouse; h: human). The order of the proteins on the list reflects their sequence 
similarity. HMO domains from the first six proteins (dHmgd-hHmg2b) are known to 
bind DNA in a non-sequence-specific manner, whereas the others (hLefl-hSoxI3) 
bind DNA sequence-specifically. Secondary structure elements of Sox2 from the 
OctllSox21FGF4 crystal structure are shown beneath the alignment. Protein residues 
that are highly conserved are boxed in grey. It is noteworthy that the protein residues 
that play an important role in the ordering of the C-terminal region of the HMO from 
Sox2 (V3, R5, P6, H63, H67, P68, Y70, Y72, R75 and R76) are conserved in almost 
all members of the Sox family. However, these residues are divergent in HMG 
domains that bind DNA in a non-sequence specific manner. Residues P68, Y72 and 
P74, which play the most prominent role in positioning the HMO C-terminus into the 
compressed minor groove in the OctllSox21FGF4 complex (cf. figure 4.4A), are 
colored in red. 
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contacting a loop of the Oct! POUs domain between a-helices 1 and 2. The crystal 
structure reveals only one sequence-specific interaction between the two domains, a 
salt bridge between R75 (HMO) and D29 (POUs), which could provide a rationale for 
the observed indiscriminate nature of POU/HMO/DNA complex formation 
(Ambrosetti et at., 1997). Since the HMO C-terminus was unstructured in the HMO-
proteinlDNA structures solved to date and since it interacts with POUs of Oct!, the 
ordering of the C-terminal part of the Sox2 HMO domain is most likely induced by 
the presence of a POUIHMO interface. 
In order to test whether the amino acids mentioned above are indeed 
necessary for POU-Sox interaction on FGF4, they were mutated by site directed 
mutagenesis through which their charges were reversed. In the HMO domain, the 
positively charged arginine (R75) was mutated into a negatively charged, bulky 
glutamic acid (E). In the POU domain the negatively charged aspartic acid (D29) was 
mutated into a positively charged arginine and isoleucine (121), which forms a van-
der-Waals interaction with the HMO domain of Sox2, was mutated into a bulky 
tyrosine (Y). EMSAs show that the unmutated POUI and HMO domain of Sox2 (wt) 
bind to FGF4 together (figure 4.2C lane 2). As soon as either the I21Y,D29R Sox2 
mutant (ml) is combined with the unmutated POU1, or the R75E POUI mutant (mut) 
with the unmutated Sox2, ternary complex formation is drastically reduced (lanes 3 
and 5). The two mutated proteins do not dimerize on FGF4 at all (lane 6). 
The EMSA in figure 4.2C displays the importance ofR7S, which is at the very 
C-terminus of the HMO domain. This supports the hypothesis, based on the 
comparison of the ternary structure with other HMO-proteinIDNA ternary complexes, 
that the ordering of the C-terminal part of the Sox2 HMG domain is induced by the 
presence of a POUIHMO interface. 
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A multiple sequence alignment (figure 4.38) reveals that this HMG C-
tenninus (residues 68-79) is virtually identical among all Sox members of the HMG 
family, but unrelated in sequence to members of other HMG subfamilies. This 
suggests that heterodimer interface fonnation via the HMG domain C-tenninus is a 
property limited to the Sox subgroup ofHMG proteins. Moreover, the complementary 
POUs surface patch is also highly conserved among POU factors (Herr and Cleary, 
1995). The C-terminus of the Sox2-HMG domain, which is presumably unstructured 
in the absence of an interacting protein partner, is likely to be a major contributor to 
ternary complex fonnation, since the interaction of this portion of the protein with the 
compressed minor groove increases the HMG proteinlDNA surface by about one third 
of the total (420 A2/13S0 A2). This implies that upon HMG/POU interaction and thus 
ordering of the HMG C-tenninus, the HMG/DNA interaction surface becomes bigger 
and thus stronger, just by unspecific van-der-Waals bonds. The formation of specific 
hydrogen bonds or salt bridges would further enhance the strength of the interaction -
on top of the increase caused by proximity in space. This is the case for tyrosine 
(Y72) of the HMG C-terminus, which interacts sequence-specifically with the DNA 
via a hydrogen bond in the Octl/Sox21FGF4 ternary complex (figure 4.28). Sox2 is 
able to bind to DNA on its own, but with a significantly lower affinity compared to 
binding to DNA as part of a ternary complex with POU or Pax proteins. This 
observation is in agreement with the supposition that Sox proteins are converted into 
high-affinity ligand binders in the presence of other DNA binding protein partners 
(Kamachi et al., 2000). The ordering of the C-terminus and hence an increase in 
protein/DNA interaction surface could be one explanation for cooperativity of 
POUIHMG interaction due to a strong POUIHMG protein-protein interface. 
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4.3.4 Homology modeling of Oct4/Sox2IDNA ternary complexes 
The OctllSox2/FGF4 crystal structure allowed my collaborator Attila 
Remenyi (EMBL Hamburg) to generate a reliable Oct4/Sox21FGF4 model based on 
homology (Vriend, 1990), and to build an Oct4/Sox2/UTFI ternary complex model 
(figure 4.4A). The latter was created by using the experimental structure of the 
Octl/Sox2/FGF4 complex and keeping the Sox2-HMO domain and the Octl/Oct4-
POU domains (POUI and POU4) at their cognate DNA sequences. Because Sox2 and 
POU factors bind DNA in a highly sequence-specific manner, their positioning on 
composite DNA sites can be inferred reliably. The new model is based on a rotational 
movement of the HMO domain towards POUs, and suggests a second POU-HMO 
interface, which is different from that on FG F 4. In both arrangements, the same 
surface patch of the POUs sub domain is used. However, according to the UTF 1-
model, the Sox2-HMO domain interacts via a segment of a-helix 3 (K57-M64) on 
UTF 1 instead of its C-terminus as is the case on FGF4. The HMG interaction surface 
thus changes from an extended l3-strand-like structure to an a-helical interface. 
4.3.5 Sox2 has two surface patches for interaction with Oct4 
To test whether these two distinct protein interfaces indeed exist on the Sox2-
HMO protein, I introduced two supposed UTF I-specific mutations in its C-terminal 
region: K57E, R60E (m2) and R60E, M64E (m3). None of the mutations had a 
significant impact on Sox2IDNA interaction, as the individual proteins bound to DNA 
similar to the respective wild-type protein. 
The proteins were compared to the unmutated HMG and the FGF4-specific 
ml mutant (R75E) in terms of heterodimer formation with Oct4 in EMSAs (figure 
4.4B). The three mutants showed differential ternary complex formation with the 
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Figure 4.4 
Comparison ofPOUIHMG complexes formed on FGF4 and UTFI 
(A) Upper panel: model of POU/HMGIFGF4 (POU domain of Oct! or Oct4) (left), 
compared to the model of Oct4-POUIHMGIUTF 1 (right). The figure illustrates that 
different spacing between the binding sites for the POU and HMG domains within 
FGF4 and UTFI elements causes formation of different heterodimeric interfaces. 
Lower panel: close-up views of the HMGIPOUs interfaces on FGF4 and UTFI. The 
POUIHMGIUTF 1 model suggests involvement of a-helix 3 instead of the C-terminus 
of the HMG domain to form the HMG-POUs interface, while the same surface patch 
of the POUs domain appears to be involved in both interfaces. The DNA molecules 
are depicted with a transparent surface and are colored in grey. 
(B) To validate the homology models in the upper panel, mutations in Sox2-HMG 
were designed to selectively interfere with ternary complex formation on the FGF4 
(ml) or on the UTF 1 element (m2 and m3); ml: R7SE; m2: K57E,R60E; m3: 
R60E,M64E. mut: mutant version ofOct4 POU (I21Y,D29E). In agreement with both 
models, ml specifically impaired heterodimerization on FGF4, while m2 and m3 
specifically abrogated heterodimerization on UTF 1, whereas POU4 mut affected both. 
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FGF4 and UrF 1 elements. Although both FGF4 and urF 1 mediated assembly of a 
ternary complex with the POU domain of Oct4 and wild-type Sox2-HMG, 
heterodimerization with either m2 or m3 on UTF 1 and with ml on FGF4 was 
selectively compromised. As established earlier, 121 and D29 of the POU domain 
play a prominent role in protein-protein interaction with HMG in the 
POUIHMGIFGF4 complex (figure 4.2C). According to the POU/HMGIUTF 1 model 
the same POU surface patch implicated in heterodimerization on FGF4 is also 
involved on UTF 1. In agreement with this observation, the 121 Y, D29R double 
mutation in POU4 disrupted the ternary complex formation on both elements. In 
summary, these results validate the proposed models of Oct4/Sox2/DNA complexes, 
in which distinct surface patches of the HMO domain of Sox2 interact with the same 
surface patch of the POU domain of Oct factors on FGF4 and UTF1. 
4.3.6 Sox2 interacts with Oct4 and Pax6 via the same interface 
Sox proteins can also establish direct functional partnerships with members of 
the Pax transcription factor family (Kamachi et al., 2000). Pax factors contain a 
conserved 128-amino-acid DNA binding 'paired domain' and a C-terminal 
transactivation domain. They play critical roles in mammalian development and 
oncogenesis (Mansouri et al., 1996). Sox2 specifically interacts with Pax6 on the DC5 
enhancer (Kamachi et al., 2001). This enhancer controls the expression of the b-
crystallin gene, which plays a pivotal role in eye development during late 
embryogenesis (Kamachi et al., 2001). 
To test whether Pax6 interacts with one of the two interfaces on Sox2 introduced 
earlier, an EMSA of the DC5 element and Pax6 was performed with mutants m 1, m2 
and m3 in comparison to the wild-type HMO (figure 4.5). Figure 4.5A depicts the 
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Figure 4.5 
Sox2-Pax6 on DC5 and Sox2-0ct4 on FGF4 use the same HMO interface 
(A) Schematic representation of the Sox2 and Pax6 DNA binding site in the De5 
enhancer. 
(B) EMSA showing that the same mutation in HMO, which interferes with POU/Sox2 
on FGF4 (ml), also impairs complex formation with Pax6 on DC5, indicating that 
Sox2 uses the same interface for ternary complex assembly on these elements. 
(C) Schematic presentation showing the two non-overlapping interfaces of Sox2 
required for protein-protein interactions. The position ofR75 (ml) and the positions 
of K57, R60 and M64 (m2 and m3) are shown on a transparent surface of the 
Sox2/DNA complex from the Octl/Sox2/FGF4 crystal structure in yellow and 
magenta, respectively. 
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sequence of the De5 element and the Sox2 and Pax6 DNA-binding sites therein. As 
can be seen in the EMSA (figure 4.5B), in contrast to the HMG mutant ml, wild type 
HMG as well as mutants m2 and m3 heterodimerize with Pax6 on De5. This 
experiment revealed that the same HMG domain mutation, R75E (ml) that 
specifically interferes with OctlSox21FGF4 binding also abrogates Pax6/Sox21DC5 
ternary complex formation, whereas the UTF1-specific mutants (m2, m3) interacted 
with Pax6. This finding suggests that the same Sox2 interface (the C-terminal region 
ofHMG) is required for heterodimer formation with Oct4 on FGF4 and with Pax6 on 
De5, although these two Sox2 partners are members of different transcription factor 
families and, as such, unrelated in sequence and structure. A schematic representation 
of the non-overlapping areas of the HMG domain involved in the interaction with the 
POU domain of Oct factors and Pax6 is presented in figure 4.5C. 
4.4 Discussion 
4.4.1 POU and Sox proteins establish combinatorial codes during development 
Sox genes are expressed in various phases of embryonic development and cell 
differentiation. They are recognized as key players in the determination of cell fate 
(Pevny and Lovell-Badge 1997). Because HMG domains of Sox proteins are similar 
to each other in their DNA sequence preference (Mertin et al., 1999) and in their 
DNA-bending activity (Kamachi et al., 1999), it remains elusive how they are capable 
to regulate different target genes. Assembly with unrelated transcriptional regulator 
proteins, however, provides a plausible explanation of how they can distinguish their 
targets as well as act in a cell-specific fashion (Kamachi et al., 2000). Partnering with 
members of the POU and Pax family of transcription factors, as shown in this chapter, 
may provide paradigm examples. 
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Interactions between various Sox and POU factors provide the best 
characterized examples for Sox partnerships with members of other transcription 
factor families. There is a substantial number of well-characterized examples for this 
alliance in mouse (Oct4/Sox2, Oct6/Sox 1 0, Brn 1 ,2/Sox 11) and in the fruit fly 
(Drifter/Dichaete) underlying their versatile involvement in different biological 
functions (Yuan et al., 1995; Botquin et al., 1998; Nishimoto et al., 1999; Kuhlbrodt 
et al., 1998a,b; Soriano and Russell 1998). The Oct4/Sox2 partnership, for example, 
plays a fundamental role in determining the pluripotent cell state in early embryos 
(Yuan et al., 1995; Nishimoto et al., 1999). In contrast, Oct6/Sox I 0 and 
Bml,2/Soxll pairs have been shown to be involved in glial cell development in 
mouse (Kuhlbrodt et al., 1998b). The Drifter/Dichaete cooperation induces 
development of the central nervous system in the fruit fly (Soriano and Russell 1998). 
This latter finding suggests that POUIHMG partnerships during development might 
be evolutionarily conserved from invertebrates to mammals. 
The list of Sox-interacting partners, however, is not limited to the POU and 
Pax families of transcription factors. Sox9, for example, activates two of its target 
genes in conjunction with yet other transcription factors (Kamachi et al., 2000). It 
regulates CoI2a}, encoding type II collagen, during chondrogenesis in cartilage tissue, 
and the anti-Mullerian hormone gene (AMH) during male sex determination in the 
genital ridge. In both cases the proper expression pattern of the target gene requires 
the Sox binding site in proximity to another conserved DNA binding motif on the 
regulator sequence. Activation of expression requires the concomitant binding of 
Sox9 with an additional transcription factor. In the case of Col2a] the factor has not 
been identified yet, for AMH it has been established as SF 1, a member of the orphan 
nuclear receptor family (De Santa Barbara et al., 1998). 
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The work in this chapter sheds light onto the molecular mechanism of POU 
and Sox partnering on certain enhancers. It will be interesting to see if the principles 
unraveled here can be directly applied to other POU and Sox factor pairs or even -
similarly to the resemblance of POU/Sox and Pax/Sox interaction - for partnerships 
with further protein families. 
4.4.2 In vivo importance of differential POUIHMG interaction on FGF4 and 
UTFl 
As F G F 4 and UT Flare differentially expressed during early mouse 
development, insight might be gained by comparing the activity of these two genes to 
the levels of their regulators: Sox2 and Oct4. The cell lines ES, F9 EC and P 19 EC 
are the in vitro counterpart of early stem cell types of different embryonal stages and, 
as such, provide useful cell culture models (Yeom et ai., 1996). Oct4 protein levels 
are similar in the three cell lines, while Sox2 protein levels vary (figure 4.6) (Yeom et 
ai., 1996; Botquin et ai., 1998). An interesting finding is that both, Sox2 and FOF4, 
have the highest expression level in ES cells followed by F9 EC and then P19 EC 
cells, whereas UTF 1 levels are similar to each other in all three cell lines (figure 4.6). 
One formidable hypothesis is that the different FGF4 and UTF 1 activities 
during development are related to differences in the cooperativity of POU and HMO 
domain interactions on their respective elements. Differential cooperativity may 
provide a rationale for how the FGF4 and UTFJ genes respond to varying amounts of 
Oct4 and Sox2 proteins present during early development. Due to a higher level of 
cooperativity, Oct4 may require comparably little Sox2 to heterodimerize and activate 
UTF 1 expression. Conversely on FGF4, heterodimers and thus increased gene 
expression levels may depend on higher amounts of Sox2. The comparative titration 
experiments (figure 4.1A) demonstrate that a weaker concentration of the HMO 
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Figure 4.6 
Expression levels of gene products in three different cell lines representing different 
cell types during early embryonic development 
= indicates that the level of a gene product is similar between the cell lines. 
The comparison is based on the following references: 
Oct4: IBotquin et al., 1998 
Sox2: 2Yuan et al., 1995; 30ailey et al., 1994 
FGF4: 4Schooriemmer and Kruijer 1991 
UTF 1: sOkuda et al., 1998 
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ES cells F9 EC cells PI9 EC cells 
Oct4 _1 _1 _1 
Sox2 high 2 medium 2,3 low 3 
FGF4 high 4 medium 4 low 4 
UTFI = 5 = 5 5 = 
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domain ofSox2 permits heterodimerization with Oct4 on UTFl than on FGF4. 
The different degrees of Sox2/0ct4 cooperativity on the regulatory elements 
in vitro are in congruence with the sequential up- and down-regulation of UTF 1 and 
FGF4 during development, but these associations need to be tested in vivo. A 
stringent functional test would require specific point mutations to be introduced into 
the Oct4 and Sox2 genes. This approach has become practical only after the 
construction of reliable three-dimensional models presented in this study, and their 
verification by testing the involvement of specific amino acid residues of the HMO 
domain of Sox2 and the POU domain of Oct4 in heterodimerization by mutating them 
and assessing their capability to interact with each other on the DNA elements 
concerned. 
4.4.3 Comparison of POU/POU homo- and POUIHMG heterodimerization 
In collaboration with two former members of the laboratory in which I 
performed the research for this dissertation, we have reported that Oct factors are 
capable ofhomodimerization on two functionally distinct elements, termed PORE and 
MORE (Tomilin et al., 2000; Remenyi et al., 2001). This binding is mediated by 
separate dimerization surface patches of the conserved POU domain. The POU 
domains of all factors tested can dimerize via the two different surface patches on the 
PORE and the MORE without steric clashes. Even though several interacting amino 
acids are not conserved from one protein to the other, their characteristics are similar 
enough to perform the same function (Remenyi et al., 2001). On the MORE, for 
example, the C-terminal residues of POUH of one molecule dock onto the loop region 
between a-helices 3 and 4 of POUs of the other molecule. The side chain of 
isoleucine 159 of Oct 1 fits into a hydrophobic cavity of the POU s subdomain, which 
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forms a "knob-in-the-hole" structure. In Oct4 its counterpart serine 159 could playa 
pivotal role in the MORE interface: it could be involved in hydrogen bond formation 
with glutamine 6 from POUs of the other Oct4 molecule. The modeling, along with 
previous biochemical data (Botquin et al., 1998; Tomilin et al., 2000), suggests that 
the observed interface swapping is a property widely shared in the POU family. 
Clearly, the transcriptional properties of each POU factor and its regulatory 
mechanisms need to be better characterized, in order to discover to what extent the 
potential of interface-domain swapping is generally used to acquire differential 
transcriptional activity. 
Interestingly, Sox2 also contains two functionally and structurally distinct 
protein interaction surfaces. As is the case for POU dimers, the distance between the 
domain binding sites within the DNA motif is critical for selecting between different 
interfaces of Sox2. This property is very likely to be instrumental in creating various 
multi-protein/DNA complexes with distinct biochemical properties. The differences 
in vitro, such as varying amount of cooperativity in complex formation, could result 
in distinct functional properties in vivo, such as varying thresholds of transcription 
factors required for activation or different extents of transcript level production. 
Furthermore, the different quaternary arrangement of transcription factor/DNA 
complexes could serve as the basis for differential recruitment of specific 
coregulators, as has been shown for POU factor homodimerization of Oct 1 and Pitl 
on different elements (Scully et al., 2000; Tomilin et al., 2000; Remenyi et al., 2001; 
Remenyi et al., 2002). 
4.4.4 DNA mediated interaction surface swapping as a general model 
The data presented in this chapter supports the emergence of a novel 
integrative approach to define the principles underlying differential complex 
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formation on DNA. Specifically, it subsumes that vanous combinations of 
transcription factors and their coregulators are possible, along with the potential of 
some of these proteins to interchange their quaternary DNA-mediated arrangements 
via one of multiple surfaces capable of protein-protein interactions (figure 4.7). 
Therefore, a certain dimerization surface patch appears to be adept at mediating 
Velcro-like surface interactions with different interacting protein partners in a 
versatile fashion. As such, this study provides insight into the adaptive mechanisms 
used by transcription factors to assume a regulatory stronghold on various complex 
processes during mammalian development. 
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Figure 4.7 
DNA sequence dependent protein interaction surfaces of Sox2 and Oct factors 
Interface areas involved in protein-protein interaction in a DNA-sequence specific 
manner are marked on the sequence of Sox2, Oct! and Oct4 (non-variant residues of 
Oct4 and Oct! shown with a dot). Several of these areas interact with several other 
protein partners resulting in various combinations of homo- and heterodimers. The 
loop region between the first and second a-helices in the POU domain, for example, 
is involved in interactions with Sox2 on the FGF4 and urF J elements as well as in 
the homodimerization with a second Oct factor on the PORE element. Also, the C-
terminal region of the POU domain interacts not only with a second Oct factor on the 
MORE but - in the case of Octl - also interacts with a coactivator (OBF1) on the 
PORE as well as on the octamer motif (Chasman et at., 1999; Remenyi et al., 2001; 
Chapter 3). 
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5.1 Abstract 
The transcription factors Oct4 and Sox2 regulate transcription of Osteopontin, 
FGF4 and UTF1. The first intron of Osteopontin contains a Sox-binding site and a 
unique PORE with two overlapping elements, binding Oct4 either as a monomer or a 
dimer. Whereas both factors synergistically activate FGF4 and UTF 1, Sox2 interferes 
with Oct4-mediated activation of Osteopontin. This chapter reveals that Sox2-specific 
repression depends on the upstream Sox site and an intact PORE, although neither the 
Sox nor the PORE sites are negative elements on their own. The Oct4 dimer mediates 
high levels of activation via the PORE, which is reduced if Sox2 can communicate 
with the Oct4 monomer. The results presented in this chapter indicate that the 34 bp 
distant Sox site serves as a recruiting site helping Sox2 proteins enter and bridge the 
gap to the Oct4 monomer. This results in a replacement of the Oct4-0ct4 homodimer 
by an inactive Sox2-0ct4 heterodimer and consequently a net reduction of 
Osteopontin enhancer activity. 
5.2 Introduction 
Development is defined by a series of genetic and epigenetic events that 
generate the adult body from the unicellular zygote. In contrast to the complex 
regulatory network that is established during embryogenesis, only a small number of 
transcription factors interact with each other and cofactors to enable this differential 
gene expression during development. 
Members of the POU and Sox families play critical roles in diverse 
developmental processes, providing a model for investigating the mechanisms of gene 
activation by transcription factor complexes (Ryan and Rosenfeld, 1997; Wegner, 
1999). For example, most recently, the synergistic activation of the Sox 17 promoter 
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by the Oct4-like POU factor SPG and the Sox-related Casanova was shown to be 
required for endodenn fonnation in zebrafish (Reim et al., 2004). To date, more than 
20 metazoan POU factors and over 30 Sox members have been identified (Ryan and 
Rosenfeld, 1997; Bowles et al., 2000). The members of these two families are 
involved in diverse developmental processes and, with the exception of the ubiquitous 
Octl, are differentially expressed during embryogenesis. 
Sox factors (reviewed in Wegner, 1999), a subgroup of the HMG-box 
superfamily, all recognize a similar DNA binding motif, C(A/T)TTG(AlT)(AlT), and 
induce a sharp bend in the double helix. Sox proteins may function both as 
conventional transcription factors and as architectural proteins organizing local 
chromatin structure and assembling other DNA-bound transcription factors into 
biologically active multiprotein complexes (Ferrari et al., 1992; Giese et al., 1992). 
Oct4 and Sox2 are representative transcription factors of these two families, 
and can be used to study the combinatorial crosstalk between two developmentally 
relevant factors. Oct4 is expressed in the early mouse embryo and is later restricted to 
the germline. The gene is active in a number of distinct embryonic cell lines, 
including embryonic stem (ES) and embryonic carcinoma (EC) cell lines (for reviews 
see Ovitt and Scholer, 1998; Pesce et al., 1999). Oct4 is downregulated upon the 
differentiation of the embryonic cell lines (Scholer et al., 1989a) and it is required for 
the maintenance of embryonic cell potency (Minucci et al., 1996; Yeom et al., 1996). 
Furthermore, it may serve as a determinant of the germ cell fate by preventing their 
differentiation to a somatic cell phenotype during gastrulation. Sox2 is coexpressed 
with Oct4 in early mouse embryogenesis, ES and EC cells (Avilion et al., 2003). 
Oct4 and Sox2 are considered to be involved in the transcriptional regulation 
of various genes that are differentially expressed during early mouse development, 
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including FGF4, Osteopontin (OPN), UTF 1, Sox2 and Fbx15 (Yuan et al., 1995; 
Botquin et al., 1998; Nishimoto et al., 1999; Tomioka et al., 2002; Tokuzawa et al., 
2003). The regulatory regions of these three genes contain binding sites for Oct- and 
Sox-factors located within the 5' promoter of UTF 1, the 3' UTR of FGF4, the first 
intron of OPN, and the 3' enhancer of Sox2. 
It appears that the arrangement of their binding sites dictates whether Oct4 and 
Sox2 interact synergistically or antagonistically. In FGF4 and UTF I the Oct4 and 
Sox2 binding sites are 3 base pairs and 0 base pairs apart, respectively, with both 
factors cooperating in a synergistic manner (Nishimoto et al., 1999; Yuan et al., 
1995). In FGF4, a specific spatial arrangement between both binding sites enables 
Oct4 and Sox2 to form a ternary complex with precise stereospecific requirements 
(Ambrosetti et al., 1997, Ambrosetti et al., 2000, Chapter 4). Moreover, Oct4 and 
Sox2 can bind to each other, in vitro, in the absence of DNA (Ambrosetti et al., 
1997). 
OPN is expressed in various tissues and cell types, including ES and EC cells 
(Denhardt et al., 1995; Botquin et al., 1998). It is a candidate target gene of Oct4, and 
contains an EC cell-specific enhancer element that is regulated by Oct4 and Sox2 
(Botquin et al., 1998). The spatial arrangement of the octamer and Sox recognition 
sites in the first intron of the OPN gene is different from their configuration in the 
FGF4 and UTFI enhancers. The PORE site, on which Oct4 can bind as a monomer or 
homodimer, was found to be both necessary and sufficient for strong transcriptional 
activation of the OPN enhancer. In contrast, Sox2 repressed the Oct4 stimulatory 
activity via a Sox element located 34 base pairs upstream of the PORE (Botquin et al., 
1998). These results are in dissonance with those of others regarding the synergistic 
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function of Sox2 and Oct4 in the transcriptional regulation of genes (Yuan et al., 
1995; Nishimoto et al., 1999). 
Based on these contrasting findings, I sought to understand how Sox2 
interferes with Oct4-mediated transcriptional activation. I performed the experiments 
for this study in close collaboration with Valerie Botquin, a former member of the 
laboratory I conducted the research for this thesis in. The intact PORE as well as the 
upstream Sox site is required for Sox2 repression. The data presented in this chapter 
suggest that repression occurs by Sox2 binding to the Sox site and thereby facilitating 
Sox2 heterodimer formation with Oct4 on the downstream PORE. Sox2-mediated 
repression occurs as a consequence of the occupancy of the ternary complex on the 
PORE, thereby preventing Oct4 homodimer formation. 
5.3 Results 
5.3.1 Cross-talk between Oct4 and Sox2 in embryonic cell lines 
Previously, Botquin et al. (1998) identified the PORE in OPN as a POU factor 
dimerization site, containing an octamer motif. A point mutational analysis showed 
that the Oct4 dimer elicits higher transcriptional activity than the monomer. Oct4 and 
Sox2 are thought to regulate UTFl, FGF4 and OPN (Yuan et al., 1995; Botquin et 
al., 1998; Nishimoto et al., 1999). Their binding sites are adjacent in UTFJ, 3 base 
pairs apart in FGF4, and 41 base pairs in OPN. The Oct4/Sox2 heterodimer activates 
transcription of FGF4 and UTF 1, but Sox2 represses OPN enhancer activity. This 
chapter is aimed at determining how Sox2 interferes with Oct4-mediated dimer 
activity. 
In order to assess the modality of Sox2 interference with Oct4 activation of the 
OPN enhancer, hexamers of different binding elements were inserted upstream of a 
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minimal herpes simplex virus thymidine kinase promoter (HSV tk) driving the 
expression of the luciferase (Iuc) reporter gene. The SDM oligonucleotide contains 
the wild-type sequence found in OPN. S, D, and M denote the three recognition 
elements in the OPN intron from 5' to 3' (S: canonical S.ox2 recognition element; D: 
POU Dimer binding site; M: the octamer motif, a POU Monomer binding site within 
the dimer site; referred to as OS in Botquin et al., 1998). Lower case letters (s, d and 
m) indicate mutated elements that specifically impair Sox2, Oct4 dimer, and Oct4 
monomer binding in vitro, respectively (Botquin et al., 1998). 
The activities of the reporter plasmids were determined in two embryonic cell 
lines (F9 EC and Rl ES) expressing both Oct4 and Sox2 (figure S.IA, B). The 
activity of the wild-type SDM reporter, although high, was 4.3- and 7.S-fold lower 
than that of the mutated sDM reporter in F9 EC and Rl ES cell lines, respectively. A 
lower activity in Rl ES cells correlate with a higher level of Sox2 protein in these 
cells compared to F9 EC (Chapter 4; Botquin et ai., 1998). 
Poor induction of reporter activity was observed when the POU dimer site had 
been mutated and only the monomer site was left intact (compare SdM and sdM to tk 
in figures 5.lA and B). In both cases octamer activity was moderately higher when 
the Sox element was left intact (not obvious in the figure due to scale). Whereas the 
dimer mutations were almost inactive, the monomer mutants SDm and sDm were 
highly active, indicating that transcriptional activation is due to the dimer. Like for the 
dimer mutants, the monomer mutant with the intact Sox site (SDm) was slightly more 
active than the one with a mutant Sox site (sDm). These results showed that the Sox 
element, per se, is not a negative element, as it neither interfered with Oct4 monomer 
nor with dimer activity. If Sox2 acted as a general repressor of reporter gene activity, 
the s D m and sdM activation levels would have been higher than those 
147 
Chapter 5 Sox2-0ct4 dimer modulates PORE activity via remote Sox2 site 
Figure 5.1 
Transfection assays of OPN enhancer and derivatives thereof 
(A, B) Transfection of 6xSDM luciferase reporter plasmid and derivatives with 
mutated Sox, Oct4 dimer or Oct4 monomer sites (s, d, m) into F9 EC (A) and Rl ES 
cells (B). An empty tk-Iuciferase reporter was used as a control. The results indicate 
that the Oct4 dimer is more active than the monomer and that the Sox element is not 
an independent negative element. 
(C) Cotransfection of 6xSDM reporter plasmid and derivatives thereof with 
increasing amounts of Oct4 expression vector and increasing amounts of Sox2 
expression vector with constant amounts of Oct4. This assay analyzes the effect of 
mutations in the recognition sequences on Oct4' s activating potential and Sox2' s 
repressing potential. Sox2 only represses transactivation in the presence of an intact 
PORE (OM) site. 
(D) Repression is Sox2 specific. Cotransfection of 6xSOM reporter plasmid with 
constant amounts of Oct4 expression vector and increasing amounts of different 
HMO-protein expression vectors, namely Sox2, Sry and Sox9. 
All values are relative luciferase activities. 
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of SDm and SdM, respectively. On the contrary, Sox2 appeared to act positively as 
soon as the PORE was mutated. 
The reporter plasmids were highly active only with an intact dimer-binding 
(D) site. However, differences between the activity of the wild-type reporter (SDM) 
and the monomer mutants SDm and sDm were observed in both cell lines. In F9 EC 
cells SDm and sDm were l.8- and 2.2-fold more active than SDM, respectively 
(figure S.lA), and in Rl ES cells the differences were even higher (5.5- and 6.5-fold, 
respectively; figure 5.1B). In these monomer mutants (m) the left part of the octamer 
motif had been mutated (left part underlined in ATTTGAAAGGCAAAT, bold G 
mutated from original T), which previously had been shown to abolish Oct4 monomer 
but not dimer binding in vitro (Botquin et al., 1998). 
These results indicate that Sox2 does not communicate with the Oct4 dimer 
but possibly with the Oct4 monomer binding to the PORE. The communication of 
Sox2 and Oct4 monomers resulted only in a very weak activation (e.g. S d M 
compared to tk), whereas any dimer reporter was far more active. One way to explain 
the activity of the wild type PORE is that activation by the Oct4 dimer and 
communication by the Sox2 and Oct4 monomers are mutually exclusive. The more 
the Sox2 and Oct4 monomers are able to communicate, the less Oct4 could bind as a 
dimer, resulting in lower activity of the SDM. The increases in Rl ES and in F9 EC 
cells if the octamer site is mutated are in agreement with this notion. Moreover, since 
Sox2 is more abundant in Rl ES than in F9 EC cells Sox2-0ct4 monomer 
communication might be more likely in RI ES than in F9 EC cells. 
5.3.2 Sox2-specific repression depends on intact PORE and Sox element 
To directly assess the effect of Sox2 on Oct4 monomer and dimer activities, 
cotransfection experiments were performed in 293 cells, lacking both of these factors. 
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Increasing amounts of Oct4 and Sox2 expression vectors were cotransfected with 
wild-type and mutant reporter plasmids. 
Sox2 alone did not have any effect on reporter activity. In the absence of 
Sox2, reporter activity increased with addition of increasing amounts of Oct4 
expression vector (figure S.IC). Cotransfecting increasing amounts of Sox2 with a 
constant amount of Oct4 resulted in activation (8Dm), repression (8DM) or no 
significant change (sdM) in reporter activity, depending on the reporter construct 
tested (figure S.lC). A negligible effect was observed when reporter plasmids with a 
mutant Sox site were used (sDm and sdM). Furthermore, Sox2-mediated repression 
of Oct4 activity is only observed when Oct4 can bind to the PORE either as a dimer 
or as a monomer. As soon as only one of both can bind, Sox2 increases reporter 
activity mediated by Oct4, albeit from different levels (8Dm and 8dM). In contrast, 
Oct4 monomer- or dimer-mediated activity remained unchanged upon the addition of 
Sox2, when the Sox2 site had been mutated (sdM and sDm). Therefore, activation 
and repression appear to be mediated at least in part by the canonical Sox site located 
34 base pairs upstream of the PORE. Sox2 repression depends on an intact PORE. If 
the PORE is mutated the Sox element activates expression. 
These results are comparable to those in F9 Ee and RI ES cells (figure S.IA, 
B). In both cases, the loss of Oct4 monomer binding increased reporter activity 
(compare 8DM to 8Dm and sDm). In addition, the monomer plasmids were 
stimulated less than the wild-type reporter (compare 8DM to 8dM and sdM). 
However, in contrast to the results obtained with the embryonal cell lines, the 
difference in activity was less pronounced in 293 cells. 
Next, the question whether other Sox proteins also repress Oct4-mediated 
activity was to be answered. To this end, the effect of Sry and Sox9 on Oct4 mediated 
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activation of OPN was compared to that of Sox2. Increasing amounts of HMO-box 
expression vectors were cotransfected with a constant amount of Oct4 expression 
vector and 6xSDM reporters into 293 cells. Neither Sry nor Sox9 were able to repress 
Oct4-mediated transactivity (figure 5.1D). The presence of Sry did not affect 
transcription, while the addition of Sox9 stimulated activity of the SDM reporter. 
Taken together, these results point to a Sox2-specific repression mechanism of Oct4-
mediated activation of the SDM element. 
5.3.3 Sox2 and Oct4 form a heterodimer on the PORE 
The Oct4 dimer contributes to the predominant transcriptional activity of the 
OPN PORE element. I have shown above that Sox2 acts as a repressor only when the 
Oct4 monomer and dimer can bind to the PORE. Thus, Sox2 must repress Oct4 dimer 
activity. Sox2 is known to interact with Oct4 via protein-protein interactions 
(Ambrosetti et al., 1997, Chapter 4). One possible mechanism by which Sox2 could 
repress the Oct4-mediated activity is preventing Oct4 homodimerization by 
interacting with the Oct4 monomer on the OPN enhancer. The absence of the Oct4 
homodimer may account for the net decrease in transcriptional activity. In such a 
scenario, repression would result from physical competition between Sox2/0ct4 and 
Oct4/0ct4 dimer complex formation. 
As an initial step to test this hypothesis, electrophoretic mobility shift assays 
(EMSAs) using the DM oligonucleotide, representing the PORE without the upstream 
Sox site, and F9 EC cell extracts were performed to analyze Oct4/Sox2 complex 
formation (referred to as 0 in Botquin et al., 1998 and PORE in Tomilin et al., 2000, 
Remenyi et al., 2001 and Chapter 3). 
Increasing amounts of F9 whole cell extract were tested for Sox2 complex 
formation on the DM oligonucleotide (figure 5.2A). As reported previously, Oct4 
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Figure S.2 
F9 cell extract EMSA on PORE and 5SDM 
EMSA of F9 cell extracts (2, 4 and 8J.1g) on (A) the PORE-containing OM 
oligonucleotide and (B) 5SDM where a canonical Sox site is 5 base pairs upstream of 
the DM sequence. Antibodies against Oct4, Octl and Sox2 (aOct4, aOctl, aSox2, 
respectively) eliminate complexes containing these proteins. Poly[d(IC)] prevents 
Sox2 from binding DNA and S, a Sox site containing unlabeled oligonucleotide, also 
competes for Sox2. The lower bands in the 5SDM EMSA are Sox2 degradation 
products. They do not appear at low levels of F9 cell extract and are prevented from 
binding DNA in the presence of poly[d(I-C)]. The protein complexes with DNA are 
as follows: OctllSox2 (112); Octl (1); Oct4/Sox2 (4/2); Oct4/0ct4 (4/4); Sox2 (2); 
two differently phosphorylated Oct4 monomers (4a, 4b; V.B. unpublished). 
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formed monomer (4a and 4b) and homodimer (4/4) complexes on the PORE. The two 
monomers probably represent differently phoshorylated forms of the Oct4 protein 
(Botquin et al., 1998). Furthermore, a monomer of Octl was detectable in these 
experiments. 
A new complex (4/2) of slightly lower mobility than the Oct4 homodimer 
appeared on the OM oligonucleotide with increasing amounts of protein extract added 
(figure 5.2A, lanes 1-3). The complex was found to contain Oct4 and Sox2, as it was 
abolished both by Oct4 and Sox2 antibodies (lanes 4 and 6). Moreover, the formation 
of Oct4/Sox2 complex was affected by the presence of poly[ d(1 -C)] or by increasing 
amounts of unlabeled S oligonucleotide containing a canonical Sox binding motif -
both decreasing Sox2 binding (lanes 7-9). In contrast, Oct! polyclonal antibodies did 
not recognize the complex, excluding that the antibodies have an unspecific effect 
(lane 5). Taken together, these results confirm that Sox2 and Oct4 can form a ternary 
complex on the OM oligonucleotide. 
In order to analyze the effect of an additional Sox2 element on Oct4 complex 
formation, a canonical Sox2 binding site was included 5 base pairs upstream of the 
PORE (oligonucleotide 5S0M). Only a weak Oct4 homodimer complex formed here, 
which was almost replaced by the Oct4/Sox2 ternary complex. Furthermore, a Sox2 
monomer could not be shown in the presence of Oct4, even after long exposure, 
indicating high cooperativity between Oct4 and Sox2 proteins (figure 5.2B, lanes 1-
3). 
A Sox2 monomer complex (2) of weak intensity was observed following 
addition ofOct4 antibodies to the binding reaction (figure 5.2B, lane 4). However, the 
Sox2 monomer did not form on the OM oligonucleotide (figure 5.2A, lane 4), 
implying that Sox2 can only bind to the PORE as a heterodimer with Oct4. 
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An additional mobility complex containing Octl and Sox2 appeared above the 
Octl-DNA complex (figure 5.2B, lane 3, complex 1/2). This complex was only 
formed on the 5SDM oligonucleotide but not on DM (cf. lanes 3 in figure S.lA and 
B). The complex formation was increased following Sox2 protein release from the 
Oct4/Sox2 ternary complex (lane 4). The composition of all protein-DNA complexes 
were confirmed by their competition with specific antibodies (lanes 4-6). 
Taken together, these results demonstrate that Sox2 can form a ternary 
complex with Oct4 on the DM oligonucleotide, representing the PORE. Moreover, a 
canonical Sox2 sequence located in close proximity to the PORE (5SDM) strongly 
enhances the formation of an Oct4/Sox2 protein complex and reduces the binding 
intensity of the Oct4 homodimer. 
5.3.4 Sox2 binds to the non-octamer half of the PORE 
The abovementioned results demonstrate the formation of an Oct4/Sox2 
ternary complex on the PORE (DM oligonucleotide) (figure S.2A). In order to assay 
the binding properties of the heterodimer, EMSAs of recombinant Oct4 (rOct4) and 
Sox2 (rSox2) proteins with DM and mutated versions thereof were performed (figure 
5.3A). 
The recombinant Sox2 can form a monomer (2) on DM, in the absence of 
rOct4 (figure 5.3A, lane 2). A similar rSox2 binding activity was observed on the Dm 
oligonucleotide containing a mutated octamer site (figure S.3A, lane 8; figure 3B). In 
contrast, Sox2 binding activity on the dM oligonucleotide where the non-octamer 
half-site of the PORE contains a point mutation was markedly reduced (figure 5.3A, 
lane 12; figure 3B). These results suggest that Sox2 recognizes and binds to this part 
of the PORE. Comparison to a canonical Sox2 recognition element reveals that the 
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Figure 5.3 
EMSAs on PORE and derivatives with recombinant proteins 
(A) Binding pattern of recombinant Sox2 and Oct4 (rSox2, rOct4) on the PORE 
(OM), its monomer mutant (Om), dimer mutant (dM) or 1 W (part of the Ig heavy 
chain gene enhancer element). 
(8) Oligonucleotide sequences and their ability to bind Sox2 compared to the 
consensus Sox2 site. 
(C) EMSA as in (A) on SSOM where a canonical Sox site is located 5 base pairs 
upstream of the OM sequence. Increasing Sox2 levels cause the appearance of a 
multiprotein complex (MPC). Sox2 degradation products are detectable with Sox2 
only and when antibodies against Oct4 are added to the reaction. 
(D) EMSA with Oct4 and Sox2 on the phasing mutant P+l where one nucleotide was 
inserted between the two half-sites of the PORE. 
Antibodies against Oct4, and Sox2 (a4, a2) abolish complexes containing these 
proteins. The protein complexes with DNA are as follows: multiprotein complex 
consisting of Sox2 and Oct4 proteins (MPC); Oct4/Sox2 (4/2); Oct4/0ct4 (4/4); Sox2 
(2); Oct4 monomer (4); lower bands represent Sox2 degradation products. 
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non-octamer half-site of the PORE represents a half-core motif of a Sox2 consensus 
binding site (figure S.3B). 
The binding pattern of recombinant Sox2 and Oct4 was then analyzed on the 
DM oligonucleotide (the PORE element). As reported previously, rOct4 formed a 
monomer- (4) and homodimer-DNA complex (4/4) on the PORE (figure S.3A, lane 1; 
Botquin et al., 1998). Following rSox2 addition to the Oct4 binding mixture, another 
protein-DNA complex (4/2) of lower mobility than the Sox2 monomer and the Oct4 
homodimer appeared (lanes 3 and 4). The composition of all protein-DNA complexes 
was confirmed by their competition by specific antibodies (lanes Sand 6). 
All Sox2 monomers bound to the PORE were involved in the ternary complex when 
Oct4 was added (figure S.3A, lanes 3 and 4). This is in agreement with the results 
obtained with whole cell extracts, where Sox2 also readily forms a heterodimer with 
Oct4 on the PORE sequence (figure S.2). As a consequence of the Sox2/0ct4 
interaction, Oct4 monomer binding activity is reduced in the presence of Sox2 (figure 
S.3A, lanes 1, 3 and 4). These results, as well as the fact that the Oct4 dimer and the 
Sox2/0ct4 heterodimer are mutually exclusive, indicate that the Oct4/Sox2 ternary 
complex forms on the PORE. Such an interaction is most likely through Oct4 
monomer binding to the octamer motif and Sox2 binding to the non-octamer half of 
the PORE, representing an additional Sox binding site. Consequently, Oct4 and Sox2 
would compete for the non-octamer half of the PORE. 
Only an Oct4/Sox2 ternary complex of weak intensity could form on Dm, 
which contains a mutated octamer motif (figure S.3A, lanes 9 and 10; figure 3B}. The 
formation of the 4/2 complex on the dM oligonucleotide, on which the potential Sox2 
binding site of the PORE is mutated, was affected similarly (lanes 13 and 14). These 
results support the notion that formation of the ternary complex on OPN requires both 
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intact half-sites of the PORE - an octamer site and an alternative Sox binding site. 
They reveal that in OPN, the binding of the ternary complex requires an intact PORE 
element on which the Oct4 homodimer and the Oct4/Sox2 heterodimer can compete 
for the same binding site. 
The Ig heavy chain gene enhancer element (1 W) contains a similar potential 
recognition site for Sox2 close to the octamer motif but does not contain a POU 
dimerization site. 1 W was tested for ternary complex formation (figure S.3B; compare 
TTTAGAA from lW to ATTTGAA of the PORE), and although only a Sox2-DNA 
complex of weak intensity formed, a relatively strong Oct4/Sox2 ternary complex 
appeared on the 1 W oligonucleotide (figure S.3A, lanes 17 and 18). 
Then the effect of an additional Sox2 element in close proximity to the 
octamer site on ternary complex binding activity was tested. In the presence of the 
upstream Sox2 element on 5SDM, the formation of the ternary complex was greatly 
enhanced and, consequently, the Oct4 monomer and dimer complexes were strongly 
reduced (figure 5.3C, lanes 1, 3 and 4). In addition, a multiprotein complex (MPC) 
became evident (lanes 3 and 4). Upon addition of the Oct4 antibody, Sox2 is released 
and forms a monomer of stronger intensity on the DNA (lane 5). The Sox2 antibody 
captures all Sox2 molecules, resulting in only the Oct4 monomer and dimer binding 
to DNA and the absence of an MPC (lane 6). This suggests that the MPC contains 
both recombinant proteins. Therefore, this MPC may represent Sox2/Sox2/0ct4, 
Oct4/0ct4/Sox2 or even higher-order protein-DNA complexes. 
In the presence of Sox2 alone, a lower mobility complex was evident, which 
may consist of Sox2 homodimers or two individual Sox2 molecules bound to the two 
potential Sox2 binding sites on the 5SDM oligonucleotide (lane 2). In the presence of 
increasing amounts of Sox2 protein and constant amounts of Oct4 protein, formation 
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of the multiprotein complex on the 5SDM oligonucleotide was even more pronounced 
(lanes 7-10). Under these conditions, only weak or no binding of the Oct4 monomer 
and homodimer could be detected; however, the fonnation of the Oct4/Sox2 complex 
fonnation was unaffected. 
5.3.5 Oct4/Sox2 ternary complex is cooperative 
Botquin et al. (1998) have shown that POU proteins cooperate with each other 
to fonn dimers. A logical following question was whether Oct4 and Sox2 behave in a 
similar fashion. Phasing mutations, by inserting or deleting one or more nucleotides 
between two binding sites, were shown to abolish POU dimer fonnation (Botquin et 
al., 1998). Likewise, figure 5.3D shows that Oct4 and Sox2 cannot heterodimerize on 
the P+ 1 oligonucleotide, in which one nucleotide had been inserted between the two 
halves of the PORE. Negligible amounts of 4/2 complex fonned on P+ 1 (figure S.3D, 
lane 3). These results suggest a cooperative interaction between Oct4 and Sox2 on the 
PORE. 
5.3.6 Oct4/Sox2 heterodimer is more stable than Oct4 homodlmer 
Sox2 mediates a strong repression of Oct4 transcriptional activity (see figure 
5.1). This could be attributed to a greater stability of the Oct4/Sox2 ternary complex 
on the PORE compared with the Oct4 homodimer. To test this hypothesis, the 
stability of Oct4 and Sox2-containing complexes was investigated. To this end, off-
rate EMSAs using F9 extracts and the DM oligonucleotide were perfonned to assess 
the complexes' dissociation (figure 5.4A). To distinguish between Oct4 homodimer 
and Oct4/Sox2 heterodimer complexes, poly[d(I-C)] was added to prevent Sox2 from 
binding to the DNA in one experiment (compare figures 5.4A and B). 
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Figure 5.4 
Off-rate EMSA showing stability of protein-DNA complexes 
A binding reaction is prepared into which a 500-fold excess of unlabeled 
oligonucleotide is added after the proteins have been allowed to bind to the labeled 
probe. Aliquots of the reaction mixture are loaded onto a gel at regular time intervals 
between 1 and 30 min after addition of the unlabeled oligonucleotide. Dissociating 
proteins become undetectable on the gel as they re-associate to the unlabeled 
oligonucleotide. 
(A, B) Stability of proteins from F9 cell extract and F9 extract with poly[d(IC)], 
which circumvents Sox2 binding to the PORE (OM). 
(C, D) Off-rate experiment of recombinant Oct4 (rOct4) and recombinant Sox2 
(rSox2) off OM. This excludes an effect of any factor within the whole cell extract 
other than Oct4 and Sox2 on the stability of the protein-DNA complexes. 
The protein complexes with DNA are as follows: Oct4/Sox2 (4/2, emphasized by 
arrowhead); Oct4/0ct4 (4/4, emphasized by arrow); Sox2 (2); Oct4 monomer (4); two 
differently phosphorylated Oct4 monomers (4a, 4b; V.B. unpublished). 
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The Oct4/Sox2 ternary complex remained bound to OM longer than the Oct4 
homodimer (compare arrowhead and arrow in figure 5.4A), which dissociated rapidly 
under both conditions (figures 5.4A and B). The Oct4 monomer was more stable than 
the Oct4 homodimer. Interestingly, the presence of Sox2 lowered the binding activity 
and accelerated the dissociation of the Oct4 monomer and dimer. By preventing Sox2 
binding, Oct4 homodimer binding was still detectable after 15 min of competition 
(see arrow in figure 5.4B). In contrast, under conditions allowing for Sox2 binding, 
Oct4 homodimer dissociation occurred within 7.S min (see arrow in figure 5.4A). 
Comparison of the lanes of the IS-minute interval shows that more monomer is still 
bound when Sox2 binding on OM is inhibited. 
To exclude the possibility that cellular factors other than Sox2 affect the 
stability of the Oct4 monomer- and homodimer-ONA complexes, similar competition 
experiments were performed with recombinant Oct4 and Sox2 proteins (figure S.4C 
and D). Like for the F9 cell extracts, the Oct4/Sox2 heterodimer complex exhibited a 
slower dissociation rate than the Oct4 homodimer. Moreover, the latter dissociated 
faster in the presence of Sox2 (within 10 min as opposed to 30 min in the absence of 
Sox2). The effect of Sox2 on the Oct4 monomer was not as pronounced. Taken 
together, the effect of Sox2 on the dissociation rate of the Oct4 homodimer can be 
reproduced in vitro using recombinant proteins. These results demonstrate that 
binding of Sox2 increases the dissociation rate of Oct4 homodimer. 
5.3.7 Dissociation rates of Oct4-containing complexes 
In order to quantify the dissociation rates of the different protein-DNA 
complexes, a similar competition assay using recombinant proteins was performed in 
an extended time course. The SSDM oligonucleotide was used in parallel with OM to 
determine the influence of a Sox2 binding site on the stability of the different 
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complexes. The intensities of the complexes were quantified using the 
Phosphorimager (figure 5.5). 
Percentage of bound complex at a specific time (percentage of [bound protein-
DNA complex at time x]/[I of total bound protein-DNA complex at time x]) was 
then plotted as a function of time on a semi-logarithm graph (figures 5.5C, D). The 
half-lives of the protein-DNA complexes in minutes were interpolated from the 
graphs (figure S.SC-E) and the dissociation rate constants (~) were calculated from 
the equation In2/T[so% complex bound] (figure S.SE). The half-life of the Oct4/Sox2 
heterodimer on the PORE is 5 times longer than that of the Oct4 homodimer. 
Moreover, the presence of a Sox2 recognition element upstream of the PORE further 
destabilizes the Oct4 monomer and dimer complexes. The half-life of the heterodimer 
on SSDM is II-fold longer than that of the homodimer. This clearly proves that the 
Sox2/0ct4 heterodimer complex is more stable than the homodimer. 
In contrast to all Oct4-containing complexes, binding of the Sox2 monomer 
complex to both oligonucleotides increases during the time course of the experiment. 
This indicates that the Sox2 protein-DNA complex by itself is remarkably stable and 
as such favors the formation of the newly Oct4/Sox2 ternary complex. The 
dissociation of the Oct4/Sox2 complex reflects only the dissociation of the Oct4 
molecule from the DNA. The Sox2 molecule remains bound, resulting in an increase 
in Sox2 monomer bound to DNA over time. 
5.3.8 Upstream Sox binding site recruits Sox2 to the PORE 
The transfection results in figure 5.1 indicate that the Sox2 site located 34 base 
pairs upstream of the PORE is necessary for repression. In addition, the EMSAs show 
that Sox2 binds to the PORE (DM) in a stable Oct4/Sox2 heterodimer complex. The 
Sox2 element presumably acts by recruiting Sox2 proteins, which in tum contribute to 
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Figure 5.5 
Dissociation constants of protein-DNA complexes 
(A,8) Off-rate experiments of recombinant Oct4 and Sox2 of DM (A) and 5SDM (B) 
as in figure 5.4. The protein complexes with DNA are as follows: multiprotein 
complex consisting of Sox2 and Oct4 proteins (MPC); Oct4/Sox2 (4/2); Oct4/0ct4 
(4/4); Sox2 (2); Oct4 monomer (4). 
(C,D) Plot of percentage of bound complex at a specific time (percentage of [bound 
protein-DNA complex at Time-x]/[~ of total bound protein-DNA complex at Time-
x]) on semi-logarithm graph for DM (C) and SSDM (D). 
(E) The half-lives of the protein-DNA complexes in minutes were interpolated from 
the graph. Dissociation rate constants (~) in S·1 were calculated with the equation 
ln21T [500;0 complex bound]. 
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the formation of a ternary complex on the PORE. 
My collaborator Valerie Botquin (EMBL, Heidelberg) conducted DNase I 
footprint assays to determine which mechanism accounts for the ability of Sox2 to 
contribute to the formation of the ternary complex from its cognate site (figure 5.6; 
for methods see Botquin et al., submitted). Footprint analyses were performed using 
recombinant Sox2 protein and a PCR fragment of the first intron of OPN (i-opn). 
Strong protection was afforded to the Sox2 consensus binding site (site A) (figure 
5.6A-C). Moreover, two additional regions were highly protected: a sequence located 
downstream of site A, representing a partial Sox2 recognition element (site B), and an 
NT rich region located 30 base pairs downstream of the PORE (site C). In addition, 
regions spanning from site A to the PORE were moderately protected independent of 
Sox2 concentration. Although EMSAs have demonstrated that the left half-site of the 
PORE is a potential Sox2 binding site, no strong protection was detected in this 
region (figure 5.6A-C). 
The experiments were performed using recombinant Sox2 protein (figure 5.6A 
left) and the recombinant HMG domain of Sox2 (figure 5.6A right), which lacks the 
C-terminus of the protein. For the HMG domain, lower amounts of protein were 
applied (10-50ng). The lowest amount already showed a protection pattern similar to 
that with full-length Sox2. In contrast to full-length Sox2, enhanced protection of the 
PORE was observed with the highest amount ofHMG (figure 5.6A right). 
In order to quantify the degree of protection afforded to the PORE, Valerie 
Botquin carried out phosphorimager analyses of the full-length Sox2 DNase I 
footprint (figure 5.6B). A comparison of the relative band intensities between DNase I 
digested DNA in the presence (+ Sox2; red) and absence (- Sox2; black) ofSox2 was 
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Figure 5.6 
Footprint assays determining location of Sox2 binding on DNA 
(A) Footprint of increasing amounts of recombinant Sox2 (rSox2) and the HMO 
domain (rHMO) of Sox2 on a DNA fragment of the first intron of OPN. Sites A, B, C 
and the PORE were bound by Sox2 or HMO and thus protected from DNase I. 
(8) Relative band intensities without (black) and with (red) Sox2 protection, 
measured by a phosphoimager. Lower intensities as shown with Sox2 at sites A, B, C 
and the PORE indicate protection from DNase I due to the binding of Sox2 to these 
areas. 
(C) Sequence of the DNA fragment of the first intron of OPN displaying the sites 
protected by Sox2. 
(D) Footprint of Sox with increasing amounts of NaCI proving that Sox2 binds 
specifically to this region. 
(E) Footprint with increasing amounts of rSox2 on a derivative of the DNA fragment 
with a mutated site A. Protection of site A, the PORE and sequences in between is not 
seen anymore. Only site B is protected slightly, but less than that of the wild-type 
DNA (figure S.6A). Site C is unaffected by the mutation. 
(F) Increasing amounts of Sry confer no protection in footprint assay, revealing that 
binding to all sites is Sox2 specific. 
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obtained. In the presence of Sox2, the band intensities measured on the PORE region 
were significantly reduced to about 45%. 
To discount the possibility that the protection between site A and the PORE is 
due to nonspecific binding of Sox2, the Sox2 binding reaction was performed in the 
presence of increasing salt (NaCl) concentration (figure 5.6D). Nonspecific binding to 
DNA is very sensitive to salt because ionic interactions (between negative charges on 
the DNA and positive charges on the protein) are responsible for a considerable part 
of the favorable energy that drives nonspecific binding. NaCI competes for these 
interactions, and thus weakens them. In contrast, binding to a specific DNA site is not 
as sensitive to N aCI, as this interaction includes the additional stabilizing energy of 
hydrogen bonds between the protein and the DNA binding site. 
The pattern of protection was still visible with up to 150mM NaCl. The 
protection was lost in the region upstream of and including the PORE in the presence 
of 200mM NaCI only. In this case, reduced protection was also observed for sites A, 
B, and C. These results indicate that Sox2 binds specifically to the region downstream 
of site A. 
Then, footprint analyses were performed with an i-opn PCR fragment 
containing a mutated site A similar to sDM. As expected, no protection was afforded 
to the mutated site A (figure 5.6E). In contrast, Sox2 protection was still apparent at 
site C and to a lesser extent at site B. However, no significant protection occurred on 
the PORE region (figure 5.6E). These results suggest that site A is essential for the 
recruitment of Sox2 proteins to the PORE. 
A variety of mechanisms explain how proteins acting on distant cis-elements 
may regulate gene expression, including looping, twisting, sliding and oozing 
(reviewed in Ptashne, 1986). The mechanism of oozing describes the binding of a 
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regulator protein to its cognate sequence as helping the binding of another molecule 
to adjacent sequences. This in turn helps another protein bind next to it, and so on, 
until a procession of proteins has oozed out from the control sequence to the target 
element. Sliding involves the binding of a protein to a DNA element with high 
binding affinity, from which it slides along the DNA where binding is still stable but 
not sufficient to allow binding initiation. For both models, a mutation of the upstream 
Sox site (site A) that prevents initial Sox2 binding would result in the inhibition of 
Sox2 heterodimerization with Oct4 on the downstream PORE. 
Cotransfection experiments have shown that neither Sry nor Sox9 proteins 
were able to repress Oct4 activity, suggesting a Sox2-specific repression mechanism 
(figure S.ID). This could be attributed to Sox2-specific sliding or oozing. To test this 
hypothesis, increasing amounts of recombinant Sry protein were assessed in a DNase 
I footprint assay with the wild-type i-opn fragment (figure S.6F). Although binding of 
Sry on the OPN fragment occurred in the mobility shift assay, footprint analyses 
detected only modest protection of sites A, Band C. However, no protection appeared 
on the regions next to site B and on the PORE, even with the highest amount of Sry 
protein. This suggests that weak binding of Sry to the OPN fragment is not sufficient 
to allow sliding or oozing to occur to adjacent sequences, or that sliding or oozing is 
Sox2 specific. 
5.3.9 Influence of site A on gene repression 
The experiments described above indicated that the upstream Sox site recruits 
Sox2 to the PORE by sliding or oozing. Mutating the Sox site (site A) prevents the 
recruitment, suggesting that it is essential for the formation of a multi-Sox2 complex 
that reaches the PORE site. Mobility shift assays have revealed the formation of 
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multiprotein complexes (MPC) only when a Sox2 consensus binding site and the 
PORE are present in an oligonucleotide (figure 5.3C). 
The next step was to determine whether this MPC formation is controlled by 
site A. To this end, an EMSA was performed to assess the ability of the MPC to form 
on the wild-type SDM oligonucleotide compared to one with a mutated Sox site 
(sDM). 
Increasing amounts of recombinant Oct4 were used in combination with 
constant amounts of recombinant Sox2. As expected, a multiprotein-DNA complex 
was detected on the SDM oligonucleotide (figure 5.7A, lanes 6-9). Both, Oct4- and 
Sox2-specific antibodies interfered with this complex, indicating that both proteins 
are in the MPC (cf. figure 5.3C). The complex also migrates at a higher position than 
that on 5SDM, indicating that it contains more protein molecules. In contrast, no 
higher-order Oct4/Sox2-DNA complex could be formed on the sDM oligonucleotide 
(figure 5.7 A, lanes 15-18). These results indicate that the Sox2 recognition element is 
necessary for multiprotein complex formation. 
To further demonstrate that Sox2 reaches the PORE by sliding or oozing from 
its recognition site, I surmised that a shorter region between the upstream Sox site and 
the PORE could enhance Oct4/Sox2 heterodimerization on the PORE due to more 
efficient sliding or oozing over a shorter stretch of DNA. For this purpose, tk 
luci/erase reporter plasmids containing oligonucleotide hexamers in which the 
upstream Sox site was brought 5 base pairs (6x5SDM) and II base pairs (6xIISDM) 
away to the PORE were transiently transfected into F9 EC and R I ES cell lines. Their 
luciferase activity was compared to that of the wild-type vector 6xSDM, in which the 
Sox site is 34 base pairs upstream of the PORE (figure 5.7B, C). 
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Figure 5.7 
Oct4/Sox2 MPC fonnation depends on site A 
(A) EMSA of increasing amounts of recombinant Oct4 with or without constant 
amounts of recombinant Sox2 on the wild- type OPN fragment (SDM) or a derivative 
thereof containing a mutated Sox site (sDM). The multiprotein complex (MPC) only 
binds in the presence of an intact Sox site (SDM). The other protein complexes with 
DNA are: Oct4/Sox2 (4/2); Oct4/0ct4 (4/4); Sox2 (2); Oct4 monomer (4). Sox2 
degradation products are detectable in the reaction containing Sox2 without Oct4. 
(8, C) Reducing the distance between Sox2 and the PORE motifs increases gene 
repression. Transfection assay of SOM reporter plasmid and its derivatives with only 
11 (11SDM) or 5 base pairs (5SDM) between the PORE and Sox sites into F9 EC (8) 
and Rl ES cells (C). The -37tkluc reporter plasmid was used as a control. 
174 
Sox2-0cJ.J dimer moduLates PORE activity via remole Sox2 site ChapJer 5 
A 
rSox2 
rOct4 
MPC[ 
4/2-
4/4-
2-
4-
B 
SDM sDM 
+ + + + + + + + + + 
____ ... 0. 0 ______ 0. C 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 
F9 I c 
175 
Sox2-0ct4 dimer modulates PORE activity via remote Sox2 site Chapter 5 
In both cell lines, the highest activity was obtained with the wild-type 6xSDM 
reporter plasmid and activation decreased the closer the Sox site was brought to the 
PORE (figure S.7B, C). This repression effect was even more increased in Rl ES cell, 
which have a higher level of Sox2 protein (figure S.7B, C; Botquin et al., 1998). 
These results demonstrate that repression of Oct4-mediated transcriptional activation 
by Sox2 directly correlates with the proximity of the upstream Sox site to the PORE, 
probably by enhancing the formation of the Sox2/0ct4 ternary complex. 
5.4 Discussion 
Cumulative analysis of Sox-POU partnerships in transcriptional regulation has 
shown that these transcription factors interact in a physical, synergistic manner, as in 
the case of Oct4 and Sox2 transactivating FGF 4 and UTF J (Yuan et al., 1995; 
Nishimoto et al., 1999; Chapter 4). In this chapter I demonstrate that Sox2 and Oct4 
can interact together in regulating OPN in an apparent distant manner, with the Sox 
site located 34 base pairs upstream of the octamer motif-containing PORE. To my 
knowledge, this is the first study that provides a mechanism of Sox2-mediated 
interference of Oct4 activity. 
5.4.1 General models of gene regulation from a distance 
Transcription of genes is regulated by a set of transcription factors that bind to 
promoter or enhancer elements located in close proximity to each other or at a 
distance. Several mechanisms have been postulated to account for transcriptional 
regulation at a distance, including looping, twisting, sliding and oozing (Ptashne, 
1986). 
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The first indication of looping came from studies of gene regulation in 
Escherichia coli. Irani et al. (1983) showed that two operators separated by about 90 
base pairs are required for efficient repression of the gal operon, and they suggested 
that interaction between the Gal repressors bound to this operator could only be 
possible by a mechanism of looping (Gal repressors bound to this operator as one 
possible mechanism of looping. In fact, they reasoned that only DNA looping could 
allow for this type of interaction.). This conclusion followed the observation that 
efficient repression was maintained when an integral number of helical turns of DNA 
was added or deleted between the two transcription factor binding sites, but not when 
the spacing was varied by half integral numbers of turns. Irani et al. (1983) reasoned 
that proteins separated by a distance can interact by simple looping only if located on 
the same side of the helix. This concept has been extended to other regulatory 
elements, like the early gene promoter of simian virus (SV40) and B-globin gene 
regulation via locus control regions (LCRs) (Takahashi et al., 1986; Bulger and 
Groudine, 1999). In addition to phasing evidence, DNase I fooprint analyses have 
shown that as the proteins bind, the DNA between the sites becomes alternately 
sensitive and resistant to DNase I cleavage at half turn intervals (Hochschild and 
Ptashne, 1986), since the bent DNA becomes differently exposed to DNase I. 
Twisting has been proposed as a model in which conformational unwinding of 
DNA, following enzymatic activity of a binding protein, allows binding of 
transcription factors and thus regulates transcription. This model finds an example in 
the matrix attachment regions (MARs). MARs are DNA regions spanning 250 base 
pairs to several kilobases in length; they are enriched in AT nucleotides and bind to 
nuclear matrix. They often contain consensus topoisomerase II cleavage sites, single-
stranded, kinked and curved DNA and potential binding elements for homeobox-
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containing DNA-binding proteins (Boulikas, 1993). MAR elements are capable of 
unwinding DNA and are thought to play an important role in transcriptional activation 
(Bode et al., 1992). Footprinting studies demonstrated that DNA unwinding often 
presents an aberrant pattern of sensitivity to DNAse I caused by an asymmetric 
distortion of DNA (Basak and Nagaraja, 1998). 
Sliding is a mechanism in which a protein recognizes a specific site on the 
DNA and then moves along the DNA to another specific sequence where it regulates 
transcription, possibly by interacting with another protein. Sliding has been described 
for the bacteriophage T4 gene 45 protein (gp45), which serves as a sliding clamp of 
viral DNA replication and as the activator of T4 late gene transcription (Tinker-
Kulberg et al., 1996). The proliferating cell nuclear antigen (PCNA), the eukaryotic 
functional homolog of gp45, tethers DNA polymerases onto DNA templates in order 
to increase the speed and the processivity of DNA replication (reviewed in Kelman 
and O'Donnell, 1995). These proteins have a central channel large enough to 
accommodate a DNA duplex, with positive charges lining the inside of the channel 
and negative charges distributed along the outside (Kong et al., 1992; Krishna et ai., 
1994), clearly implying their close association with DNA. In footprint analyses, the 
dynamic of DNA-tracking proteins can be characterized by their extreme lability to 
bind a specific recognition element. 
Finally, oozing is a model characterized by the binding of a transcription 
factor to its recognition site and aiding another molecule to bind to adjacent 
sequences, which in tum aids another molecule to bind next to it, and so on, until a 
procession of proteins has oozed out from the initial binding site to the target element 
(Ptashne, 1986). To date, there are no published studies of this mechanism of 
transcriptional regulation. 
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5.4.2 Possible mechanisms of Sox2 recruitment to the PORE 
DNAse I footprint analyses showed the ability of Sox2 to migrate from its 
recognition site to the PORE (figure 5.6). Strong Sox2 protections were found in three 
different areas: the Sox2 consensus binding site (site A); a sequence downstream of 
site A, representing a partial Sox2 recognition element (site B), and an AT rich region 
30 base pairs downstream of the PORE (site C). In addition, the region between site A 
and the PORE was moderately but specifically protected even in the presence of the 
lowest amount of Sox2 protein. This low protection area was probably due to a low 
binding affinity of Sox2 to these regions. Moreover, mutating site A abrogated the 
ability of Sox2 to migrate out to the PORE, indicating the potential of site A as a 
loading site for Sox2 proteins. 
In EMS As, Sox2 multiprotein complex formation was also dependent on the 
Sox consensus-binding site (Site A), confirming the data obtained in DNAse I 
footprint analyses (figure 5.7A). Reducing the distance between site A and the PORE 
was shown to directly correlate with a decrease of the OPN enhancer activity (figure 
5.7B, C). 
Footprinting assays of the oozing mechanism should result in a uniform, 
overall protection pattern of the DNA. The degree of protection may constantly 
decrease with increasing distance from the initial binding site due to incomplete 
traveling of the proteins along the DNA. According to earlier reports of sliding 
(section 5.4.1) protection offootprinting assays is less pronounced due to the dynamic 
of the DNA tracking protein. In twisting and looping however, patterns of protection 
are interrupted. The pattern of the DNase footprints presented in figure 5.6 supports 
the notion that Sox2 reaches the PORE by the mechanism of sliding or oozing as 
shown in figure 5.8. The oozing mechanism is supported by the fact that the 
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Figure 5.8 
Mechanistic model applicable to sliding or oozing 
A Sox2 molecule binds to the consensus Sox binding site upstream of the PORE. In 
the case of oozing this would then enhance another Sox2 molecule to bind next to it, 
etc. In the case of sliding the model would look similar, but the Sox2 molecule would 
slide along the DNA towards the PORE making the consensus Sox site available for 
another molecule to bind and slide downstream, etc. For both mechanisms, finally, 
one Sox2 molecule binds to the non-octamer site of the PORE, which was made 
available by the less stable Oct4 dimer. 
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Sox Oct4 on PORE 
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protection along the DNA is fairly strong and not labile. Furthermore, proteins that 
slide along the DNA have so far only been reported as those which have a central 
channel that accommodates the DNA duplex and, to my knowledge, they have not 
been reported to bind as MPCs to DNA. Nonetheless, it is very difficult to distinguish 
between the mechanisms of sliding and oozing in biochemical experiments. One 
experiment that might shed light on which of these mechanisms best explains the 
results presented in this chapter would be to determine whether the upstream Sox site 
(site A) cross-linked to a Sox2 molecule would still allow Sox2 proteins to reach the 
PORE. Sliding would not be possible, since the anchored Sox2 molecule cannot move 
along the DNA anymore, but it might still be able to assist another Sox2 molecule to 
bind next to it and thus ooze to the non-octamer part of the PORE. 
5.4.3 Repression mechanism by Sox2 
In this chapter, the mechanism by which Sox2 mediates repression of the Oct4 
dimer activity on the OPN gene was identified. The repression requires a Sox2 
binding element upstream of, and within the PORE. The upstream Sox2 site serves as 
an initial stable loading site for Sox2 protein recruitment to the DNA. This initial 
loading site then allows other Sox2 proteins to bind next to each other as described in 
the oozing model, or might allow Sox2 to stably anchor to the DNA and slide along 
the DNA until it reaches the PORE. The upstream Sox site is necessary for the 
initiation of multiprotein complex formation. On the PORE, Sox2 cooperatively binds 
to Oct4 forming a ternary complex with the DNA. The Oct4 homodimer and the 
Sox2/0ct4 ternary complex bind to exactly the same binding site. Binding of the 
ternary complex is favored over the homodimer as the former is more stable. 
Repression is indirect, since Sox2 forms a ternary complex with Oct4 thereby 
preventing physical access of the activating Oct4 homodimer to the PORE. 
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Furthermore, repression is Sox2 specific. Neither Sry nor Sox9 repress 
transcription of a downstream reporter in the context of the OPN sequence. Functional 
cooperation of Sox and POU proteins is not haphazard, as particular Sox and POU 
factors form partnerships. For instance, on the FGF4 enhancer, SoxlO functions best 
with Tst-I/Oct6/SCIP and Soxll with Brn-l and Brn-2 depending on the location of 
FGF4 expression (Kuhlbrodt et al., 1998b). 
5.4.4 Sox2/0ct4 interaction on a submolecular level 
Sox2 recognizes the non-octamer site of the PORE while Oct4 binds to the 
octamer site. The binding requirements of the ternary complex on the PORE are 
different than those on the FGF4 enhancer element. On the OPN intron, both 
respective binding sites were closer to each other (compare sequence FGF4 
TCTTTGTTTGGATGCTAAT (Yuan et al., 1995) and OPN PORE ATTTGAA 
ATGCAAA T). The spacing between Oct4 and Sox2 binding sites on the PORE 
resembles that of UTFJ (CATTGTT ATGCTAGT) (Nishimoto et al., 1999). Like on 
the FGF4 enhancer element, the assembly of the ternary complex on the PORE 
depends on a specific spatial arrangement of both binding sites. In the case of OPN, 
the insertion of one nucleotide between both binding sites interfered with the 
formation of the ternary complex. In Chapter 4 of this thesis I described how Sox2 
interacts with Oct4 through two separate surface patches, whereas the same surface 
patch of Oct4 is involved in the interaction. The sequence analysis suggests that Sox2 
and Oct4 interact in a UTF I-like manner on the PORE, but this still remains to be 
shown. 
In conclusion, this chapter presents evidence of a new mechanism of Sox2-
mediated transcriptional regulation. The results reveal that Sox2 reaches the PORE by 
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migrating along the PORE through a mechanism of sliding or oozing and forms a 
remarkably stable ternary complex with Oct4. This prevents Oct4 dimer formation on 
the PORE and consequent OPN transcriptional activation. These findings may be 
used to identify other target genes regulated by Sox-POU partnerships, particularly 
those that harbor a Sox site at a distance from the octamer motif. 
5.4.5 Addendum 
In order to clarify some interpretations of the results in this chapter the 
following section is added to the discussion. 
A misunderstanding might arise concerning the role of the Sox2 molecule at 
its binding site 34bp upstream of the PORE as well as one the PORE. First, I want to 
discuss activation mediated by the PORE (DM) and mutations thereof, in the next 
paragraph I will discuss these results in relationship to protein binding. In a set of 
experiments, the Oct4 monomer can bind and activate reporter gene expression via 
the upstream PORE. This was shown by cotransfection experiments with Oct4 
expression vector and reporter plasmid with dM driving the luciferase gene (figure 
5.1 and Botquin et al., 1998). The Oct4 dimer activates transcription much more 
effectively (cf. sDm and sdM in figure S.lC). The Oct4/Sox2 heterodimer also 
activates transcription, but not as efficiently as the Oct4 homodimer (Yuan et al., 
1995; Nishimoto et al., 1999). Thus, the Sox2 itself is not a repressor, but its presence 
results in a net reduction in transcriptional activity if Sox2 is allowed to bind the 
PORE, since the Oct4/Sox2 heterodimer competes for the same binding site as the 
more potent Oct4 homodimer. The activating effect of Sox2 on transcription can also 
be seen when SDm is cotransfected with the Oct4 and Sox2 expression vectors into 
293 cells (figure 5.1 C). The more Sox2 vector is added to the cotransfection the 
higher the transcriptional activity becomes. Sox2 can bind to its binding site 34bp 
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upstream of the PORE, but not to the PORE. Thus, it helps activating transcription 
from its distal site, but does not compete for binding to the PORE, where the Oct4 
dimer can display its potent transcriptional activity. 
This interpretation is in agreement with all EMSAs shown in this chapter. The 
Sox2 can bind to the PORE, even without the distal Sox site, although it binds more 
efficiently when the distal PORE site is present (figure 5.2 cf. lanes 3 of DM and 
SSDM). The higher stability of the Oct4/Sox2 heterodimer compared to the Oct4 
homodimer on the PORE (figure 5.5) is also in agreement with the functional data: 
when Sox2 is expressed, transactivation of genes regulated by an SDM-type element, 
such as OPN, might have to be downregulated just in this manner - not ceasing 
expression altogether, but ensuring that it is reduced. Reduction of transcription is 
thus only achieved, if the less active heterodimer is more stable on the PORE than the 
more active homodimer. It is unclear at this stage, if another transcription factor or 
cofactor is required for further downregulation. 
The question remains how Sox2 binds to the PORE. Fact is that the presence 
of the Sox site 34 bp upstream of the PORE somehow assists Sox2 recruitment to the 
PORE (figure 5.2cf. lanes 3 of DM and 5SDM; figures 5.5, 5.6 and 5.7). After 
additional analysis of the results I think looping or bending can be ruled out since, 
according to Irani et al. (1983), an integral number of helical turns of DN A has to be 
present between the two sites involved. This would be roughly the case for the Sox 
site and the PORE in the non-mutated SDM, which are 34bp apart. It could also be 
possible in the case of the 11 SDM construct, in which the two sites are II bp apart. In 
5SDM though, there is only half a helical tum between the Sox site and the PORE. A 
number of EMSAs have been performed with this construct and the cotransfection 
experiments (figure 5.7) show that Sox2 has a negative effect on downstream gene 
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expression of 5SDM, as is the case for 11 SDM and the non-mutated SDM. Thus, 
sliding or oozing appear more likely, as described and discussed in section 5.4.1 and 
5.4.2 of the discussion in this chapter. 
All results in this chapter were obtained by transfection and band shift assays. 
Certainly, there is no guarantee that Sox2 and Oct4 have the same effect on the 
endogenous osteopontin expression in cell lines and in the developing embryo. What 
points towards a net reduction of Sox2 on osteopontin expression, though, is the fact 
that the expression levels of Sox2 and osteopontin are inversely correlated. 
Osteopontin has a higher expression level in F9 than ES cells and Sox2 has a higher 
expression level in ES than F9 cells (figure 4.6 and Botquin et al., 1998). 
Furthermore, the protein levels are also inversely correlated during the early phase of 
development. One feasible explanation for this inverse correlation is that Sox2 has a 
negative effect on osteopontin expression, thus the higher the Sox2 expression level 
the lower the osteopontin level would be, and vice versa. Net reduction, as discussed 
above, would be in agreement with this explanation, but would need to be further 
substantiated by alternative assays. One possible way would be to use a system, with 
which Sox2 could be inducibly expressed. This would allow to monitor the effect of 
Sox2 on the endogenous osteopontin gene and, even more interestingly, on stem cell 
fate. 
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The work presented in this thesis supports earlier findings that transcription 
factors mainly act in combinatorial control with other transcription factors. This 
provides a means to integrate responses to a variety of signals using a limited number 
of transcription factors. More specifically my work focuses on how interaction 
surfaces on transcription factors increase the versatility of this family of proteins. 
6.1 Transcription factors have multiple interaction surfaces 
With the research I conducted and presented in this thesis I contributed to the 
concept of multiple interaction surfaces on transcription factors as an integrative 
approach to define the principles underlying differential complex formation on DNA 
(Tomilin et ai., 2000; Remenyi et ai., 2001; Chapter 3 and Chapter 4 of this thesis). 
The structures of the Oct! POU factor in complex with the MORE and PORE 
demonstrate how the same transcription factor can form unrelated arrangements using 
different, non-overlapping surface patches for domain-domain association (Remenyi 
et ai., 200 I). Each arrangement is induced by the specific positions and nature of the 
four protein segments binding to the respective DNA element. The resulting 
heterotetrameric arrangement of the POU dimers allows two alternative 
conformations of the POU molecules, one across the longitudinal center of each DNA 
response motif and one within each half-site. However, the crystal structures 
demonstrate that each complex reveals only one conformation, using two distinct 
interaction surfaces for the PORE and the MORE on both POUs and POUH. On the 
MORE the molecules bind across the center of the DNA element, whereas they each 
bind to one half-site on the PORE. In Chapter 3 I now propose that in the case of the 
POUI dimer interacting with OBFI on the PORE, the POU molecules are located 
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across the longitudinal center (similar to the MORE) but with the molecular 
interactions and subdomains being arranged as on the PORE. 
Sox2 is another example of a transcription factor with more than one 
interaction surface (Chapter 4). Like for Oct! different patches of the C-tenninal part 
of the HMO domain interact with partner transcription factors. Octl as well as Sox2 
depend on the specific DNA sequence to bring the interacting surface patch into 
position. 
6.2 Interfaces interact with more than one type of transcription 
factor 
These surface patches can interact with those of other members of their family 
as well as with surface patches of members of other transcription factor families. This 
results in a combinatorial variety that could enormously increase the complexity of 
the transcriptional network (Tomilin et al., 2000; Remenyi et al., 2001; Chapter 3 and 
Chapter 4 of this thesis). For example, the POUs interface, which can interact with the 
POUH of the second molecule on the PORE can also interact with Sox2. Interestingly. 
when interacting with Sox2 the same interface of POUs is in use on the F G F 4 
element as on the UTFJ promoter. The comparison of the UTFJ sequence with that of 
the PORE and preliminary data suggest that Sox2/0ct4 heterodimerization on the 
PORE resembles that on UTF 1. Furthermore, the interaction surface of Sox2 with 
Octl and Oct4 on FGF4 seems to resemble that of Sox2 with Pax6 on the DeS 
element in the ~-crystallin promoter. Specifically, it subsumes that various 
combinations of transcription factors are possible, along with the potential of some of 
these proteins to interchange their quaternary DNA-mediated arrangements via one of 
multiple surfaces capable of protein-protein interactions (e.g. figure 4.7). Therefore. a 
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certain dimerization surface patch appears to be adept at mediating Velcro-like 
surface interactions with different interacting protein partners in a versatile fashion. 
6.3 Surface patch interaction with cofactors 
The interaction surface that is not being used in an Oct-dimer becomes 
exposed to the exterior of the protein (Remenyi et ai., 2001). Thus the unused 
interface is accessible to other factors. As shown on the example of OBFl binding to 
the Octl dimer on the PORE, cofactors can get recruited to these available surface 
patches (Chapter 3). On the PORE as well as on the octamer motif, OBFl interacts 
with the same POUs surface patch as POUH does on the MORE. Since POUH 
engrosses the POUs surface patch, OBFl cannot bind the MORE-type Octl dimer. 
In addition to binding transcription factors, cofactors can also severely change 
the properties of that specific dimer. OBFl, for example, enhances Octl dimerization 
on PORE-like sequences. It loosens the sequence's stringency the heterotrimer can 
bind to, in terms of the sequence of the two Oct-binding sites and the spacing between 
them. Furthermore, OBF 1 dramatically stabilizes the Octl dimer on the PORE and 
thus reduces its off-rate tremendously. 
6.4 Different transcription factor combinations can bind to the same 
binding site 
In addition to the fact that different transcription factors can bind to the same 
interaction surface, this may also happen on the same binding site. With the example 
of the PORE a binding element was revealed, on which Oct factors may 
homodimerize, Octl even with the cofactor OBFl, and also heterodimerize, as is the 
case for Oct4 and Sox2 (Botquin et ai., 1998; Chapter 5). Homodimers and 
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heterodimers compete for the same binding site. On the PORE, regulating the 
expression of Osteopontin, this results in activation of expression when the Oct4 
homodimer is bound and repression of the Oct4-mediated activation when the 
Oct4/Sox2 heterodimer is recruited to the element. In this case it is specifically 
interesting to observe that an additional Sox binding site upstream of the PORE is 
required for Sox2 recruitment. The data presented in Chapter 5 are in agreement with 
the model that Sox2 is recruited to the PORE from the upstream Sox binding site by 
oozing, a mechanism that so far has only been postulated. 
As such, the studies presented in this thesis provide insight into the adaptive 
mechanisms used by this set of transcription factors to assume a regulatory stronghold 
on various complex processes during mammalian development. 
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